ClickCease
+1-915-850-0900 [email protected]
Select Page
Podcast: Metabolic Syndrome Explained

Podcast: Metabolic Syndrome Explained

 

Metabolic syndrome is a collection of risk factors that can ultimately increase the risk of developing a variety of health issues, including heart disease, stroke, and diabetes, among other problems. Central obesity, high blood pressure, high blood sugar, high triglycerides, and low HDL are the 5 risk factors associated with metabolic syndrome. Having at least three of the five risk factors may suggest the presence of metabolic syndrome. Dr. Alex Jimenez and Dr. Mario Ruja explain the 5 risk factors associated with metabolic syndrome, in further detail, as they recommend diet and lifestyle modification advice and guidelines to help people with metabolic syndrome improve their overall health and wellness. From eating fiber and staying hydrated to exercise and better sleep, Dr. Alex Jimenez and Dr. Mario Ruja discuss how diet and lifestyle modifications can help improve the 5 risk factors associated with metabolic syndrome to ultimately prevent the risk of developing a variety of other health issues, including heart disease, stroke, and diabetes. – Podcast Insight

 


 

[00:00:07] And we are live. Yes, we are. Hi, this is Dr. Alex Jimenez. Today we’re gonna be talking with Dr. Mario Ruja. We’re here together today. We’re testing out a new technology of head to head conversations regarding the whole process. Mario, how you feeling, baby?

 

[00:00:24] Feeling incredibly metabolic, Alex.

 

[00:00:29] Yes, really metabolic. I’m about to go through this mic right now. That’s what I’m talking about. Hey, we’re here.

 

[00:00:37] Mario and I are, you know, we’re gonna be hitting you every day. Every week. Every time we can. As much as we can. We’re gonna be going through the airways. Yeah. And we’re gonna be using the new technology to discuss exactly what we’re up to. Today, we’re focusing on an interesting disorder called metabolic syndrome. Many of you have heard the word. But really, you know, tying in exactly what it is that we’re talking about requires kind of elaborate conversation. You’ve seen it in many pictures. Mario, you can pop up the picture there PIP and you can see that a lot of times people see this gut thing going on. And that’s one of the components of it. Metabolic syndrome, when you break it down is ultimately and people notice it when they go to their doctors. Doctors are very good at assessing clinical assessments at the point where they show up in the lab work. Now, metabolic syndrome is one of these issues that many people have. And when they’re diabetic, well, they are pretty much in that range already.

 

[00:01:39] But before it happens, the body can stray into a metabolic area where a lot of times, for example, if your blood sugar is over 100 and you’re starting to feel like really bad, your bellies are really large. We need to have some parameters to determine it. But most people end up having metabolic syndrome and just feeling like crap. So the idea behind this process and understanding what metabolic syndrome is, understanding that there are some underlying pathologies with it. So what we’re going to talk about today is we’re going to talk about issues that are related to it. Now, in the areas of diabetes, we have, you know, complicating issues such as sleep apnea, large waistline, people who take metformin, liver disorders, nonalcoholic delivered diseases that we have heard of all fall under the realm of metabolic. But we have certain criteria that we can do that actually determines what metabolic syndrome is. Now, Mario, you’ve noticed some things regarding blood pressure. Yeah. Now, if you can show the PIP and when we see this, we can actually determine if you can kind of explain that a little bit.

 

[00:02:44] Yeah, it’s very simple, when you’re looking at blood pressure, your whole system. When you are out of balance in terms of your sugar, Alex, and your gut is overflowing your belt and you have issues tucking in your shirt. Now that blood has to pump hard. It has to work as a turbo. So what happens is this, at that point, this is what we call the breaking point. Anything over 140. OK, and over 90.

 

[00:03:27] Systolic, diastolic. Now you’re running into problems that that engine has so much pressure to make up for the resistance.

 

[00:03:38] Yeah, OK. Yes. The overweight, the diabetic factor, the inflammatory factor. You’re talking about triglycerides over 150. You’re talking about type 2 diabetes. OK, again, type 2 diabetes, basically, you know, you’re not born with it. It’s something that you create. You create that diabetes. Where that insulin is out of balance. And now you’re talking about, again, a very large waistline, abdominal obesity. So a lot of times if you look at people, Alex, they look great.

 

[00:04:16] From the chest up. Yeah. And that mid-abdomen. That torso is scary. Yeah. Yeah. It’s a showstopper, as they say. OK. So this is where the high blood pressure comes in because again, that abdominal aorta, that pressure on it puts so much pressure that it goes above 140 and sometimes it goes over 180, which is like critical, critical. And again, with these characteristics, again, it creates abdominal cholesterol. It creates blood glucose over. We mentioned that over a plus 100 and again, high blood pressure connected with what stroke? So you have triglycerides.

 

[00:05:15] Clogging up. Triglycerides and yes, this is huge when the arteries clog up.

 

[00:05:21] Yeah. We have an issue with ultimately all the roads metabolically lead to the liver. Right. So one of the things that we’ve noticed is that when we assess the liver, sometimes they look pretty good and the symptoms may be highly elevated. There’s a huge range of liver enzymes. But what we’re noticing is that if we start having a blood sugar that is elevated. If we start having enzymes, if we start having disorders like what we call nonalcohol, this was a new disease that actually just came aboard. We always knew about alcoholic liver disease or cirrhosis. Now we have nonalcoholic liver cirrhosis and liver disease. Now, how did that happen? Because our sugar was too high and the triglycerides add these fats into the fat level of the liver and start actually destroying the liver. So we started having this disorder and it’s a huge issue, as you indicated, when we start having HDL levels and that which we measure, we start noticing greater levels in 40, lower levels than 40 for men and 50 for women. We start noticing little trends. We also start noticing abdominal obesity, high blood pressure. There are other areas like ovarian cysts.

 

[00:06:35] Mario, you’ve noticed that there are other areas that are indicated that are collaborative or even equal or what we use to determine metabolic syndrome.

 

[00:06:44] What are the ones you have noticed? The two major ones where we’re looking at the studies that you see. I’m going to pull this up for you. So we can kind of get a grasp on that. We’re looking at two just very simple.

 

[00:07:04] Let’s make things simple for the listeners and viewers. Number one.

 

[00:07:11] Right away. You’re talking about.

 

[00:07:15] Abdominal obesity. OK, that’s number one. Number two, insulin resistance. So what happens is that your whole sugar balance within your system is not tolerating, the insulin is not effective in your body. So this is where people, Alex, are always hungry and are always eating. And so what I call it. It’s almost like you’re overeating and you’re starving at the same time. Yeah. Because that sugar is in your blood vessels. Okay. And it’s not being taken into the cells. So the cells are starving. But your whole body is overeating. Does that make sense?

 

[00:08:01] Mario, you know, in your practice. Like, how many people? What percentage of people? Do you notice that even have metabolic syndrome?

 

[00:08:10] Just a scan and again, the literature says 23 percent of the population now, I would say and in our past community here, I would say at least double that to 40 to 45. And it’s really, really a point. This is why we’re here today. You know, we’re here to educate, inspire and most of all, give people simple understanding and solutions on what to do. And one thing that I can tell you with a lot of my patients, number one, increase your fiber intake. Like, eat more vegetables. You know, I tell them that. So what do you eat? Yeah. OK. You know, so, I mean, you come in and people want to get on treadmills and they want to climb mountains. They want to do burpees. It’s like, yeah, you know what? You’re 100 pounds overweight. Those burpees are going to kill you. Okay. You’re going to wake up tomorrow morning. You can’t get out of bed. So the major factor to really start to address this is not getting in and starting a workout in gyms. First, we’ve gotta handle and we need to really educate the public on, the food intake is the solution. That is the primary solution. Medicine of the body. The food is primary medicine. And this is what we’re talking about, becoming more vegetarian, increasing fiber, reducing alcohol intake. I know I’m hurting some folks right now. Yeah. Yeah. And the point is, you know, again, reducing. It doesn’t say, you know, if you want to have a beer or something, that’s great. But again, let’s be mindful. This metabolic syndrome is a beast. OK.

 

[00:10:07] It’s a beast that’s affecting our parents, our grandparents. And now, Alex, I can see these patterns in elementary school kids, OK? And what they’re eating, they’re eating a lot of sugars, right? They’re eating a lot of fast foods, processed foods. This is one thing like right now I’m looking at you and you’re drinking this green. Green, you know?

 

[00:10:32] Yeah. There you go. Yeah.

 

[00:10:35] It’s like a jolly green giant drink. OK. That is a live food. It’s uncooked. It’s raw. The vitamins are there. The nutrition is there. It’s not denatured. OK. Anytime we cook food, you kill it. Right. Anytime you bottle it up and you preserve it for a month and two months.

 

[00:11:02] I can tell you right now, you are not eating live. So the rule that I share with my patients and when I do seminars all over the nation and people invite me over, I say, look, if you want to be alive, why are you eating dead? Simply, why are you eating dead? Right. And like right now, you know, let’s make it simple. Number one, increase hydration. Right. OK. Have a gallon of water or more is a must. Excellent. That’s number one. Number two, increase live foods. Live foods are what? Vegetables. Fruits, right? Juice them. Eat them.

 

[00:11:38] I mean, from what I understand and what I do is that everything leads to, any sort of nutritional component, whether it’s a treatment for diabetes or a treatment for, let’s say, rheumatoid issues when there is a nutritional component, many times it’s hard getting the foods that you need. So the world has turned on smoothies. Smoothies can date different formats. And these smoothies, as we work them, ultimately have the solution. Now, what kind of smoothies? What’s the best type of approach with them? Well, we have that stuff in terms of awareness in our offices and gladly we’ll share that stuff whenever it’s necessary. However, the reason is that those inner parts of the cells, those living enzymes, those DNA molecules, those proteins, those…

 

[00:12:37] Actually, probiotics, even in the fiber, prebiotics, because when you do these smoothies or even do juicing that fiber you eat, that fiber that sometimes is lost while you do it juicy, juicing. This is important for the bacteria. So that helps even with disorders, such as leaky gut or intestinal dysbiosis, because they all come together. Someone who has metabolic syndrome most likely has leaky gut and vise versa. And not every single time, we can assess that, but what we want to do is we want to assess a person completely in terms of the drugs. You pretty much know that your doctor is trying to get you away from diabetes because you’re in that losing control place when you’re taking metformin.

 

[00:13:20] Metformin is very powerful, it’s a special medication that ultimately guides to restores the blood sugar back to where or it makes it more effective or makes you less insulin tolerant and more sensitive. So there’s a lot of things that we’re looking at that are useful for us. But one of the things is, well, what am I going to do with this?

 

[00:13:41] How am I going to get better? Well, diet? Diet has everything to start with. You start with your diet. You start with being vegetarian. You start with Mediterranean style foods. What kind of techniques do you use in terms of diets? Because I can go off and explain those things. But I want you to kind of get. Simple.

 

[00:13:56] You know, simplicity is golden. Complexity is chaos, Alex. The more complex we make it for ourselves, the more likely it is that we’re going to quit. OK. You can’t sustain complex things. We need to make them simple. So number one, as much as possible, eat raw, eat live foods. That’s number one. Number two. Number two, stop eating processed things like you’re talking about like high corn sirup, like simple, stop drinking Cokes and all of these fruity drinks and everything else, you know. And it tells you right there on the bottle, right there on a can. It’s 10 percent fruit. Do you know what 10 percent means? It’s not 100 percent. There’s a missing zero, baby. OK. It’s missing. So you know what? After a while, you’re gonna be missing off the planet. OK. You’re going to be extinct. Yeah. So, yeah. We need to get real, you know, this is real stuff. Like I can tell you, you know, I visit, I do home visits sometimes because I give back to the community and I go to families and I sit there and, you know, people are losing legs. People are losing limbs. They have wound care, you know. They have, you know, they have issues in terms of that. And that’s painful, not only for the person but for the whole family. So you know what? I take this very seriously. We take this very seriously at the show. You know, we want to make it live. We want to make it interesting. But I want to tell you right now, I’m not playing games. This is not game time. This is showtime. And so in terms of that, get off the Cokes, get off the fruity drinks, get off the candy bars. OK. You know, I think that commercial with Snickers, they need to change that. You know, instead of the Snickers satisfy, how about the Snickers gonna kick your ass? How about that one? Yeah, yeah. I said it. Thank you. I think we are physicians so we can say that word. Right. So that’s what’s happening. And then again, the lifestyle. If you’re drinking, the two things I can tell you right now. Yeah. Two things that are going to kick you in your gut, no pun intended. Metabolic boys and girls. OK. Number one is going to be smoking. And number two is going to be alcohol. You do those two.

 

[00:16:16] OK. And here it is. I’m going to tell you what it’s, you know, can you find that on the slide. OK. It’s gonna be the statistic. Oh, here it is. There. Bam, right there. Pull that up. Yeah, ok. Bam. OK. So if you’re looking at that, I’m going to tell you this is scary. Lifestyle factors, the two factors right there. Can you enlarge that? So we can see that. We can do that. OK. Excellent. I appreciate that. That’s all big. There it is. So now watch this. Do you see this? OK. Here it is. The number one life factor right here. Number one, is that? Yes. The one right here? OK. Now watch. I want to circle this. OK, where is it? It’s right there. Tools. I’ll get it for you. OK. Go ahead. Circle that, smoking and heavy drinking. Okay. I just want everyone to kind of take note, smoking and heavy drinking. That is one of the most destructive things that you can do right now. And guess what? Most people do them together, don’t they? Yes, sir. That’s it. So now watch, the ratio that metabolic syndrome affecting the man. OK. This is, again, something new. Mm-hmm. It’s affecting the man less than the women. Do you see that, guys? Yes, I do. Look at that. The women is 4.45. The women are affected most out of everyone. Out of everyone. And the men are at1.85. Now, the lesser evil is heavy drinking and poor diet, and the less one is smoking and physical activity. But if you really look at it, that’s what’s scary, smoking and heavy drinking. And this has really come down to a shift.

 

[00:18:04] You know, you used to be that men smoked and men drink. Now it’s changed, Alex. This is scary because it’s affecting, you know, momma is the boss. And to me, you know, mom is the doctor in the house. OK. And no, I don’t want to take responsibility for the man because you know what? We need to be the head, not the tail, but at the same time, who is going to take care of the kids?

 

[00:18:28] It’s got to be mama. You know, most of the time. Who’s going to take the kids to the doctor? Who’s gonna be wrong? So we need moms healthy. We need moms healthy. OK. We can, you know, because there’s a saying that says this, Alex. When mom ain’t happy. Dad ain’t happy.

 

[00:18:44] Nobody’s happy. No, thank you. Here, even the dog ain’t happy, Alex. He’s leaving now. He’s gone. He’s gone.

 

[00:18:52] I happen to know a lot of, I think after about 40, I think that in general there’s a tendency for the love of wine and it gets a little crazy for a wine to three a night. Yeah. This leads to metabolic syndrome. So we need to. Moderation is key. Right. Yeah. So we’re going to you know, if you’re if one of the biggest treatments is cardio, well why give yourself those extra calories and doing their process?

 

[00:19:19] Now one glass is fine. I understand that. But we don’t have to go crazy with the wine in the evening because it’s a more relaxing thing. You know, there’s always women’s night out, right? You know, I mean, it’s shot here, but women’s night out. You know, and when there’s women’s night out. And for many women, it’s a little bit of vino. So we need to kind of cater to those things, shall I say.

 

[00:19:39] And it’s woman’s night out. But it’s not all night, baby, you know?

 

[00:19:42] Yeah, OK. I mean, you know, there is.

 

[00:19:45] Exactly. I mean, you know, let’s have a glass but not the bottle, baby. Come on. Well, you know. Right. If you have 4 people a bottle is OK. OK. I said wine. Okay. I’m sorry. I lost. I lost the meaning of that. Go ahead Alex. Yeah.

 

[00:19:57] So the bottom line is, that we’re here to bring in awareness of this disorder, which is metabolic syndrome.

 

[00:20:05] Honestly, I’ve been going to school for a long time. And this is a new revelation of the last decade.

 

[00:20:12] The gastroenterologist is really focusing on. They’re the first to see it, the dimensions of. And here’s the thing. Crazy metabolic syndrome leads to nonalcoholic, fatty liver disease. And you were seeing this in rampant levels, literally. Gallstones. Exactly. Because the liver, the cholesterol issues, all these dynamic changes are affecting even our children. We’re having kids with nonalcoholic fatty liver disease. Why? Too much sugar? Too much sugar? We have to control the sugars. And there are things that we can do in our diets. Plan on bringing all those concepts.

 

[00:20:46] But we want to bring awareness as to what happens. Lack of sleep, cortisol raising, you know, all this kind of stuff alters the blood sugar in our system. So it’s very important to do the best we can. Exercising is awesome for this stuff in terms of cardiogenic exercises, cardiometabolic dynamics, though. That’s where we want to still focus on. We have to do a little bit of cardio. We got to, you know, eat more of vegetables, greens, juicing, those kinds of things sleep better. It’s important to sleep.

 

[00:21:15] Alex. Oh, OK. I want to jump in because I know we’re jumping here, you know, and people and I like the fact what you mentioned earlier, you know, we want to, you know, get some wine and some things to relax. Why don’t we do this? I encourage people to meditate. OK. And to try to create some stress management strategies. OK. Right.

 

[00:21:38] Like a nice, you know, nice warm cup of tea an hour before we go to sleep. You know, some chamomile tea and I mean, you know, chamomile, you know, and.

 

[00:21:50] Yeah. Good stuff. Yerba buena. You know, stuff like that. You heard about it? Yeah. Yeah. So.

 

[00:21:56] So you know, all of these things. Meditation because why? Stress levels, as you mentioned, I’m on one accord with that stress level increase cortisol, which contracts, arterial function and then decreases dopamine.

 

[00:22:13] OK, and oxytocin, which is like the love thing going on. OK. And so now all of this creates sleep apnea. And how many people do you know, Alex, that suffers from sleep apnea and instead of dealing with the causation? OK. So this is why chiropractic is such a beautiful thing.

 

[00:22:35] You know, for 25 plus years, a quarter of a century plus, you know, between both of us, we’re like, gosh, 60 plus years. Correct? Yes, 60 plus years. All right. Chiropractic and chiropractors have such a beautiful story and beautiful platform because we’re all about natural healing and helping our community and our country at very, very cost-effective.

 

[00:23:09] You know, we do one of the most cost-effective ways of not only treating health but preventing health. And we are ambassadors of health. I mean. And so this is where when we’re talking about, again, sleep apnea, meditation, I see so many people in my practice, they’re taking a pill to go to sleep.

 

[00:23:32] Every night.

 

[00:23:34] They suffer from depression. They suffer from anxiety. Okay. And then I look and I go, you know what? Let’s talk about your lifestyle. What are you doing? What are you doing every day to put your body in a high, intense, inflammatory system in high, intense stress? Yeah, you’re redlining. I always tell people. Right now you’re redlining it’s just like a car. You cannot maintain it. You better change gears, otherwise, you’re going to blow the engine. And this is what I see, sleep apnea. Sleep is again, all the way from athletics to life function. That is where the neuroreceptors neuroplasticity, Alex. Okay. That’s where we heal. We recover. We reset for the next fight, which is early in the morning. And if we don’t do that, we go to the next day with that fog. Yeah. You know that mental fog. Alex. Hey, you know, and this is where people say, you know, I can’t focus. I’m forgetting, you know, and I don’t know what’s happening, you know, and I’m going, you know why you’re not sleeping?

 

[00:24:47] Exactly. You know, we’ve done the studies and the studies specifically about sleep. If you’re a person that you need seven hours of sleep and you miss one hour, just one hour of sleep.

 

[00:24:58] The mind is very just speaking about just the brain fog that happens with this metabolic syndrome because it really starts disrupting everything. One hour of sleep actually diminishes your ability to be creative. Creativity. Yes, the brain is altered. And you may think that you know, 25 percent by one hour, it makes a difference. But literally two hours of sleep, you lose 50 percent of your creativity if you lose four hours of sleep. Well, no one of those when you just push it like four hours. Your creativity is so low that even just trying to figure out how to find where your keys are or creativity, how to solve problems, how to deal with issues, you go to work and someone’s got some drama. It stresses you out and metabolically and then what would a lot of people do? You go to work. You jack yourself up with some coffee and then you grab what? Many people grab the donut instantly, send in the blood sugar into chaos. This constant repetitive issue of habits leads to the disorder of metabolic syndrome.

 

[00:26:02] The body, the body. Alex cannot sustain us. You know, you can’t. As I mentioned before, you can’t drive that, that your car in first gear going 80 miles an hour. You cannot. And so it’s going to rip at the seams. The gasket is going to come off. The oil is going to spray out. OK. And this is what’s happening. If you really look at the body, we look at the HDL cholesterol, it’s lower than 40. They should be the highest, high density.

 

[00:26:33] High density should be the highest. Cholesterol, good cholesterol stuff.

 

[00:26:37] You know, you want, LDL should be low and the HDL should be high. You’re looking at insulin. You’re looking at strokes. You’re looking at again, you know, triglycerides over 150, you know, sleep apnea again, more than ever. Now I’m hearing about it. Polycystic ovaries. I just hear this, you know. You know, I have another surgery. You know, I have cysts.

 

[00:27:04] I have this with all of these things. If we really look at it, we are seeing that we are pushing ourselves over the cliff. Yeah, OK. And then I’m going to throw this in there with the onset of overuse of cell phones by adults and by youth. Now it is disrupting the cognitive pattern, the focus pattern. And it’s throwing people where they don’t go to sleep because they have a cell phone in front of them at 11 o’clock at night in bed. You know, and then you’re talking about like one hour less than two hours. Well, let me tell you, the worst thing you could do, Alex, is have your cell phone next to your head with the radiation, with the sounds every time that phone beeps. Tweaks a bell, sounds for an email or your Facebook. Guess what your subconscious in your brain does? It wakes up. It wakes up and bam, it blows up.

 

[00:28:11] That REM sleep you only have. What is it, Alex? What, ten, 10 minutes, less than 15 minutes, of REM sleep? Oh, there’s a lot of. What is it?

 

[00:28:20] What happens is the body goes into a bunch of different stages as it does. What we’ve learned over the years is that we used to believe that REM was something intermittent. It goes into these deep, deep levels throughout the night.

 

[00:28:31] Your body temperature, what your blood sugars at, what’s your mental state, what’s your tired levels is, what your electrolyte balance is. This matters. So sleeping is very important. So in the restoration of your body through to get it back in order. Sleep is one of the greatest ways to be able to restore the body. So it’s important to try to you know, if you go to bed at 10, push yourself to start working the process, to go to bed probably about an hour earlier or start working. And the TV is going to be there. They’re going to keep on going 24/7. But, you know, we’re the ones dealing with the issue later on in the next day where we are brain doesn’t work well.

 

[00:29:10] Our bodies are needing carbohydrates, our foods are. And don’t eat, you know, and put yourself on one of the things that I encourage. Again, my children and, you know, Karen and the kids. Is this. Put your cell phone in the kitchen and get a real alarm clock. I don’t think they make them anymore, do they? They don’t make alarm clocks anymore. Now, forget it. What’s an alarm clock? It’s kind of like a pager, Alex. You know what? We’re gonna get to the point where we’re going to say, hey, do you have an alarm clock? And I go, now I’ve got a pager. All right. Okay. It’s ridiculous. We need to have a phone in the kitchen. You remember back in the days with that long cord. About like 80 yards. You used to take it in your room for those private sessions, you know, with your girlfriend and all of that.

 

[00:29:58] Well, let me tell you, that cell phone needs to be in the kitchen. It needs to be turned off. Okay. And then you need to have an alarm clock next to your bed. You need to honor sleep. You cannot eat foods before you go to sleep. Go to sleep hungry.

 

[00:30:16] One of the things that I’m reading more and more in terms of research and in terms of data. Go to sleep, hunger, you’re not going to die. All right. Calm down. Well, I know what you’re talking about. Yes. Intermittent fasting. Absolutely. OK. Yeah. Yeah. You can’t. I mean, at the end, you know, let’s say 8:00. That’s enough. Put the burger down.

 

[00:30:35] Yeah. Look at that. You know.

 

[00:30:37] You know, 300 years ago, we would be we many of us were nomadic. You know, people live culturally on the sides of the earth. And the terrain was different. We got the food during the daytime. Nighttime was a time when you kind of just, you know, settled in. All right. If you did, have you had some grains, some nuts, and it was different. So just by using the sunlight in order to kind of like you, as soon as the sun comes up, you can eat and shut off at night if you get really good and you start using what we’re learning, that is a great method, which is intermittent fasting. The body has the ability to rectify itself. This is an amazing, metabolic syndrome or not. The body even activity stream has the ability to rectify itself.

 

[00:31:23] So if you allow the body to cleanse itself throughout the day, let’s say you do an eating cycle of only eight hours on a window, so to speak. Well, you got a good, you know, 16 hours of what period of where your body breaks things down. Well, the metabolic processes of the breakdown of usually the mitochondria, the mitochondria, as it starts working, the process needs to rest. Our bodies need to rest. I mean, if I told you to cut the grass, Mario, you know, cut the grass. And as soon as you walked in the house and you were done and I gave you some lemonade and you were just kinda, that was rough. And I said, go back and cut it again. Right. And then also you go back out and you’re like, wow, this is crazy. When what kind of guy? And then right when you’re tired and you’re shaking because you have no energy and you’re about to go to bed. All right. And you go get up because you’re gonna go cut the grass again and you never let the body rest. Eventually, your body breaks down. That’s what happens with mitochondria. If you’re constantly eating, you’re constantly going through a process, burn out, burning, burning and burning. It needs time to settle and relax, to recover. And that’s what metabolic syndrome recovery process is. Do we try to calm the body through sleep, through lifestyle changes, through blood sugar issue changes? And little by little, we’ll start getting back control of your life because otherwise you have increased steroid or what we call a cortisol steroid production, which then makes the body store fat. Right. And then that’s where you get the belly issues because one of the first indicators of metabolic syndrome is a big belly. Right. For a woman, it’s over a certain amount, over 35 inches. And for men, anywhere over 40, that’s a lot of people over 40 inches. You pretty much have a kickoff towards metabolic syndrome.

 

[00:33:00] And how many times have you heard in your practice, Alex? You know, people come in and go, you know, I just need to lose weight. I just need to lose weight. And, you know, I look at him and I go, you know, forget about the weight.

 

[00:33:14] What are you doing?

 

[00:33:15] Are you sleeping well? All right. Right. Exactly. I mean, first. I mean, let’s forget about the weight. The body knows how to calibrate, Alex. It knows how to calibrate. It knows the zone, the sweet zone, the target zone. It knows genetically DNA, RNA. We have an innate intelligence. OK. We learned this in school and chiropractic school.

 

[00:33:38] The body has innate intelligence to know how to heal, to know how to recover, to know how to grow. And to know how to survive when we put undue stress to our system, to that fiber optics, to that circuit, we blow it and then it goes a wall. And that’s what happened. So I tell people, you know, no, the answer is not for you to go to a gym for 20 hours a day. No. Why don’t you start with letting go of high corn, syrup high fructose corn, syrup drinks?

 

[00:34:17] Why don’t you do that first? That’s what I tell them right away. Do that first. Number two, eat more fiber. What does fiber mean? Eat more legumes. Spinach, OK. Like broccoli. And instead of cooking them. And I know most people don’t want to eat raw. Why don’t you just steam them? OK. Just kind of steam them a little bit. OK. Don’t fire. Don’t kill them. Steam them. The other thing you want to do is, you know, get up on a Mediterranean diet, you know, fresh seafood, things like that, regular exercise, just get up in the morning. The first thing that I would share with people is just make things simple.

 

[00:34:53] Wake up when the rest of the animals wake up, OK? Wake up. And just go for a walk.

 

[00:35:02] At least, you know, let’s not get on a treadmill and break a record, OK? Let’s not do that because you’re gonna do that twice. You’re gonna get hurt and you’re gonna quit for the next three months to recover. So why don’t you just get up and walk? And then next time walk a little more and walk a little faster and next time walk a little faster and jog. So we need to create that patterning, rituals. We need healthy rituals, Alex, in our lives instead of rituals that are killing us slowly. OK. And so in terms of that, I look at eating more fresh vegetables, Mediterranean, sleep better and honor that sleep. Get up earlier, get up before 5 o’clock. OK. Get up. Get into a routine that way when you when you’re not sleeping late. OK. Your body’s tired. So now you can go to sleep at nine-thirty, at ten o’clock, OK. And then create a new pattern to where you let go of the cell phone. And I would say, you know how people do like fasting or cleansing. I recommend at least two cleanses a year, two cleanses a year. You know, stop eating meats.

 

[00:36:15] OK. Stop eating meats.

 

[00:36:17] And just go vegetarian. Okay. Let your body cleanse, I know you have wonderful programs at your clinic. Alex, in terms of detox, I believe in that twice a year. You gotta do it. It’s just like flushing your car. Alex Right.

 

[00:36:31] From detoxing. We start we really begin the process at the intestine. So from the things we start eating. So one of the best ways to do it is to go through a detox program and the detox programs help us cleanse it.

 

[00:36:45] You know what? If your garage is full of mud, if you’re you know, you just open the garage, you see it’s just a mess and your body’s metabolically a wreck similar to a garage as an analogy. Well, you can have a couple of things. The first thing we do is we open up the garage and we got to plunge that garage. We’ve got to get the hose. Or you can take the broom. And you know what? Many times you’ll realize that taking the hose is probably the best thing. So when we do detox programs, we begin by helping with the colon cleanse. And we basically clean out the colon and eventually also repurpose the direction where the probiotics go. We actually add probiotics in the diet. We add the fibers, the prebiotics, the post probiotics. And we start working from the intestine out. The body instantly starts recovering. And little things that we can do in the mornings on a regular basis such as increase water, take a lemon, for example. We start with water. We start with let’s say you squeeze four or five, three lemons, just three lemons, squeeze the juice, put it in a drink that you’re gonna spend all day. Take one whole lemon to squeeze it nice and just take it as a shot. Some people use apple cider vinegar. Exactly. So what we do is we start that well, that goes into the intestines, into the stomach. It is much it just basically showers the liver with a process that begins the process of cleansing as the body starts recovering. You start eating better. You let’s say you do a fast and you begin your process of eating at around 12:00 and you stop at six or maybe seven or maybe eight. And it gives you an eight-hour window, six to eight-hour window and that’s it. And then you start recovering in that process. So early on, we start doing the changes with the beautiful thing about the body if you give it time, it’s all recoverable to do it. And if you teach the body, you don’t have to be taken metformin the rest of your life. Now, if your doctor thinks it’s appropriate, well, then, you know, you speak to your doctor. And here’s the other thing is, is that when you’re dealing with metabolic issues and you’ve got someone that’s giving you metformin and as it or other diabetes or different types of medications that help with diabetes, it is appropriate to have it under a doctor’s control. Now, the constant taking medications without, having lifestyle changes or not having dietary alterations is inappropriate. It’s malpractice, I believe, in my opinion, after being here so long, you just don’t give people pills and not change their diet. You got to have a doctor who’s willing to sit down and help you out with lifestyle changes, diet or someone that has some staff to support you or a dietician or a registered dietetic dietitian. So that can help you or a nutritionist. Sorry. Or a health coach that can help you. We have to have people that can do that. So to help you with the process, because it’s not just saying, hey, take a pill and go off on your own, that confuses a lot of people. We have to have a change and we’re here to help you with that. So as we go through this process over the next couple of weeks, Mario, as we discuss each one of these particular topics, we’re going to bring it to you. We’re going to talk about ways that you can change your diet that simple. Just make it simple and it adapts. So I know you’ve got some points you want to mention again.

 

[00:39:50] Absolutely. You know, with metabolic syndrome, the two things that are markers are number one, your belly fat. OK, so let’s get going in at home. Yeah. Let’s wrap it up. You know, let’s button this thing up and make it simple. First of all, it’s belly fat. So. So if your belt, when you’re buying a belt and you’re looking at the little notches and the little holes and they’re over 40 inches, OK, 40, you’re in trouble. For male. Yeah, for male. And if you’re over 35 for a female, you’ve got issues.

 

[00:40:24] Metabolic syndrome. Absolutely. Absolutely. And the other point is this. If you have a hard time and you can’t even wear a belt, then I don’t need to explain any further. It’s time to come in and get a coach, get a health coach, get someone to make you accountable because time is ticking. Time is ticking and we need to be proactive instead of reactive. And at the same time, when you are always hungry, you’re overeating and you keep being hungry. You cannot lose weight. Now the things are coming to fruition. And on top of that, if you have blood pressure, over 140, over 90. So let’s say 145 over 100, let’s say 150 over 105. It’s time to get real. You can do this. Just go buy a blood pressure cuff, OK? Quit playing games. Get-go. Go to Walgreens. Get a blood pressure cuff and check it tonight. And if it’s over. Check it at least. I always tell people, don’t do it once. Keep a record and do it for at least three, three to four days. OK. And take it in the morning. In the afternoon at night so you can see a cycle. Bring that over and find yourself a team. Find yourself a team that will that has a program for you to naturally empower you and give you the right tools to get back to your best life ever. It is up to you. It’s called self-responsibility. No pill is going to take the responsibility from you. And at the same time, you can enjoy your family more, enjoy your life, and be happier in the process.

 

[00:42:19] So I really appreciate it, Alex. And I want to thank our listeners and viewers and we look forward to continue the conversation of health and wealth. Because I want to tell you, the message for today is your health is your ultimate wealth. Thank you. And we’ll leave it there.

 

[00:42:38] All right, guys. Thank you.

 

[00:42:39] And we’ll come back tomorrow and we’ll add another health nugget, so to speak, for you guys. Two miners.

 

Podcast: BIA and Basal Metabolic Rate Explained

Dr. Alex Jimenez and Dr. Mario Ruja discuss basal metabolic rate, BMI, and BIA. Body mass and body fat can be measured in a variety of ways, however, several measurement tools may ultimately be inaccurate for many athletes. According to Dr. Alex Jimenez and Dr. Mario Ruja, calculating an individual’s body mass and body fat utilizing various tools is essential to determine overall health and wellness. BMI uses a person’s height divided by twice their weight. The results may be inaccurate for athletes because their body mass and body fat are different, in terms of weight, compared to the average person. Dr. Alex Jimenez and Dr. Mario Ruja demonstrate that BIA, or bioelectrical impedance analysis, and various other tools, such as the DEXA test, the Tanita scale, and the InBody, among others, can help more accurately determine an athlete’s body mass and body fat. Basal metabolic rate, BMI, and BIA are essential for parents that have young athletes as well as for the general population. Healthcare professionals that have these tools available can ultimately help provide individuals with the results they may need to maintain overall health and wellness.

 

 


 

Neural Zoomer Plus for Neurological Disease

 

Dr. Alex Jimenez utilizes a series of tests to help evaluate neurological diseases. The Neural ZoomerTM Plus is an array of neurological autoantibodies which offers specific antibody-to-antigen recognition. The Vibrant Neural ZoomerTM Plus is designed to assess an individual�s reactivity to 48 neurological antigens with connections to a variety of neurologically related diseases. The Vibrant Neural ZoomerTM Plus aims to reduce neurological conditions by empowering patients and physicians with a vital resource for early risk detection and an enhanced focus on personalized primary prevention.

 

Food Sensitivity for the IgG & IgA Immune Response

Food Sensitivity Zoomer | El Paso, TX Chiropractor

 

Dr. Alex Jimenez utilizes a series of tests to help evaluate health issues associated with a variety of food sensitivities and intolerances. The Food Sensitivity ZoomerTM is an array of 180 commonly consumed food antigens that offers very specific antibody-to-antigen recognition. This panel measures an individual�s IgG and IgA sensitivity to food antigens. Being able to test IgA antibodies provides additional information to foods that may be causing mucosal damage. Additionally, this test is ideal for patients who might be suffering from delayed reactions to certain foods. Utilizing an antibody-based food sensitivity test can help prioritize the necessary foods to eliminate and create a customized diet plan around the patient�s specific needs.

 

Gut Zoomer for Small Intestinal Bacterial Overgrowth (SIBO)

Gut Zoomer | El Paso, TX Chiropractor

 

Dr. Alex Jimenez utilizes a series of tests to help evaluate gut health associated with small intestinal bacterial overgrowth (SIBO). The Vibrant Gut ZoomerTM offers a report that includes dietary recommendations and other natural supplementation like prebiotics, probiotics, and polyphenols. The gut microbiome is mainly found in the large intestine and it has more than 1000 species of bacteria that play a fundamental role in the human body, from shaping the immune system and affecting the metabolism of nutrients to strengthening the intestinal mucosal barrier (gut-barrier). It is essential to understand how the number of bacteria that symbiotically live in the human gastrointestinal (GI) tract influences gut health because imbalances in the gut microbiome may ultimately lead to gastrointestinal (GI) tract symptoms, skin conditions, autoimmune disorders, immune system imbalances, and multiple inflammatory disorders.

 


Dunwoody Labs: Comprehensive Stool with Parasitology | El Paso, TX Chiropractor


GI-MAP: GI Microbial Assay Plus | El Paso, TX Chiropractor


 

Formulas for Methylation Support

Xymogen Formulas - El Paso, TX

 

XYMOGEN�s Exclusive Professional Formulas are available through select licensed health care professionals. The internet sale and discounting of XYMOGEN formulas are strictly prohibited.

 

Proudly,�Dr. Alexander Jimenez makes XYMOGEN formulas available only to patients under our care.

 

Please call our office in order for us to assign a doctor consultation for immediate access.

 

If you are a patient of Injury Medical & Chiropractic�Clinic, you may inquire about XYMOGEN by calling 915-850-0900.

xymogen el paso, tx

 

For your convenience and review of the XYMOGEN products please review the following link. *XYMOGEN-Catalog-Download

 

* All of the above XYMOGEN policies remain strictly in force.

 


 

 


 

Modern Integrated Medicine

The National University of Health Sciences is an institution that offers a variety of rewarding professions to attendees. Students can practice their passion for helping other people achieve overall health and wellness through the institution’s mission. The National University of Health Sciences prepares students to become leaders in the forefront of modern integrated medicine, including chiropractic care. Students have an opportunity to gain unparalleled experience at the National University of Health Sciences to help restore the natural integrity of the patient and define the future of modern integrated medicine.

 

 

Podcast: BIA and Basal Metabolic Rate Explained

Podcast: BIA and Basal Metabolic Rate Explained

 

Dr. Alex Jimenez and Dr. Mario Ruja discuss basal metabolic rate, BMI, and BIA. Body mass and body fat can be measured in a variety of ways, however, several measurement tools may ultimately be inaccurate for many athletes. According to Dr. Alex Jimenez and Dr. Mario Ruja, calculating an individual’s body mass and body fat utilizing various tools is essential to determine overall health and wellness. BMI uses a person’s height divided by twice their weight. The results may be inaccurate for athletes because their body mass and body fat is different, in terms of weight, compared to the average person. Dr. Alex Jimenez and Dr. Mario Ruja demonstrate that BIA, or bioelectrical impedance analysis, and various other tools, such as the DEXA test, the Tanita scale, and the InBody, among others, can help more accurately determine an athlete’s body mass and body fat. Basal metabolic rate, BMI, and BIA is essential for parents that have young athletes as well as for the general population. Healthcare professionals that have these tools available can ultimately help provide individuals with the results they may need to maintain overall health and wellness.

Podcast Insight

 

[00:00:08] All right. It’s Mario and Alex time. The two favorite chiropractors from El Paso, TX. Ok. We’re going to be… Functional medicine, Alex. That’s what we’re gonna do. It’s about functional medicine in 2020, baby.

 

[00:00:21] This 2020, we’re gonna be focusing on BMI and we’re gonna be focusing on everything. Mario, my awesome co-host here we’re tearing it up. We’re gonna give some points of view. We’re gonna be discussing certain things. Today our focus is going to be on anthropometric measurements and measuring the body composition rationale and its interpretation.

 

[00:00:46] Now I’m afraid of that. All right.

 

[00:00:49] I’m afraid of measurements, Alex, I’m telling you right now, I don’t want measurements around my body.

 

[00:00:55] Okay. Thank you. All right Mario. Yeah.

 

[00:01:00] Mario, we’ve got to get a little bit of knowledge here. Okay. Well, what we’re not going to do is we’re not going to try to make this boring. No. If you really want to see boring. I think we have plenty of examples of what boring looks like. Yeah. Have you seen those boring guys, Mario? You know, it’s like the measurement of what’s going on. Yeah. Here you go.

 

[00:01:20] Video plays in the background.

 

[00:01:31] You know what? I can go to sleep with that one, Alex. Now, that’s what I’m talking about Mario. I can go to sleep and just shut it off.

 

[00:01:40] But, you know, learning has to be fun. It has to be interactive and it has to be functional.

 

[00:01:47] So that’s what we’re… Absolutely I totally agree. So what we’re gonna do is we’re gonna try to bring the facts as it can be and we’re gonna try to bring it with a little bit of slapstick fun.

 

[00:01:56] So it’s gonna be fun. Mario, tell me a little bit about your interpretation of BMI as how people understand basal metabolic rate.

 

[00:02:05] Well, this is what I understand and what I hear about basal metabolic rate.

 

[00:02:13] Bottom line is, can you put your belt around your pants and can you tuck your shirt in? How about that?

 

[00:02:25] You know, that’s pretty scientific. Right. That is scientific. Yes, that is scientific. Yes. We could talk pear, we could talk apple, sizes, apple-shaped bodies types.

 

[00:02:33] But we’re going to get specific here because people want to know, Ok, what’s going on. Let’s start. One of the things that we can do is we can start discussing calculating energy requirements, because one of the things that we want to see, as you can see, I put up here a little bit of facts so that it can help us out a little bit in terms of figuring out what’s the best approach in terms of what we do. Now, you can tell here that sedentary, no exercise, what we want to do is talk about basal metabolic rate. Ok. So this is a measurement that has occurred by height as well as weight index. So it comes out to that number and we can start looking at calorie, caloric intake burn. But when we do a BMR and we calculate this number, we typically want to get about a 1.2. And that’s what would be normal in most situations if you’re sedentary, light activity, we start noticing that there’s an increased activity expenditure and BMR should be one point 1.375. If you are moderately active, you should start doing that. So in its interpretation…

 

[00:03:33] Mario, when you see these kind of things and these kind of figures, what does it bring to mind for you in terms of these numbers? As we keep on going back to this, we’ll be able to see exactly what’s going on. What’s your incentive sense of the rates and the metabolic processes?

 

[00:03:52] Well, again, very simple, when you look at it as the more active you are, the higher your metabolic rate is. That’s it. So at the end of the day, we want to put it in very simplistic terms to the public. We want to be more active about that. So science is supporting that, you know, park the car as far away as possible from the Wal-Mart entrance and your work. So by doing that every day, you are creating a higher function. Ok, metabolic, that’s the burn. That’s your whole system burning fuel within yourself. So it’s simple. And the studies are showing that the more active you are, the higher your metabolic rate is. It can go up to a 1.9 from a 1.2. Correct.

 

[00:04:50] Exactly. So what we’re looking at here is that the requirements are going to be pretty high. If you are one of those people that are very active. So ultimately, our goal is to get you as active or what you’re your lifestyle could require. So, you know, if you’re a mechanic, you say moderately active. If you’re someone who works in, let’s say, an office, your BMR is going to be calculable. Using these numbers for the body mass index, the whole idea is to try to figure out the body mass index using the BMR. So the BMR allows us to kind of give an estimate, the best estimate as to where you’re BMR should be at and then we can use the same number, this BMR to assess your body mass index. So our goal is to continue with kind of learning about this thing. And as we kind of go through that, we look at body measurement types. Now, in the past, what we’ve looked at in terms of this, we assess the body in a bunch of different ways. Historically, we’ve been able to do a weight, underwater weight assessment. Remember, Mario, we used to have like a tank and put someone in water, have them float, actually measure the oxygen consumption. Those were the old methods, the true standard way of doing our fat analysis.

 

[00:05:57] Pretty expensive. Sometimes, though, we use the DEXA test. The DEXA test is a similar test that is used for bone density. We can actually do that. We also have, historically the body pod test. Now, I know that you have noticed different types of tests and we’re going to put up here.

 

[00:06:13] What are the other tests that you’ve seen? Alex, on that one. When you’re talking about the underwater weighing and DEXA and even the body pod, those are again, more research-based, more scientific.

 

[00:06:30] Exactly. In that. So when you’re looking at that, I look at it from my perspective.

 

[00:06:38] You know what’s functional? What’s can everyone do? Exactly. Skinfold is easy. Yeah. You know, skinfold and the BIA and the Tanita scale. Yeah. I mean that one, electrical impulses going through and you’re looking at resistance and impedance. Those are simple. You can’t just buy them from Wal-Mart or anywhere and step on it. Make sure you don’t eat and make sure you don’t drink before you do your test. So do it early morning. Let’s say six, seven o’clock. Right. On an empty stomach so you can get some good readings with the scan. And also, you know, skin fold is easy.

 

[00:07:21] And again, with the BMI, you’re looking at weight divided by twice your height, your height squared. Exactly.

 

[00:07:31] So that’s kind of like a simplistic view in terms of BMI. Anyone can do this. Yes. So those are right now. Those are the standards. Those are things, most of the time, when you go to your trainer. Most of the time when you go workout in your CrossFit gym or your, you know, what I call functional gym. Now people are going into more a functional aspect of fitness.

 

[00:07:55] So they incorporate less wear-and-tear and trauma. Now they’re looking at skin fold and InBody. They even have the new InBody systems that are very popular that give you a nice ratio even of your hydration, which is really nice.

 

[00:08:13] You know, when you actually say that, when we look at this thing like the Tanita, these scales, like you said, that you can get them at home. The BIA is where it’s at. What we’re finding is that a lot of the studies are reflecting that the BIA actually shows quite a correlation with accuracy with these more complex underwater weighing as well as the DEXA test. So these standards research-based, you’d always want to maintain some sort of research-based, at least collaborative information that makes sense. Right. So now the BIA assessment machines, they can actually determine through OHMS, through impedance to fat analysis to actually measuring the electrical current of the body, a very accurate approach to weight assessment. And by, you know, basal metabolic rates. So now the studies are actually better and they’re easier for people to do. And we don’t have to do some real complex things.

 

[00:09:09] Yeah. And, you know, if you can show everyone the body part, I think that’s really cool. That’s like a cool thing. You know, I mean, look at that. Can you. Yeah.

 

[00:09:21] Yeah. That’s really cool. So when you look at a body pod. Right.

 

[00:09:24] This is an incredible thing. But this is not something you would want to have in your office. Right? Thirty, Forty-thousand dollars. Right. Jesus, man.

 

[00:09:31] Yeah, you know, it’s crazy, I mean, they’re probably looking at you like they should have you on an alien channel or something. But the simple one, if you can scroll up on the BIA, it’s a simple machine and the readings are awesome. You know, the readings are very good. They’re portable. And you can see the resistance level and you can see the phase angle, which is really nice because then you’re looking at very specific patterns and turns your metabolism.

 

[00:10:06] Absolutely. These tests now are available in most clinics, or at least the clinics that focus on functional fitness. We have them at the fitness centers and many fitness centers have them. And you and I are used to using these things in our offices. So as we do these things, as we assess these things, we really can give kind of the patients a quantitative point of view that really helps them figure out exactly how everything is.

 

[00:10:38] You’re exactly right, Alex. You know, in my work, you know, working with athletes and also what I call performance professions, where we’re talking about military S.F., Special Forces, Rangers, things like that. It’s all about performance. So in that, we use calipers. You know, those are very, very useful, easy to use. And the one that I particularly like, which.

 

[00:11:08] Again, with BMI, there are a lot of discrepancies, Alex, and you know, this being, you know, in the world of bodybuilding and athletics and all of our kids are athletes. I mean, they’re, that’s just part of the family structure. That’s who we are. So now you got to run, jump, catch a ball or kick a ball or do something. Right. So the point is in that what I have found out is that the BMI is not very accurate. Not very accurate at all Alex, when it comes down to athletes. Right. So this is where the discrepancy comes in, where it gets crazy because now you go to a regular assessment, a regular assessment or a regular, I don’t want to say regular doctor, but, you know, your doctor and then he’ll test your BMI and you’re gonna be off, you’re going to be high and you’re going to say, you know, you need to get your BMI lower. Yeah, the point is that the BMI is the mass, right? So again, muscle is heavier than fat. So in your environment of bodybuilding, what do you think about that?

 

[00:12:22] I mean because I’m sure it was crazy. Well, one of the things that I’ve been able to see over the years is that when you have someone, as we understand this, that the BMR is obviously the thing that we’re using to assess height and weight. But those numbers get skewed when you have an athlete and they don’t work well for the muscular individual, someone that’s I mean, my son, for example, he was 195 pounds, 5′ 8″. In all reality, he’s clinically obese. Right. Yet he’s shredded and ripped. And he was a national champion in wrestling. Literally had no body fat. So the caliper method, the BMR, the BMI based on height and weight has deficiencies. And that’s where the BIA came in and the body impedance assessment. That’s where the studies became very popular. And as what we see, Mario is that in essence, when we look at these situations, we find out that there are great assessment tools out there. These tools are the ones that are actually going to give us the ability to kind of come up with an accurate for a large range of individuals, whether they’re bodybuilders, whether they’re women. There’s a standard between, you know, a good 13 percent body fat and 29 percent body fat for females. Women typically have a larger number of between 18 and 29 percent body fat. At times, that’s a range that is kind of in there. Hopefully, they can stick around 22 to 24, boys in the 13 range just because the body density is different in a female. Right. So what we look at is what’s the norm? One of the things that we can do is try to calibrate people for their numbers so that they make sense for that individual and be able to work them towards it because a true athlete will be able to almost blow the BMR, BMI into the wrong number skew. And if we can get it to a nice number, we’re gonna have to use a lot of different tools. Now, what we’re going to present today are our ideas and fundamental philosophies and knowledge points that we use to determine actual true health. Right. So we’re going to be discussing those particular issues and we’re going to go over those particular areas here. Now, the BIA is the body impedance. Okay. So when we look at the bioimpedance areas, we can see that these kinds of tests are not only just affordable, but they actually determine the electrical current. And because of the body amount of muscle fat and the fat that occurs, we are using the fat as kind of like the thing that allows us to assess body dynamics as well as body density. Right. So as the more, there’s more impedance or more ohms or more resistance in the body, the greater the body fat. So it’s very important that these tests be done properly. Many of the times before you do a BIA, you’ve got to kind of, you know, you’ve got to not take, first of all, you’ve got to be dry. Ok. Because if you’re sweaty, it throws it off. Right. If you eat too much or too many fluids. So typically you try to keep away from foods, eating food prior to this and you try to get this thing to work. So resistance, as we look at it, are the things that we’re trying to measure. So one of the things that, when you look at these particular graphs, you see low resistance associated with large amounts of body fat mass, which is where the body is stored. Right. So when we look at this, this is one of the areas we can kind of put together when we look at the resistance numbers. Now, as we look at different angles, let’s say we got the phase angles. We also look at the ability. This is the new number that is assessing actually the intracellular and extracellular activity as well as the permeability of the cells. Ok. Now, as we range this. They’re looking at ranges between 0 and 20 percent. But the higher the phase angle, Ok, the higher the number where it pops, the better it is for the individual, the lower it is. It’s not as good. So what we want to do is we want to see where your phase angle is and we want to be able to assess it as it gets calculated. So one of the things that we look at, we assess this and our tools that we use, such as the BIA assessments, such as the InBody testing systems, we can actually determine the ranges that are for the individuals. But here’s where things make sense. But what we’re in general, when you look at this, Mario, what is your take from when we assess this particular type of under fundamental research technology as we can apply to athletes? Your daughters are athletes, right? And do you? What have you used in the past for this?

 

[00:17:07] Usually, when they go on to programs, I mean, they’re super fit, first of all. So they’re looking more at anywhere between like performance in terms of speed, agility, and sustainability. Right. Like, you know, vertical in terms of explosiveness, those types of things. In the area of recovery and energy. This is where I can tell you with the girls and even the boys, they really focused on the energy consistency. Ok. And I can see even with this, which is critical that the phase angle, again, the lower the phase angle, it shows the inability of the cell to store, you know, energy.

 

[00:18:09] So that’s why that storage of energy, Alex, is real critical because why that is where we get the maximum output and everyone is talking about performance and performance is about what, output. So if that cell can not store the energy, it cannot release the energy and perform. So that’s how nice these are nice markers. I would say that with the latest technology, we need to use them. We need to use them and we need to have benchmarks where it’s not just generalities. A lot of times we talk about generalities. How do you doing? I’m doing good. You know, I had a good workout. Well, what does it mean to you to have a good workout? And what does it mean to have a great workout? The difference is, show me proof. Show me results. It’s all about results. So the better, I guess a good takeaway. A good, good. Kind of, you know, assessment for people. Look at number one. Go to a professional and get your BMR and BMI done. That’s number one. And use the equipment.

 

[00:19:26] And the specifics so you can mark and you can assess them afterward.

 

[00:19:34] If you don’t have a straight baseline of pre, you will not have a post. And this is the same thing in performance. If you don’t have your electronic time and track your pre, then your post is meaningless. You really don’t know where you’re going. So for a lot of the performance, you know, to me, life is performance. You’re going to have to perform either at work or at home or you’re going to perform on the field, whatever that may be. On a mat. On a field, you know, in your sports. It’s about keeping track of markers, your pre and post. That way, you know where you’re going and you know your performance in our world. We love scores. Just imagine, go into a game and you never have a score. We don’t keep score. We just want to have fun. It doesn’t. It’s not fun anymore. Right. So.

 

[00:20:34] So for the things that we’re covering today in terms of the instruments, the methods of measuring body composition all the way from professional, DEXA and water displacement and body pods to skin folds, you know, everyday use, that you can just buy it at your local Wal-Mart anywhere and do the count protest.

 

[00:21:02] That’s a great baseline.

 

[00:21:06] And with a lot of the trainers, make sure that when you are training with someone, make sure that they do a baseline so you know and they know where you’re at and the performance and the programming.

 

[00:21:23] It’s really important to understand programming. There has to be a scaling. There has to be a periodicity in that development. And I know when little Alex was training for state, you know, in the wrestling, there has to be a periodicity. You can’t just go hard and go home like everybody says. No. You have to have your point of performance and you’ve got to have your track, your flow to that. Just like when Mia is training for nationals or international competition in tennis, there has to be a plan where she is developing to peak at that time. Is that correct? Yes, yes, yes, yes. That’s so critical. And we, you, cannot create that plan to peak at that specific if you’re in the dark in terms of having a knowledge of where you’re at. And I think for our listeners and our viewers, it’s critical and it’s very, very easy to get. I think sometimes people get lost, like all, you know, BMI. I would venture to say 80 percent of the people that are listening today. Right. That are watching this video. Have no clue what BMI means. They’ve heard about it, but they have no clue what it is. Yeah, they think it’s some scientific something. No, it’s not. All right. We want to bring it down to earth, down into your living room, where you can actually do a BMI for your kids, right? Yeah. Why don’t we do that? Why don’t we do a BMI for your kids? Do it for your husband, your wife. Make sure you know where you’re at again, with a BMI. And this, you know, refresh my memory. The target is from 19 to 20. Ok, 19 to 20. Anything beyond that is obesity. If you’re talking about 25 BMI, you’re in the obesity range. Right. If you’re talking about 30, you are morbidly obese. And the word morbidly obese means death. That should get everyone’s attention. Oh, yes. Yes, it does. It kinda like wakes you up. So what we’re looking at is, number one, understand where you are. Then measurements and then also understand that these measurements fit the profile of a person. So if you’re a bodybuilder, if you are very heavy muscle-bound. Ok. Then you already know you need to go into impedance. Not measurements. But what I have found out. A very reliable measurement is. The measurement for your waist and that’s where, Alex, I want to kind of share this with our listeners and viewers. Just a simple waist measurement is so powerful because it is actually…

 

[00:24:24] Some people say it’s better than BMI. It sure is. Right. I mean, actually, yes, it’s yes, it’s very much. That waist measurement gets down and makes it so simple because that abdominal mass, that abdominal fat is the one that’s gonna kill you.

 

[00:24:41] That’s the one that has the highest risk. Is that correct?

 

[00:24:44] That’s correct. And if your belly is wide. If it sticks over your belt, we got issues. Ok. So we’re noticing that if there is a certain distance between the chest and the waist, those are better measurements in general. Yeah. So as those numbers are calculated, you don’t need a high-level test. To do this. Ok. I like that. So it’s a very important component to look at. But as we advance and we’re dealing with high-performance athletes, people want to know and you can take a sport like, let’s say, just wrestling, for example, you got these individuals. Or soccer. Huge. We’re dealing with to assess a tight BMI or in a tight body mass index. You got to have body fat. You got to have body fat to be able to sustain the loads of an exercise routine. You’re going to see that during season you got some guys that got some good body fat density. Right. And let’s say their weight class is 198, for example. And the guy is about 215 pounds. Well, if he drops from 215 to 198 overnight, he’s going to be exorbitantly exhausted. And this is something that we’re going to see now if he slowly works towards the goal towards the arena of 198 over a period of two weeks. Or he is better off. But let’s assume he gets there to the exact bodyweight 198 and its 3 days before competition, right? It’s going to be exhausting. He’s gonna be tired. However, if he can get there two weeks earlier and adapt his body as his body starts getting better, it will be able to respond better during the loads that it needs.

 

[00:26:31] And this is what we are talking about, that it needs to be sports specific. You follow me Alex? Exactly. So that same conversation cannot be held with a soccer player. Exactly. A football player and a tennis player or anything in that what I call long aerobics exertion of over, you know, over, let’s say 10, 15 minutes. And this is what’s happening is and I love it when you said that example with wrestlers, you know, I would say the same goes towards MMA fighters, which I take care of. Yes. MMA fighters in Phoenix and in different areas that then you’re talking about also boxers. Again, they have to make weight. Yes. Ok. Though the world of making weight is a beast, that is a world where you have to be on or you’re going to die. Exactly. You either go into that fight feeling like a beast or you’re praying that it ends quickly. And so. Yeah. Yeah. You gotta pin him in the first 10 seconds. Yes. So. So this is where it’s so important that the training, the measurements, the analytics, and metrics. We’re in a world of analytics and metrics, Alex. We’re not in a world of. Oh, he looks good.

 

[00:28:09] No, no, we’re past that. We’re way past. No, Mario, we’re in the world of making sure that when we wait, when we compare the athlete, we can measure their changes. And every stage down the road as they compete, as they become more and more in tune to that moment of competition, their body changes, their bodies adapt, their bodies become more refined. And as the season gets better or further along in the season, towards the competitions, towards the season, towards the heavy loads. Yeah. That’s when we can kind of see how the body’s changing. So these tests can actually help us determine how the body reacts. And once these competitors have years of competing and during those years they have offseason and on the season and we need to be able to measure those things in an easy way. That’s what these tests do in terms of tennis, for example, when you’ve done these kind of things. What have you noticed in terms of, let’s say, just the athlete of tennis or even the boxers that you deal with? What have you noticed in terms of the, specifically the…

 

[00:29:15] Progression through the season. It’s critical, it’s critical and Alex, I can tell you this, that it’s not just performance. The other conversation that I think really needs to be. Dialed in is recovery, recovery, Alex. Ok. And the other one that fits together with recovery is the phase angle. Yes. And decreasing injuries. Exactly. That’s where it kind of gets real, real crazy because you can not have this sustainable pattern. Without recovery and without that specificity and knowing when to push it, one to max out, as they say, and when to shut it down or when to go half-speed, and these are conversations that are really, really critical for young athletes. Alex. Yeah, I see a lot of them, you know, and they’re starting nowadays. They’re starting earlier. They’re starting at six and seven years old. Six and seven. I mean, tell your body hasn’t even woke up to the conversation of sports yet. And they are practicing three times a week, having games every weekend, or some of them practice three times a week with one team and then go with another team and practice the other two days just so they can be at their best peak.

 

[00:30:48] What sports are you dealing with that kids are doing at six or seven?

 

[00:30:53] They’re running like right now. I have patients that are doing basketball and track at the same time.

 

[00:31:01] Yeah. And during middle school.

 

[00:31:05] That’s amazing. This is crazy. Yeah. So this is my question. Our question. We’re here to help the community. We’re here to help the parents because their vision is my little kid’s gonna be a superstar, right. He’s going to sign a D1 contract. UT Austin, Texas tag, guns up, baby. Yeah, guns up or U of A. You have Wildcats wildcat.

 

[00:31:34] No, you know walk-ins.

 

[00:31:35] Yes. And I’m thinking you’re not gonna make it past high school. I mean, you’re not gonna make it past Montwood or past Franklin. I mean, you are going to hit the wall so hard, so hard with repetitive traumas. Ok. And so those are the components that to me as a health care provider, as a, you know, a sports functional medicine…

 

[00:32:05] Cognitive.

 

[00:32:08] Coach, I mean, I need to teach people this, forget taking care of injuries. I want to teach you so you don’t get injured. It’s critical. And then they go into middle school and high school and there’s no season off. There is no season off.

 

[00:32:24] So in your opinion, what have you seen these tests do in order to help the parent or the athlete or the individual or the coach, for that matter? Understand, as a form of betterment for them? What do we get out of these tests in terms of the athlete?

 

[00:32:46] Very simple. There is a time to turn it on and a time to turn it off. Ok. So, you reach your goal, rest. Ok. You’ve done the tournament, recover, get the recovery, get the mind and body to recover, Alex. A lot of times we don’t even think about the mind. Yeah, the mind gets beat up in the war, in the battlefield of performance, the mind gets beat up. Yes. Ok. It affects your sleep pattern. It affects your focus. Emotions, anger management, all of those things. So what I would say is we’re here to share knowledge and tools or health. But most of all, for performance. Yes. So that way. Each child and each person, let’s say you’re not in middle school, high school. Let’s say you’re in your 20s and 30s and 40s. Well, you’re performing for life. And so let’s really invite everyone to learn more to look up BMI, BMR, all of these and incorporate them into their plan of workouts and challenge them and ask them, when’s the last time you got measured? How about that? Yeah.

 

[00:34:13] When’s the last time? We have to kind of teach people that these tests are not, you know, at any point. Just one test. You have to follow through these tests for a lifetime to see what’s actually going on. If you really have a center where you can go and the BIA tests are so simple now that we and the correlation between the highest level of research show that we’re very, very tight. Less than 1 percent variation from clinical research methods. So we know that the BIA works in terms of extremity inflammation, in terms of joint swelling, in terms of the metabolic processes for the mass density in the…

 

[00:34:56] In each extremity. So if you have one muscle that is larger on one side as a result of an injury from the other extremity, we’ll be able to see the changes.

 

[00:35:05] So the studies are very clear now. We use phase angles to determine health. We use fat analysis. We use the changes and the progression during a very athletic era or a very athletic season is very important to be able to determine. So that today we’re starting the children a lot younger. We’re starting them at four, five, six years old as the child has to around 4 years old, as long as he can focus is in long as he can pay attention. That’s when we start him active. So it is wise to start the process of understanding the metabolism methods that we use to calculate body mass index through their ages so that we have a measurement of what’s normal for that particular child. Because what we really have to see is what’s good for that individual. Specific gravity is another method to determine if you’re cutting down too much. But that’s another topic running. This particular issue is, particularly on the body mass index. And what we want to do is we want to bring that to the towns and to El Paso, particularly because we have those research capacities here, specifically the ones that we have liked is, you know, body mass index so InBody is one of the most top used. They use it at UTEP. They use it at the top research centers. And it’s pretty much the standard now. And, you know, and since we use it, it offers us an ability to quickly assess an individual. I’ve been at UTEP. I’ve seen the types that they use and it’s very accurate. And since we’ve seen the research said that it follows now we know that this stuff is very accurate. And specifically, now you can actually assess your own and have it online and the determinant through methods where you can keep up with your child, see what’s going on. Any other ideas, any other comments that you have, Mario, in terms of bringing this logic or this kind of approach to understanding basal metabolic indexes to the public?

 

[00:37:10] I would say, Alex. Number one, let’s make it very simple. You know, let’s make it very simple. So with that, this is as simple as getting on a scale to see how much you weigh. That’s it. So let’s bring that conversation to everyone so everyone gets a scan. Minimal. Minimal. I would say seasonal every season. You should get a scan. You should get a BMI. You should have you should log it in just like your weight. You know, let’s be functional. Let’s think of ourselves as important as our cars. Right. So. So I look at it as you have a little tag up on your windshield that says oil change, you know. So why don’t we do this? Why don’t we have? And I really challenge everyone listening. And, you know, we’re here because we need to take care of our community. You know, our community is probably one of the highest rates of diabetes in the nation. Ok. And all of that starts… Mario. Mario. Yeah. Yeah.

 

[00:38:20] I’m sorry. I don’t want to say it, but you have to. There’s a big elephant in the room. But El Paso, our town was considered the fattest, sweatiest town in the whole United States at one point. That sickened me when I heard it. It was a different town. We are much more advanced. There were very few gyms. Now we’re all about fitness. So if we’re gonna be the leaders out there and man, I gotta tell you, we got some beautiful athletes coming out of El Paso now. Absolutely. We are one of the tops. We can put our athletes against the best, even the most. Well-bred. Top schools. So as we compete in those areas, we really want to use the tools that all the other places use in order to assess our athletes, our children, and our high-performance individuals. So it’s very important we do that kind of stuff now because we have the technology. And no longer is El Paso going to be the fattest, sweetest town of the United States. That’s unforgivable. You definitely agree with that.

 

[00:39:23] So just bring in that and the division that I would like to share. Is that the measurement, the simplicity of just getting your weight and your height is now complemented with a BMI that you understand. You have some goals. It’s 2020. Yeah, yeah. It’s 2020, baby. You know what, 2020 means that let’s do better than last year. Let’s be healthier than last year and let us integrate and have a better understanding and better objective plan for our own health. And with this, I would say this test and the body measurement index is a word and an understanding that needs to be spread throughout families. So the family can talk about that, like, hey, what are we doing? How are we doing? Ok. And then with that, use it accordingly. Ok. Accordingly. To create positive outcomes where there is just to be able to play with your child if you have children. That’s your sport. Your sport is not to sit and watch. Your sport is to participate. Throw the ball. Kick the ball. Run with your child. Or if your child is really into sports. Give him the tools. Give her the best tools. They’re not that expensive. Now they’re available. So that way they can get training that is on point and results that are extraordinary.

 

[00:41:04] Exactly. I couldn’t have said it better myself. We have the technology. It’s here. This is not the six million dollar man, kind of world or this is not outside of our realm. We can give it to our kids. We can show them, parents become the educators.

 

[00:41:22] They are the ones that seek out the coaches. They are the ones that are the nutritionist for the children. They are the ones that are the psychologists that every aspect of developing a child requires a lot of different aspects. So those parents that have athletes, athletes that want to learn more about their bodies and the world of heavy tech research methods are over. Now, it’s simple. You get on scale really accurate methods and you can monitor your body a few times a year, two, three, four times a year, depending on your type of sport and your level of performance. These are the things we can do. And we need to provide that information so that you have tools in order to gage.

 

[00:42:11] You can’t get in a car without looking at a speedometer. So if don’t know how fast you’re going. You don’t know if you’ve gone too far. You don’t know if you’re having protein metabolic catabolism, which is breakdown or if you’re anabolic. So these are the tools that help us figure things out. You don’t know if certain joints or certain extremities are swollen because of just water or if it’s this protein breakdown. These tools we can actually see inside the body and monitor the improvement or changes. So the world changed. So now El Paso, we have the ability to change the way we understand our own physiology as well as the patient’s physiology and our client’s physiology. So I welcome this technology. And by no means is it limited to anything that we do. This is many providers in the town who can do this. Many hospitals have it. But for a facility, it’s within our practices as well. So we use those things. So I look forward to being able to share this with the patients as well as the town.

 

[00:43:15] Absolutely.

 

[00:43:16] I second emotion on that, Alex, and the challenge and the motivation and passion that we’re going to have this year in 2020. Absolutely.

 

[00:43:26] As to not only motivate and be cheerleaders for functional health and fitness, but also to educate and empower the community with the latest technology and knowledge so they can do their best.

 

[00:43:43] Amen, brother. This is awesome. And I look forward to being able to continue. We’re going to be coming at you often because we’re motivated.

 

[00:43:53] We’re parents and we want to be able to touch our El Paso and make it a better place because, you know, without getting too crazy, we’re pretty badass, as they say.

 

[00:44:04] Right. Yeah. We’re pretty intense in our town, right? Yeah.

 

[00:44:07] Mario. Don’t get me started.

 

[00:44:11] They’re gonna shut me down. No, no, no, no.

 

[00:44:16] We won’t do that later, guys. We’ll go ahead and see the show. And it’s been a blessing. So from all of us here, we can actually see how you guys are doing. So. Blessings to you guys. Thank you, guys. Bye-bye.

 

Additional Topic Discussion: Chronic Pain

Sudden pain is a natural response of the nervous system which helps to demonstrate possible injury. By way of instance, pain signals travel from an injured region through the nerves and spinal cord to the brain. Pain is generally less severe as the injury heals, however, chronic pain is different than the average type of pain. With chronic pain, the human body will continue sending pain signals to the brain, regardless if the injury has healed. Chronic pain can last for several weeks to even several years. Chronic pain can tremendously affect a patient’s mobility and it can reduce flexibility, strength, and endurance.

 

 


 

Neural Zoomer Plus for Neurological Disease

Neural Zoomer Plus | El Paso, TX Chiropractor

 

Dr. Alex Jimenez utilizes a series of tests to help evaluate neurological diseases. The Neural ZoomerTM Plus is an array of neurological autoantibodies which offers specific antibody-to-antigen recognition. The Vibrant Neural ZoomerTM Plus is designed to assess an individual�s reactivity to 48 neurological antigens with connections to a variety of neurologically related diseases. The Vibrant Neural ZoomerTM Plus aims to reduce neurological conditions by empowering patients and physicians with a vital resource for early risk detection and an enhanced focus on personalized primary prevention.

 

Food Sensitivity for the IgG & IgA Immune Response

Food Sensitivity Zoomer | El Paso, TX Chiropractor

 

Dr. Alex Jimenez utilizes a series of tests to help evaluate health issues associated with a variety of food sensitivities and intolerances. The Food Sensitivity ZoomerTM is an array of 180 commonly consumed food antigens that offers very specific antibody-to-antigen recognition. This panel measures an individual�s IgG and IgA sensitivity to food antigens. Being able to test IgA antibodies provides additional information to foods that may be causing mucosal damage. Additionally, this test is ideal for patients who might be suffering from delayed reactions to certain foods. Utilizing an antibody-based food sensitivity test can help prioritize the necessary foods to eliminate and create a customized diet plan around the patient�s specific needs.

 

Gut Zoomer for Small Intestinal Bacterial Overgrowth (SIBO)

Gut Zoomer | El Paso, TX Chiropractor

 

Dr. Alex Jimenez utilizes a series of tests to help evaluate gut health associated with small intestinal bacterial overgrowth (SIBO). The Vibrant Gut ZoomerTM offers a report that includes dietary recommendations and other natural supplementation like prebiotics, probiotics, and polyphenols. The gut microbiome is mainly found in the large intestine and it has more than 1000 species of bacteria that play a fundamental role in the human body, from shaping the immune system and affecting the metabolism of nutrients to strengthening the intestinal mucosal barrier (gut-barrier). It is essential to understand how the number of bacteria that symbiotically live in the human gastrointestinal (GI) tract influences gut health because imbalances in the gut microbiome may ultimately lead to gastrointestinal (GI) tract symptoms, skin conditions, autoimmune disorders, immune system imbalances, and multiple inflammatory disorders.

 


Dunwoody Labs: Comprehensive Stool with Parasitology | El Paso, TX Chiropractor


GI-MAP: GI Microbial Assay Plus | El Paso, TX Chiropractor


 

Formulas for Methylation Support

Xymogen Formulas - El Paso, TX

 

XYMOGEN�s Exclusive Professional Formulas are available through select licensed health care professionals. The internet sale and discounting of XYMOGEN formulas are strictly prohibited.

 

Proudly,�Dr. Alexander Jimenez makes XYMOGEN formulas available only to patients under our care.

 

Please call our office in order for us to assign a doctor consultation for immediate access.

 

If you are a patient of Injury Medical & Chiropractic�Clinic, you may inquire about XYMOGEN by calling 915-850-0900.

xymogen el paso, tx

 

For your convenience and review of the XYMOGEN products please review the following link. *XYMOGEN-Catalog-Download

 

* All of the above XYMOGEN policies remain strictly in force.

 


 

 


 

Modern Integrated Medicine

The National University of Health Sciences is an institution that offers a variety of rewarding professions to attendees. Students can practice their passion for helping other people achieve overall health and wellness through the institution’s mission. The National University of Health Sciences prepares students to become leaders in the forefront of modern integrated medicine, including chiropractic care. Students have an opportunity to gain unparalleled experience at the National University of Health Sciences to help restore the natural integrity of the patient and define the future of modern integrated medicine.

 

 

Branding Podcast: Basal Metabolic Rate, BMI & BIA

Branding Podcast: Basal Metabolic Rate, BMI & BIA

 

[00:00:08] Welcome to the Dr. J. Hour with our crew here and our entire staff. We’re gonna be talking today about basal metabolic rate, BMI, and BIA. What does BIA stand for?

 

[00:00:33] BIA is a bioelectrical impedance analysis. Right. And we’re gonna be talking about weight analysis and figuring things out. We got a couple of guests online. We have Alexander Jimenez. Which is going to come in, pop him in, please. Let’s hear and as you can see him here on the line there. He’s on the corner side of the HDMI. So on the HDMI, you can actually see him. Hey, Alex, how are you doing? Where are you calling from? Where are we getting in with you?

 

[00:00:58] I’m doing good. I’m calling here from Lombard, Illinois. And what is it you do, Alexander? Right now I’m going to school for chiropractic and ND, which is naturopathic doctor, kind of doing a little bit of a dual degree program here up north.

 

[00:01:11] All right. That sounds good. We also have on the line here we have Kenna Vaughn, who is the senior health coach over at our domain. We also have two wonderful individuals. We have Truide who is basically the director and the patient flow analysis individual. And we have Astrid, who is the chief editor at Injury Medical Clinic, where she writes and documents everything according to that. Can everyone hear okay? Yeah, yeah, yeah. All right. We’re all live. All right. So what we’re gonna be discussing today is the basal metabolic index. Okay. And one of the things that we do here is we’re gonna be able to assess the findings. Ok, so our goal today is to determine exactly what the primary assessment is and the assessment. So stay on me. Stay on me. You know you got that. And what we want to do is we want to see what BMI is and why is it useful? Ok. The main topics are what we’ve used to assess body fat analysis and determine the indications and the reasons…

 

[00:02:11] We use BMI alongside BIA, along with we got waist circumference variables allows also with waist-hip circumference variables and what it means because what we’re finding today is that these are great analysis tools that can be used to determine nature’s kind of a healthy cadence. It’s like blood pressure. We can kind of assess it. Then as long as we have other assessments and other evaluations, we can come up with a plan to kind of comparative. Now, all of them have their issues and we’re gonna discuss each one of them in the costs and what’s the easiest and most cost-effective methods that we can use. But one of the things that we can do is to see, why would we do this and what are the purposes. Now, there are quite a few reasons for this now in terms of it, what I’ve noticed is I’d like for you to, let’s look at the HDMI, we have the assessments here and we can actually see on the live the origination of this. We can see that there are different types over the history of BMI. We’ve gone from calipers that were just a method of measuring behind the arm, behind the waist, along with kind of in the thigh region. We would come up with a measurement of which we were probably about five to 10 percent away from accuracy. But in that process, even using those as long as you did use it on a consistent basis, you had a comparative accuracy and a method of kind of determining a change in your body dynamics and composition. It may not be accurate, but it was accurately inaccurate if that makes sense. Right. So what we did here is we’ve looked at here on our graph here. We have one thing that’s called the underwater way. But that was the standard. It is a research method. It is one of the most important things. And to determine actually what your body metabolism is we have to use things of oxygen consumption because that’s what determines the great spot of metabolism. The metabolism is controlled by the amount of cellular activity that is happening in the body. So calculating how much oxygen debt and how much oxygen use is a great way of researchers finding it out. But we don’t always have a laboratory that has I’d say, you know, one hundred million dollars of stuff and like a university. So it’s pretty much used in a research setting, the DEXA test, you may have heard it because it’s used as the clinical standard to look at bone density specifically on the hip side and the lumbar spine. We use that to determine things such as osteoporosis, osteopenia. We get a variable number and based on that number we can calculate the changes in bone density. There are certain types of medications we use to determine a better outcome for those that have estrogen deficiency. Some people have radical hysterectomy where they do remove all of both ovaries at a young age for whatever the reason is and the estrogen level is changed at that point a DEXA test every few years is determinable. The standard of care for the DEXA is one every two to three years after the age of about 50 to determine the changes in bone density. Now the skin fold that we just looked at here and you can actually, as I kind of draw it out, forgive me that I’m not drawing this, but we can actually see that the BIA and the skin fold tests are other tests that are easy to find, but as we discussed, are inaccurate. The Body Pod test, as you see here, you can see the cost of it, it’s about thirty to forty thousand. It’s extremely accurate and it allows for your body to relax. Each one of these tests has certain standards. One of the things that we have to do is prep for a BIA test or a BMI test. Now, the BMI is something that calculates an easy way of figuring out just height versus weight. However, someone like Alexander, you are how tall Alex? I am 5′ 8″. So a 5’8″ individual. How much do you weigh when you were at your deep competition and you were at your healthiest. Probably around 195 to 197. If you have a person that is 5′ 8 and 187 and I’ve seen him range from 210 and he’s still shredded as can be, he would be having a very high and he would characteristically show as minimally obese. Now you can tell that he’s not obese. So in essence, the BMI has flaw issues and bone density issues. Also, there are other disorders that sometimes fool you like sarcopenia, which is muscle wasting, and you wouldn’t be able to see the differences between those on the BMI. So what clinical assessments have determined is that the BMI and the BIA can be used together. But we have led a new technological world where we actually measure impedance. Impedance is kind of like the filtering or the kind of slowing of electrons or how fast and how quickly they go through. If electrons travel faster or something, there is low impedance or if it goes slowly through it or takes a longer time, there’s higher impedance or actually a lower flow, which allows us to understand that fat is not good a good conductor.

 

[00:07:03] So the more fat you have, the indirect relationship is, the slower the electrical current goes, therefore it’s less healthy. So using these electronic methods and what we have used in recent technology, we’ve used different companies such as Tanita, also InBody has an awesome system. We will be discussing those that assess the BIA in a way that it’s the most accurate if the most accurate is underwater weighing. And let’s give that relative value of 1.0 the actual BIA test are so accurate they are at .98. OK, so once we see that ratio, we can see that we’re the closest with the BIA test, specifically with an eight-point contact. Now any point contact means with your fingers, your palm of your hand, that’s two, both hands before. And then you have two points of the foot that can actually hit on each foot and that would be four from the feet if you can send that electrical current through the body. In that way, the BIA assessments such as done by the InBody design, we can actually determine a much more accurate assessment. So as we look at these tests, we can actually see what’s actually going on. So one of the things is we’re going to start looking at different companies and we can actually look at what a BMI is looked at. So BMI is used so you can look at it from a relative number. And it’s measuring kilograms per meter squared. And it’s measuring basically the height of the body, base of the body weight. Right. So the higher the number, as you can see, 25 to 29, you’re going to notice that the person is pretty much overweight. OK. I would venture to say that Alex would just because he’s in a situation where he would actually rate because he’s a much more muscular guy. He would not be healthy. He would basically almost reach close to 30 just because he has a large size and weight. But it’s clearly measuring only height and weight. So in order to determine the true health, that’s where the BIA and its bioelectrical impedance analysis, okay. Right. I should remember the words. So this is very typical. So one of the things is I like to show you here on these things, what kind of, Astrid, show a copy of what a BIA, kind of machine would look like. Okay. We have like here, here we have bioelectrical impedance analysis and this is what it looks like. If you notice, you’ll be able to see. And I’ll kinda take you through here and we can kind of see the ability to look at this particular region. You can see that the palm of the hand has one and you’ll notice the two points on each foot. What we’re missing is the final contact, but it’s eight and it takes only 15 seconds to be .98 versus one. Accuracy is a pretty efficient way.

 

[00:09:48] It also takes seconds to do this and not 45 minutes to do something like the Body Pod. So one of the things that we have to do is ask ourselves, why would someone do these kinds of things? Why would we do this? There are more accurate, more powerful ones, such as the 550 model, which we do not have in our office. And the model that we have is the 770 in our office. So you can see it’s much more accurate and we’re gonna discuss exactly what goes on. But one of the things we want to do is how could someone do something at home that is logical? Kenna, you got some thoughts on how someone could check out their basic health by doing some measurements? What are those measurements?

 

[00:10:25] Right. So one thing that’s really easy to do at home is gonna be to check your waist circumference, which is relatively cheap. You just need one of those flexible tape measurers you can get at the dollar store or it comes in almost all your basic sewing kits. And what you’re going to do is just gonna stand up nice and straight and you’re going to take that tape measurer, you’re going to want to make sure that you have no bulky clothes on. It’s best done just right on the skin. And you’re going to take it and you’re gonna fold it around where your belly button lies because that’s generally the largest part of your waist. So you’re just gonna wrap it around. You don’t want it to be too tight where it’s squeezing you or anything like that, because that’s going to give you inaccurate results. Take a deep breath in and on your exhale. That’s when you’re gonna get the best measurement and it’s best to do it about three times that way you make sure you’re really getting that accurate read.

 

[00:11:12] And what is that going to give us in terms of, what’s the circumference going to give us in terms of the assessment?

 

[00:11:18] What will we get from measuring our girth. That’s gonna help to see if you’re high risk for cardiovascular disease or type 2 diabetes. If you hold more of your fat around your abdomen, it shows that individuals are at higher risk for developing these later on in their life.

 

[00:11:34] Got it. Got it. There’s another one that we’ve used that most people can use at home.

 

[00:11:40] It’s a really simple one, which is that one? That one’s gonna be the waist to hip ratio. So you are going to start with that waist ratio that I just explained. But in addition to that measurement, you’re going to go ahead and also take your hip circumference.

 

[00:11:53] Alexander, one of the things that you did when you did your competition, when you were doing your stuff as a competitor, one of the things that you were doing is you were competing and weight was very important. Tell us what how that kind of stuff affected you and how could the BIA be useful in the world of, let’s say high-performance collegiate wrestling?

 

[00:12:15] So when it came to wrestling, there were a couple of different things that you just do to strategically approach the season, so the season is around six months. Most of the time wrestlers tend to gain weight in the offseason. So you do a couple of different things at the beginning of the season, they would have you use a caliper by a trained individual and they would measure your body fat and do a pretty much a calculation to see how much weight you could lose in a timely manner that was considered healthy for an average individual. And these individuals were allowed to cut a certain amount of weight within that time frame. So you kind of they pretty much gave you a plan of what you could and could not cut. I think the lowest I was ever allowed to cut was 184. And kind of just showing you kind of what’s going on here. So what they would do is kind of show you what your BMI is. I’m going to switch over to my screen here and you can kind of see just kind of just the reference ranges here. So below 18.5, they have underweight 18.5 to the rest of this kind of going into those reference ranges. And like Kenna was saying, they were doing an analysis depending on what type you had. So there’s a couple you have, your android, which is more of that apple-shaped and then your pear, which is gynoid. So they would measure for females and males completely different. So as your approach, you would either take a couple different dietary regimens and kind of approach to a different aspect of how you would go to cutting weight. So whether it was certain people did better just doing fats and protein. Some people did better just managing their carbs. Some people did better just lowering their caloric intake. So by having that BMI, you can see what your total calorie output for the day for living costs is a good way of saying it. So what’s the cost of living for every day for all your cells to function and what or how much exercise you would do. So most of us were burning between 1000 to 1800 calories between running in the morning or working out and then a two and a half hour to three-hour wrestling practice, which is all cardio intensive training. So as the month went on, we were allowed to cut weight and they would measure the weight that we were cutting at each tournament. So we were kind of scanned in, in a way to allow for us to cut weight correctly. One thing that they did start implementing when I joined, when I started wrestling in high school, was morning weigh-ins, which prevented people from really cutting weight the wrong way and not having a good benefit, because before you could cut all this amount of weight and you’d still have a 15, 16-hour window to replenish all those glycogen storages and gain 15 to 20 pounds depending on how dehydrated you are. So it was not a very healthy approach to cutting weight in that sense. So now with everything that’s going on, athletes are training smarter.

 

[00:15:01] They’re cutting weight better. They’re managing pretty much themselves a lot better in that aspect.

 

[00:15:07] So this is a great example of when you use these assessments. I remember as we’ve done a lot with the wrestling, one of the way that the university got involved and they do BIAs for people, but for the athletes, they start them out with the standard specific gravity test and that’s a urine test to determine which protein is within their urine. Also, there are electrolytes such as potassium, sodium, calcium. If the person is highly dehydrated, what happens is the specific gravity rises and they also measure specific gravity. In the beginning, it’s something to be able to measure. And we can say that the kid who weighs 200 pounds, his specific gravity is a certain amount. Right. So we don’t want a kid cutting down with the specific gravity of their body concentration. Blood constriction is too high because that means they’re dehydrated. Those individuals can, once we got that number, we can assess the person, not just with body weight, but we can use BIA to follow them through the season in a much more accurate way. So that allows a very expensive test, which is a specific gravity to go through the BIAs. We also have issues and we’re going to touch upon these. But there are other special dynamics that parents can be involved and parents like Truide, you’re a parent of an athlete. What would you want to know in a BIA?

 

[00:16:22] Well, I have two athletes. Well, basically, I guess at what point is it safe with children to start watching, you know, and being concerned about, you know, BIA? Because certainly as young adolescents, you don’t want them prone to having eating disorders or being so self-conscious about their body composition that then you have other types of side effects of psychological approaches. So that will be one of my concerns. When is it safe from a parental stand to be watching about BIA and BMI?

 

[00:16:59] You know, that’s a very good question. And I guess what we would want to know is that we know that our kids are healthy when they’re with us, but when they’re going through certain dynamic changes. We want to follow up. We want to see when is it getting too concentrated? When is the kid losing too much protein? When is the child running the risk of hurt because we do have the stories of the 180 pounder cutting down to 135. That individual is not only running themselves at risk. But in the world that they’re wrestling someone, their own body weight, they’re running the risk of being injured. So as a parent, I see that very important. The BIA offers us the ability to be able to quantify and to see the measurable changes as the child goes through the process. Now, if you can look at these areas, now there are other areas. And one of the things that we have here, our chief editor has found out some really interesting dynamics, specifically how assessing BMI actually has other consequences and things that we can assess for those things. Astrid, one of the things that you’ve seen in the process when you have gone through the process, tell us a little bit about what you’ve found out about the BMI and BIA in terms of brain health.

 

[00:18:09] OK. So there are actually quite a few research studies that have been conducted on pretty much the importance of BMI and BIA and why it’s, you know, we all want to know these, I guess, these values so that, you know, because obesity or having excess weight, you know, which you use BMI and BIA to determine, you know, it can affect a variety of functions. And like you said, research studies have actually found that obesity can actually affect your brain health. And there’s actually like probably one of the biggest things like there are several things that obesity, can affect brain health because it increases inflammation in your body and it could even speed up the neurodegeneration process like your brain ages a lot faster.

 

[00:19:09] Wait a second. Wait a second. So, it actually makes your brain kind of lose its intelligence.

 

[00:19:15] I wouldn’t say it makes you lose your intelligence. It just makes it work slower. Slower. Yes. Ok.

 

[00:19:21] So brains that get smaller. Or let’s say dementia. Well, let’s say the brain becomes, loses its size and dimension.

 

[00:19:29] So those things we could, are correlated to BMI as well.

 

[00:19:34] Well, you want to know your, it’s important to know your BMI or your BIA.

 

[00:19:39] You know, interchangeably like depending on what would it be more important to know or the person? Because like research studies have found that if you have excess weight or if you have obesity, that it can actually change the size of your brain and it can decrease or just alter the gray matter and the white matter of the brain and that can age your brain a lot faster and it can slow down your cognitive functions and it can even affect your memory. And you’ll have a harder time remembering things simply by having excess weight.

 

[00:20:25] I read something today that said even dopamine is affected by, the production of dopamine potentially is correlatable or associated with BMI values.

 

[00:20:36] Ok. So what scientists have found is that if you have a lot of excess weight, you know, if you’re overweight or if you have, you’re a person with obesity.

 

[00:20:49] The thing is that.

 

[00:20:52] Excess weight or obesity, it can go as far as affecting what’s known as your pleasure and reward center of the brain. And that is, it’s pretty much the region of the brain that controls the release of dopamine. Just being like having obesity in itself could even cause your brain to release less amount of dopamine. And that can cause a variety of mental health issues. And it could even lead to depression just by having excess weight.

 

[00:21:26] So BMI, you know, let’s pop it up first to Alexander, make his screen bigger, let’s go to the HDMI. He’s noticed some things here. Alex, can you tell us a bit about what you’re actually putting up on there?

 

[00:21:36] Perfect. So you guys can see my screen right there? Yes, we sure can. Awesome. So like Astrid was saying that adipose tissue does have an effect on certain things.

 

[00:21:46] We have to take a look at adipose tissue at the cellular level. Normally, adipose tissue, large amounts in certain areas were meant for producing hormones and not all adipose tissue is created equally. So we could see that, here’s the average individual that would have what people call a beer gut. And here’s the pear-shaped as what a normal individual would have as well, for most females. So we could see that we have pear, which would be gynoid, and android, which would be apple. But we could see that males who tend to have these tend to produce a little bit more estrogen, affects the males differently. We can also see the ratio of significant health risks. So males have a 95 percent increase in percentage for developing other health risks while females are different. Now, when it comes to losing this type of way, we have to keep in mind that not all adipose tissue is created equally, as my professor likes to say. So we can see that even though we have the same amount of adipose tissue in both areas, they’re in completely different areas.

 

[00:22:48] So most of the time you’ll hear the saying that some women have trouble losing weight, which is correct because of their adipose tissue located in different areas. It’s not as metabolically active, which is good for them because they don’t produce as much hormones from it. They don’t get much stress from it. Now, on the other hand, the visceral fat releases hormones and this is the one that is problematic to individuals but can also be reduced a lot quicker. So when you’re kind of coming down to the breakdown of the main macromolecules of the bodies, we could see there were 5 percent minerals, calcium, 15 percent fat, 1 percent carbs, and 60 percent water mostly. So we can kind of see what the reference ranges are here for the reference man aged 20 to 24 years and the reference woman 20 to 24. And coming back to Mrs. Truide when she was mentioning what is the safe and recommended way? Well, it’s hit and miss. It’s different from males and females. For males you want to keep anywhere between always stay above 3 percent body fat, anything below that becomes detrimental and your body starts to break down. But for females, on the other hand, we can see that once they start dropping below 15 percentage, they actually will miss their period if it drops below that. So if a female athlete or a tri triathlete does this, it will, honestly. So there’s been cases where female athletes develop osteoporosis just because they produce less estrogen, only because they drop below that 15 percent body weight. And females need more adipose tissue than men. It’s just the way we came through evolution and we were designed and it’s just the way it is and needs to be. So for females, as long as they’re above 15 percent body fat, they’re always gonna be healthy. For males, it’s a long as long as it’s above 3 percent, they’re always going to be healthy. It’s very hard to attain 3 percent for males, but as long as they usually stay between this, you can kind of see what body masses, lean body masses muscle on kind of the breakdown of everything from there.

 

[00:24:48] Answering the question regarding Truide’s particular question, cause that’s the bottom line is, what is the 25-year-old mom? What is the mom that’s 27, 28 years old with a five year old little boy, with a 10 year old little boy. What is she got to do? Go ahead and put up the 550 up there for me. What we’re looking at here is we want to be able to quantify these things. And one of the things I’d like to show you that is available in today’s research is the ability to determine certain things. Body composition analysis takes a lot of different studies and a lot of different dynamics in its research. We’ve been able to look at questions that are more specific for someone like Truide and her child to be able to assess the variable changes, body composition. And we’re going to follow up with the follow up videos discussing this particular issue. But the studies today, we can actually see in this particular area that we can assess muscle body fat analysis and the ranges versus the total body fat. We can look at obesity analysis and we can measure the ranges, Ok? We can look at percent body fat. We can look at extremity segmental lean body analysis versus one arm versus the other. This particularly comes in and true because let’s assume someone has an ACL injury on the right leg or left leg. You’ll notice that there will be a variation of body mass changes and to be able to determine if the body protein in that leg is getting more developed, in a leg that has noted atrophy there will be obvious changes in terms of the amount of protein or the amount of difference in percent body fat as well as water retention in that area. If someone has a swollen knee, you can also see the difference. Now the total area and the body weight, we can start measuring and just start noticing this. This is what helps mother Truide’s around the world understand the continuous. You’ll notice down here on the bottom that there are reference dates here where we can actually see the changes as time goes by. And once you see the changes as time goes by, it gives you a lot better tools. Now, the other thing that we’ve noticed here in terms of this particular area is the awareness that we can actually do visceral body fat that Alexander referred to. We want to be able to see what is inside the body. Now, visceral body fat is if you open a body up, there’s fat that surrounds each area, like the liver, the intestines. We call it the peritoneal area, Pernille, area that basically holds the body fat and holds the amount of tissue to protect it. And that’s how nature has done it. But we want to know how much it is. And if it does produce hormones that are bad like cortisol or produces hormones, that we know about that for a different video, we can see that that would mean not good. So the person with fat that’s around the viscera is at higher risk. So that analysis and to be able to give a point and see the changes is very important. So one of the things is that we can do. And as we talked about here, you can actually see the impedance by the individual depending on which extremity it is. So the tests on a regular basis, those simple as that may be standing on a thing. They’re very complex and very accurate. So it does bode well for someone that really needs it, that has a family that is going through these kinds of techniques so that we can reassess. Initially, you can start someone with a, to be real detailed and to be accountable to the individual by specific gravity to determine the concentration of body, metabolites in the body, and the proteins, and the level of dehydration the person may have. Then you can follow up with a BIA repetitively through the history of a season and you can really get a lot of information as to how your child is going if it’s a healthy form of weight loss. So, Alex, I notice that you put up some things up there. Can you open that up? And you’re putting up some interesting dynamics there. What is it that you’re noticing there? What did you put there?

 

[00:28:32] So we can see that these are some of the graphs that I just got from classes here so we can see that correlation is not cause for causation, but it does correlate to the data of many individuals. This was taken from a study. And what they found is that people with a higher body mass index tend to have a higher risk for certain diseases, such as cardiovascular disease or cancer or all other causes, just illnesses in general. And we also have to keep in mind that women do have more receptors for those hormones produced by adipose tissue. So they are more susceptible to cancers. So we have to ask ourselves, what is the point of, you know, losing weight besides just the cancer thing? So we come down here, we can just see the correlation of the lifestyle of individuals just if they lose 10 percent body weight. So if their obesity is decreased, their life expectancy increases for about seven years. But not only that, but you can see where the circle of lifestyle changes for this individual who not only begins to change their lifestyle but also operates those healthy choices into their daily environment.

 

[00:29:42] Makes sense. So these are very, very important things to assess on a regular basis. So what I’ve learned is the BIA, BMI, in general, is a very important method to be able to assess the overall health and the progression of health. So we want to get a better BMI and we want to get a better, be able to assess the regions of the body and to assess the dynamics of what someone can do to monitor their true health. We’re going to be following through with follow-up studies and the follow-up information and on these follow-up programs to teach about what we use here in our little town of El Paso, which is a big town. But we’re gonna be bringing families. We’re gonna be bringing athletes to discuss those things. We’re gonna get real technical right on the screen right now. We have a real interesting dynamics to the level that we’re gonna be pushing the knowledge of. Can you pull back to the screen? You actually can see it right there. You can actually see biochemistry. And we have our resident and biochemistry expert right there. Alexander, tell us what we’re looking at there.

 

[00:30:46] So here we’re kind of going through the synthesis of cholesterol and what it takes to actually produce cholesterol. So it’s kind of a very complex pathway. But we can also see that it takes your body a lot of stress to really produce high cholesterol levels as well as cortisol levels. So kind of coming into the main breakdown of what kind of goes down, if you have a very increased dietary cholesterol intake, not only are you putting more stress on the liver, but you’re also increasing more LDL. LDL just tends to be bad in general because the LDL is…

 

[00:31:23] I’m sorry, Alex was is LDL?

 

[00:31:25] Low-density lipoprotein. Got it. So the problem with the low-density lipoproteins is that their main job is to drop off the correct cholesterol to the proper levels. Now if they turn into LDLs, the problem is that if they don’t get reabsorbed by the liver or a good way, I think of it as, they are thought of as a suicide bomber. Pretty much so. What they do is they deposit. If they don’t deposit and don’t get absorbed by the liver because the liver is being bombarded by too much cholesterol, they will actually deposit themselves into other tissues, specifically the epithelial lining of the extracellular part of capillaries. Then at that point macrophages will actually try to eat them up and create these things called foam cells. Foam cells tend to aggregate and they’re really large cells that have no purpose other than to aggregate within the layers of the capillaries.

 

[00:32:24] Is that what the protective mechanism, is that what the body does?

 

[00:32:27] It pretty much just tries to seal it off so it can’t affect anything else. But in doing so, it clogs arteries.

 

[00:32:33] Okay. So BMI would be able to determine the overall health of the body and fat. So it would tend to, we would tend to say that a person with a, let’s say a high BMI, extremely high BMI and the obese level would have more of this action happening. Right?

 

[00:32:49] Exactly. But we also have to take a look at a different thing. So let’s say this person is already morbidly obese and their cholesterol is high. So they go to an M.D., their M.D. gives them a statin. So statins are good to an extent. So, yes, they’re going to decrease the level of cholesterol, but they’re also going to decrease. See if I can find it here. The levels of all these other hormones being produced because cholesterol is the driving force for all these hormones. So if you are decreasing your cholesterol, you are decreasing for women their progesterone for men, their testosterone, their dihydrotestosterone was kind of what people describe as the old man’s strength. As you get older, you produce more DHT, but you’re also decreasing these. Not only are you decreasing cholesterol, but you’re also decreasing by 50 percent coenzyme-Q. Coenzyme-Q it was the main electron transporter for the electron transport chain and it transports electrons that certain parts in the pathway which we won’t go into. But if you decrease that by 50 percent, most of these people feel tired all the time. And what’s the tissue that has the most mitochondria in the entire body? Muscle. The heart. Oh, okay. So the heart. So not only are they decreasing their energy levels, they’re decreasing the ability of their actual lifeline, pretty much, their heart to produce and pump blood and get energy. So by just decreasing body weight, decreasing cholesterol intake in a moderate amount because cholesterol is good, we need it for everything. Too much of one thing can kill you, though. So within moderate amounts, exercise, dietary regimens, you won’t need to be put on statins and you can be weaned off of those in time as your cholesterol levels get to an appropriate level.

 

[00:34:37] That’s amazing, Alex. So that’s at the microscopic level. At the macroscopic level, we can assess that by visceral fat. So the more visceral fat you got, the more hormones you got going haywire. And it’s fair to say that we have a situation where you’re less healthy with visceral fat. Ok. So does anyone else have any input in here? Any other questions that you would want to know about Mrs. Truide as a mom of athletes?

 

[00:35:02] No, I guess just the woman on a side note, if all of this is very complex. The bottom line is if you’re having to lay down in your bed to tie your jeans, you’re not having a healthy BMI.

 

[00:35:14] That’s very true. Right. So basically, if your gut hangs over, you’re in trouble, right? So that’s where you can use the simple tests of the waist circumference or the waist-hip balance. And if pretty much the belly is three inches bigger than the hips, you are probably at a BMI that you shouldn’t have. So I hope. OK, go ahead. Astrid, you want to say something.

 

[00:35:36] So essentially, it’s just super important to find out your, I guess, your BMI or your BIA interchangeably pretty much for overall health, because just having excess weight, as we’ve found out here, it can affect a whole variety of functions. Brain health, cardiovascular, health, and finding your BMI and your BIA seems like such an easy, you know, like an easy way to kind of find out if your weight is like at a healthier range. And it all kind of goes like hand-in-hand with all these things, as you’ve explained and as Alex explained. Pretty much like being, having obesity or excess weight, it can just disrupt our entire body, our entire system.

 

[00:36:37] Exactly. Kenna. Any other comments in terms of specifics on questions?

 

[00:36:43] Not for questions, just for that waist to hip ratio. We’re gonna want to make sure that for women, they’re under one. And the same thing for males. So you’re gonna divide your waist by your hip ratio to get that number. Right.

 

[00:36:58] So the numerator hopefully won’t be too bigger than the denominator, right? Yeah. So that would be the numerator would be the waist and the denominator would be the hip. Right. So we want to keep those in line. So all those kinds of things are very important. We’ve learned a lot today. We’re going to come back with a much more elaborate and we’re gonna splice this up in many ways. I want to thank Alexander for coming in from Illinois at the National University of Health Sciences way out there. This probably about 2000 miles away. We have Truide, Mrs. Truide who’s giving us a point of view. We have Astrid who’s given us the scientific approach of the brain and dopamine connection. But we also need to know that there’s a lot of reasons why the BMI. As we learn every day through the NCBI research institutes of information, that there are lots of reasons why to keep a BMI low and also to make sure you watch your BIAs in time. So we look forward to bringing it to you. And we thank you for watching us and we look forward to giving more information. Alexander, thank you so much for coming from a distance and making it real cool for us all.

 

[00:38:01] Ok, thank you. Thank you for having me. You’re welcome. Appreciate it. Thanks.

 


 

 

Additional Topic Discussion: Chronic Pain

Sudden pain is a natural response of the nervous system which helps to demonstrate possible injury. By way of instance, pain signals travel from an injured region through the nerves and spinal cord to the brain. Pain is generally less severe as the injury heals, however, chronic pain is different than the average type of pain. With chronic pain, the human body will continue sending pain signals to the brain, regardless if the injury has healed. Chronic pain can last for several weeks to even several years. Chronic pain can tremendously affect a patient’s mobility and it can reduce flexibility, strength, and endurance.

 

 


 

Neural Zoomer Plus for Neurological Disease

Neural Zoomer Plus | El Paso, TX Chiropractor

 

Dr. Alex Jimenez utilizes a series of tests to help evaluate neurological diseases. The Neural ZoomerTM Plus is an array of neurological autoantibodies which offers specific antibody-to-antigen recognition. The Vibrant Neural ZoomerTM Plus is designed to assess an individual�s reactivity to 48 neurological antigens with connections to a variety of neurologically related diseases. The Vibrant Neural ZoomerTM Plus aims to reduce neurological conditions by empowering patients and physicians with a vital resource for early risk detection and an enhanced focus on personalized primary prevention.

 

Food Sensitivity for the IgG & IgA Immune Response

Food Sensitivity Zoomer | El Paso, TX Chiropractor

 

Dr. Alex Jimenez utilizes a series of tests to help evaluate health issues associated with a variety of food sensitivities and intolerances. The Food Sensitivity ZoomerTM is an array of 180 commonly consumed food antigens that offers very specific antibody-to-antigen recognition. This panel measures an individual�s IgG and IgA sensitivity to food antigens. Being able to test IgA antibodies provides additional information to foods that may be causing mucosal damage. Additionally, this test is ideal for patients who might be suffering from delayed reactions to certain foods. Utilizing an antibody-based food sensitivity test can help prioritize the necessary foods to eliminate and create a customized diet plan around the patient�s specific needs.

 

Gut Zoomer for Small Intestinal Bacterial Overgrowth (SIBO)

Gut Zoomer | El Paso, TX Chiropractor

 

Dr. Alex Jimenez utilizes a series of tests to help evaluate gut health associated with small intestinal bacterial overgrowth (SIBO). The Vibrant Gut ZoomerTM offers a report that includes dietary recommendations and other natural supplementation like prebiotics, probiotics, and polyphenols. The gut microbiome is mainly found in the large intestine and it has more than 1000 species of bacteria that play a fundamental role in the human body, from shaping the immune system and affecting the metabolism of nutrients to strengthening the intestinal mucosal barrier (gut-barrier). It is essential to understand how the number of bacteria that symbiotically live in the human gastrointestinal (GI) tract influences gut health because imbalances in the gut microbiome may ultimately lead to gastrointestinal (GI) tract symptoms, skin conditions, autoimmune disorders, immune system imbalances, and multiple inflammatory disorders.

 


Dunwoody Labs: Comprehensive Stool with Parasitology | El Paso, TX Chiropractor


GI-MAP: GI Microbial Assay Plus | El Paso, TX Chiropractor


 

Formulas for Methylation Support

Xymogen Formulas - El Paso, TX

 

XYMOGEN�s Exclusive Professional Formulas are available through select licensed health care professionals. The internet sale and discounting of XYMOGEN formulas are strictly prohibited.

 

Proudly,�Dr. Alexander Jimenez makes XYMOGEN formulas available only to patients under our care.

 

Please call our office in order for us to assign a doctor consultation for immediate access.

 

If you are a patient of Injury Medical & Chiropractic�Clinic, you may inquire about XYMOGEN by calling 915-850-0900.

xymogen el paso, tx

 

For your convenience and review of the XYMOGEN products please review the following link. *XYMOGEN-Catalog-Download

 

* All of the above XYMOGEN policies remain strictly in force.

 


 

 


 

Modern Integrated Medicine

The National University of Health Sciences is an institution that offers a variety of rewarding professions to attendees. Students can practice their passion for helping other people achieve overall health and wellness through the institution’s mission. The National University of Health Sciences prepares students to become leaders in the forefront of modern integrated medicine, including chiropractic care. Students have an opportunity to gain unparalleled experience at the National University of Health Sciences to help restore the natural integrity of the patient and define the future of modern integrated medicine.

 

 

Three Metabolic Energy Systems

Three Metabolic Energy Systems

Personal Training 101

energy personal trainer

How You Get Energy & How You Use It

energy asparagus eggs tomatos We usually talk of energy in general terms, as in �I don�t have a lot of energy today� or �You can feel the energy in the room.� But what really is energy? Where do we get the energy to move? How do we use it? How do we get more of it? Ultimately, what controls our movements? The three metabolic energy pathways are the�phosphagen system, glycolysis�and the�aerobic system.�How do they work, and what is their effect?

Albert Einstein, in his infinite wisdom, discovered that the total energy of an object is equal to the mass of the object multiplied by the square of the speed of light. His formula for atomic energy, E = mc2, has become the most recognized mathematical formula in the world. According to his equation, any change in the energy of an object causes a change in the mass of that object. The change in energy can come in many forms, including mechanical, thermal, electromagnetic, chemical, electrical or nuclear. Energy is all around us. The lights in your home, a microwave, a telephone, the sun; all transmit energy. Even though the solar energy that heats the earth is quite different from the energy used to run up a hill, energy, as the first law of thermodynamics tells us, can be neither created nor destroyed. It is simply changed from one form to another.

ATP Re-Synthesis

energyThe energy for all physical activity comes from the conversion of high-energy phosphates (adenosine�triphosphate�ATP) to lower-energy phosphates (adenosine�diphosphate�ADP; adenosine�monophosphate�AMP; and inorganic phosphate, Pi). During this breakdown (hydrolysis) of ATP, which is a water-requiring process, a proton, energy and heat are produced: ATP + H2O ��ADP + Pi�+ H+�+ energy + heat. Since our muscles don�t store much ATP, we must constantly resynthesize it. The hydrolysis and resynthesis of ATP is thus a circular process�ATP is hydrolyzed into ADP and Pi, and then ADP and Pi�combine to resynthesize ATP. Alternatively, two ADP molecules can combine to produce ATP and AMP: ADP + ADP ��ATP + AMP.

Like many other animals, humans produce ATP through three metabolic pathways that consist of many enzyme-catalyzed chemical reactions: the phosphagen system, glycolysis and the aerobic system. Which pathway your clients use for the primary production of ATP depends on how quickly they need it and how much of it they need. Lifting heavy weights, for instance, requires energy much more quickly than jogging on the treadmill, necessitating the reliance on different energy systems. However, the production of ATP is never achieved by the exclusive use of one energy system, but rather by the coordinated response of all energy systems contributing to different degrees.

1. Phosphagen System

energy woman sit-ups on machineDuring short-term, intense activities, a large amount of power needs to be produced by the muscles, creating a high demand for ATP. The phosphagen system (also called the ATP-CP system) is the quickest way to resynthesize ATP (Robergs & Roberts 1997). Creatine phosphate (CP), which is stored in skeletal muscles, donates a phosphate to ADP to produce ATP: ADP + CP ��ATP + C. No carbohydrate or fat is used in this process; the regeneration of ATP comes solely from stored CP. Since this process does not need oxygen to resynthesize ATP, it is anaerobic, or oxygen-independent. As the fastest way to resynthesize ATP, the phosphagen system is the predominant energy system used for all-out exercise lasting up to about 10 seconds. However, since there is a limited amount of stored CP and ATP in skeletal muscles, fatigue occurs rapidly.

2. Glycolysis

energyGlycolysis is the predominant energy system used for all-out exercise lasting from 30 seconds to about 2 minutes and is the second-fastest way to resynthesize ATP. During glycolysis, carbohydrate�in the form of either blood glucose (sugar) or muscle glycogen (the stored form of glucose)�is broken down through a series of chemical reactions to form pyruvate (glycogen is first broken down into glucose through a process called�glycogenolysis). For every molecule of glucose broken down to pyruvate through glycolysis, two molecules of usable ATP are produced (Brooks et al. 2000). Thus, very little energy is produced through this pathway, but the trade-off is that you get the energy quickly. Once pyruvate is formed, it has two fates: conversion to lactate or conversion to a metabolic intermediary molecule called acetyl coenzyme A (acetyl-CoA), which enters the mitochondria for oxidation and the production of more ATP (Robergs & Roberts 1997). Conversion to lactate occurs when the demand for oxygen is greater than the supply (i.e., during anaerobic exercise). Conversely, when there is enough oxygen available to meet the muscles� needs (i.e., during aerobic exercise), pyruvate (via acetyl-CoA) enters the mitochondria and goes through aerobic metabolism.

When oxygen is not supplied fast enough to meet the muscles� needs (anaerobic glycolysis), there is an increase in hydrogen ions (which causes the muscle pH to decrease; a condition called acidosis) and other metabolites (ADP, Pi�and potassium ions). Acidosis and the accumulation of these other metabolites cause a number of problems inside the muscles, including inhibition of specific enzymes involved in metabolism and muscle contraction, inhibition of the release of calcium (the trigger for muscle contraction) from its storage site in muscles, and interference with the muscles� electrical charges (Enoka & Stuart 1992; Glaister 2005; McLester 1997). As a result of these changes, muscles lose their ability to contract effectively, and muscle force production and exercise intensity ultimately decrease.

3. Aerobic System

energySince humans evolved for aerobic activities (Hochachka, Gunga & Kirsch 1998; Hochachka & Monge 2000), it�s not surprising that the aerobic system, which is dependent on oxygen, is the most complex of the three energy systems. The metabolic reactions that take place in the presence of oxygen are responsible for most of the cellular energy produced by the body. However, aerobic metabolism is the slowest way to resynthesize ATP. Oxygen, as the patriarch of metabolism, knows that it is worth the wait, as it controls the fate of endurance and is the sustenance of life. �I�m oxygen,� it says to the muscle, with more than a hint of superiority. �I can give you a lot of ATP, but you will have to wait for it.�

The aerobic system�which includes the�Krebs cycle�(also called the�citric acid cycle or TCA cycle) and the�electron transport chain�uses blood glucose, glycogen and fat as fuels to resynthesize ATP in the mitochondria of muscle cells (see the sidebar �Energy System Characteristics�). Given its location, the aerobic system is also called�mitochondrial respiration.�When using carbohydrate, glucose and glycogen are first metabolized through glycolysis, with the resulting pyruvate used to form acetyl-CoA, which enters the Krebs cycle. The electrons produced in the Krebs cycle are then transported through the electron transport chain, where ATP and water are produced (a process called�oxidative phosphorylation) (Robergs & Roberts 1997). Complete oxidation of glucose via glycolysis, the Krebs cycle and the electron transport chain produces 36 molecules of ATP for every molecule of glucose broken down (Robergs & Roberts 1997). Thus, the aerobic system produces 18 times more ATP than does anaerobic glycolysis from each glucose molecule.

energyFat, which is stored as triglyceride in adipose tissue underneath the skin and within skeletal muscles (called�intramuscular triglyceride), is the other major fuel for the aerobic system, and is the largest store of energy in the body. When using fat, triglycerides are first broken down into free fatty acids and glycerol (a process called�lipolysis). The free fatty acids, which are composed of a long chain of carbon atoms, are transported to the muscle mitochondria, where the carbon atoms are used to produce acetyl-CoA (a process called�beta-oxidation).

Following acetyl-CoA formation, fat metabolism is identical to carbohydrate metabolism, with acetyl-CoA entering the Krebs cycle and the electrons being transported to the electron transport chain to form ATP and water. The oxidation of free fatty acids yields many more ATP molecules than the oxidation of glucose or glycogen. For example, the oxidation of the fatty acid palmitate produces 129 molecules of ATP (Brooks et al. 2000). No wonder clients can sustain an aerobic activity longer than an anaerobic one!

Understanding how energy is produced for physical activity is important when it comes to programming exercise at the proper intensity and duration for your clients. So the next time your clients get done with a workout and think, �I have a lot of energy,� you�ll know exactly where they got it.

Energy System Characteristics
energy

Energy System Workouts

Have clients warm up and cool down before and after each workout.

Phosphagen System

An effective workout for this system is short, very fast sprints on the treadmill or bike lasting 5�15 seconds with 3�5 minutes of rest between each. The long rest periods allow for complete replenishment of creatine phosphate in the muscles so it can be reused for the next interval.

  • 2 sets of 8 x 5 seconds at close to top speed with 3:00 passive rest and 5:00 rest between sets
  • 5 x 10 seconds at close to top speed with 3:00�4:00 passive rest

Glycolysis

This system can be trained using fast intervals lasting 30 seconds to 2 minutes with an active-recovery period twice as long as the work period (1:2 work-to-rest ratio).

  • 8�10 x 30 seconds fast with 1:00 active recovery
  • 4 x 1:30 fast with 3:00 active recovery

Aerobic System

While the phosphagen system and glycolysis are best trained with intervals, because those metabolic systems are emphasized only during high-intensity activities, the aerobic system can be trained with both continuous exercise and intervals.

  • 60 minutes at 70%�75% maximum heart rate
  • 15- to 20-minute tempo workout at lactate threshold intensity (about 80%�85% maximum heart rate)
  • 5 x 3:00 at 95%�100% maximum heart rate with 3:00 active recovery

by�Jason Karp, PhD

read more button

References:

Brooks, G.A., et al. 2000.�Exercise Physiology: Human Bioenergetics and Its Applications.Mountain View, CA: Mayfield.

Enoka, R.M., & Stuart, D.G. 1992. Neurobiology of muscle fatigue.�Journal of Applied Physiology, 72�(5), 1631�48.

Glaister, M. 2005. Multiple sprint work: Physiological responses, mechanisms of fatigue and the influence of aerobic fitness.�Sports Medicine, 35�(9), 757�77.

Hochachka, P.W., Gunga, H.C., & Kirsch, K. 1998. Our ancestral physiological phenotype: An adaptation for hypoxia tolerance and for endurance performance?�Proceedings of the National Academy of Sciences, 95,�1915�20.

Hochachka, P.W., & Monge, C. 2000. Evolution of human hypoxia tolerance physiology.�Advances in Experimental and Medical Biology, 475,�25�43.

McLester, J.R. 1997. Muscle contraction and fatigue: The role of adenosine 5′-diphosphate and inorganic phosphate.�Sports Medicine, 23�(5), 287�305.

Robergs, R.A. & Roberts, S.O. 1997.�Exercise Physiology: Exercise, Performance, and Clinical Applications.�Boston: William C. Brown.

Dietary Strategies: Treatment Of Metabolic Syndrome

Dietary Strategies: Treatment Of Metabolic Syndrome

Dietary Strategies:

Abstract: Metabolic syndrome (MetS) is established as the combination of central obesity and different metabolic disturbances, such as insulin resistance, hypertension and dyslipidemia. This cluster of factors affects approximately 10%�50% of adults worldwide and the prevalence has been increasing in epidemic proportions over the last years. Thus, dietary strategies to treat this heterogenic disease are under continuous study. In this sense, diets based on negative-energy-balance, the Mediterranean dietary pattern, n-3 fatty acids, total antioxidant capacity and meal frequency have been suggested as effective approaches to treat MetS. Furthermore, the type and percentage of carbohydrates, the glycemic index or glycemic load, and dietary fiber content are some of the most relevant aspects related to insulin resistance and impaired glucose tolerance, which are important co-morbidities of MetS. Finally, new studies focused on the molecular action of specific nutritional bioactive compounds with positive effects on the MetS are currently an objective of scientific research worldwide. The present review summarizes some of the most relevant dietary approaches and bioactive compounds employed in the treatment of the MetS to date.

Keywords: metabolic syndrome; dietary strategies; bioactive compounds

1. Metabolic Syndrome

dietary healthy unhealthy foodIt was during the period between 1910 and 1920 when it was suggested for the first time that a cluster of associated metabolic disturbances tended to coexist together [1]. Since then, different health organisms have suggested diverse definitions for metabolic syndrome (MetS) but there has not yet been a well-established consensus. The most common definitions are summarized in Table 1. What is clear for all of these is that the MetS is a clinical entity of substantial heterogeneity, commonly represented by the combination of obesity (especially abdominal obesity), hyperglycemia, dyslipidemia and/or hypertension [2�6].

dietary table 1

Obesity consists of an abnormal or excessive fat accumulation, for which the main cause is a chronic imbalance between energy intake and energy expenditure [7,8]. The excess of energy consumed is primarily deposited in the adipose tissue as triglycerides (TG) [9].

Dyslipidemia encompasses elevated serum TG levels, increased low density lipoprotein- cholesterol (LDL-c) particles, and reduced levels of high density lipoprotein-cholesterol (HDL-c) [10]. It is associated with hepatic steatosis [11], dysfunction of pancreatic ?-cells [12] and elevated risk of atherosclerosis [13], among others.

Another main modifiable MetS manifestation is hypertension, which is mainly defined as a resting systolic blood pressure (SBP) ? 140 mmHg or diastolic blood pressure (DBP) ? 90 mmHg or drug prescription to lower hypertension [14]. It usually involves narrowed arteries and is identified as a major cardiovascular and renal risk factor, related to heart and vascular disease, stroke and myocardial infarction [13,15�17].

Hyperglycemia, related insulin resistance and type 2 diabetes mellitus are characterized by an impaired uptake of glucose by the cells, that lead to elevated plasma glucose levels, glycosuria and ketoacidosis [18]. It is responsible for different tissue damage that shortens the life expectancy of diabetics, involving cardiovascular diseases (CVD), atherosclerosis, hypertension [19], ?-cell dysfunction [12], kidney disease [20] or blindness [21]. Currently, diabetes is considered the leading cause of death in developed countries [22].

Moreover, oxidative stress and low grade inflammation are two important mechanisms implicated in the etiology, pathogenesis, and development of MetS [23]. Oxidative stress is defined as an imbalance between the pro-oxidants and antioxidants in the body [24]. It plays a key role in the development of atherosclerosis by different mechanisms such as the oxidation of LDL-c particles [25] or impairment of HDL-c functions [26]. Inflammation is an immune system response to injury hypothesized to be a major mechanism in the pathogenesis and progression of obesity related disorders and the link between adiposity, insulin resistance, MetS and CVD [27].

Although the prevalence of the MetS varies broadly around the word and depends on the source used for its definition, it is clear that over the last 40�50 years the number of people presenting with this syndrome has risen in epidemic proportions [28]. Moreover, the frequency of this syndrome is increased in developed countries, sedentary people, smokers, low socioeconomic status population, as well as in individuals with unhealthy dietary habits [29,30].

For all of this, there is currently a wide concern to find effective strategies to detect, treat and control the comorbidities associated with MetS. This is a complex challenge as MetS is a clinical entity of substantial heterogeneity and therefore, the different cornerstones implicated in its development should be addressed. In this review we compiled and examined different dietary patterns and bioactive compounds that have pointed out to be effective in MetS treatment.

2. Dietary Patterns

dietarySeveral dietary strategies and their potential positive effects on the prevention and treatment of the different metabolic complications associated to the MetS, are described below and summarized in Table 2.

dietary table 22.1. Energy-Restricted Diet Strategies

dietary

Energy restricted diets are probably the most commonly used and studied dietary strategies for combating excess weight and related comorbidities. They consist in personalized regimes that supply less calories than the total energy expended by a specific individual [31].

A hypocaloric diet results in a negative energy balance and subsequently, in body weight reduction [31]. Weight loss is achieved via fat mobilization from different body compartments as a consequence of the lipolysis process necessary to provide energy substrate [32,33]. In people who are overweight or suffering from obesity, as is the case of most people with MetS, weight loss is important as it is associated with improvement of related disorders such as abdominal obesity (visceral adipose tissue), type 2 diabetes, CVD or inflammation [32�36].

Moreover, as described above, low grade inflammation is associated with MetS and obesity. Therefore, of particular importance is the fact that in obese individuals following a hypocaloric diet, a depletion of plasma inflammatory markers such as interleukin (IL)-6 has been observed [34]. Thus, caloric restriction in obese people suffering MetS may improve the whole-body pro-inflammatory state.

At the same time, body weight reduction is associated with improvements in cellular insulin signal transduction, increments in peripheral insulin sensitivity and higher robustness in insulin secretory responses [32,36]. People with excess body weight who are at risk of developing type 2 diabetes, may benefit from a hypocaloric regime by improving plasma glucose levels and insulin resistance.

In addition, different intervention trials have reported a relationship between energy restricted diets and lower risk of developing CVD. In this sense, in studies with obese people following a hypocaloric diet, improvements in lipid profile variables such as reductions of LDL-c and plasma�TG levels, as well as improvements in hypertension via depletion of SBP and DBP levels have been observed [35,37].

Among the different nutritional intervention trials, a reduction of 500�600 kcal a day of the energy requirements is a well-established hypocaloric dietary strategy, which has demonstrated to be effective in weight reduction [38,39]. However, the challenge lies in maintaining the weight loss over time, as many subjects can follow a prescribed diet for a few months, but most people have difficulty in maintaining the acquired habits over the long term [40,41].

2.2. Diets Rich in Omega-3 Fatty Acids

dietary foods omega 3 infographicThe very long-chain eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are essential omega-3 polyunsaturated fatty acids (n-3 PUFAs) for human physiology. Their main dietary sources are fish and algal oils and fatty fish, but they can also be synthesized by humans from ?-linolenic acid [40].

There is a moderate body of evidence suggesting that n-3 PUFAs, mainly EPA and DHA, have a positive role in the prevention and treatment of the pathologies associated to MetS [42].

In this context, it has been described that EPA and DHA have the ability to reduce the risk of developing CVD and cardiometabolic abnormalities as well as CVD-related mortality [42]. These beneficial effects are thought to be mainly due to the ability of these essential fatty acids to reduce plasma TG levels [43].

Moreover, different studies have shown that people following an increased n-3 PUFA diet have reduced plasma levels of the pro-inflammatory cytokines IL-6 and tumor necrosis factor-alpha (TNF?), as well as plasma C-reactive protein (CRP) [44]. These effects are probably mediated by resolvins, maresins and protectins, which are EPA and DHA metabolic products with anti-inflammatory properties [44].

There are some studies that have observed an association between n-3 ingestion and improvements or prevention of type 2 diabetes development. However, other studies found opposite results [44]. Thus, it cannot be made any specific affirmation in this respect.

The European Food Safety Authority recommends and intake of 250 mg EPA + DHA a day, in the general healthy population as a primary prevention of CVD [45]. These amounts can be achieved with an ingestion of 1�2 fatty fish meals per week [45].

2.3. Diets Based on Low Glycemic Index/Load

dietary salad unconstructedOver the last ten years, the concern about the quality of the carbohydrates (CHO) consumed has risen [46]. In this context, the glycemic index (GI) is used as a CHO quality measure. It consists in a ranking on a scale from 0 to 100 that classifies carbohydrate-containing foods according to the postprandial glucose response [47]. The higher the index, the more promptly the postprandial serum glucose rises and the more rapid the insulin response. A quick insulin response leads to rapid hypoglycemia, which is suggested to be associated with an increment of the feeling of hunger and to a subsequent higher caloric intake [47]. The glycemic load (GL) is equal to the GI multiplied by the number of grams of CHO in a serving [48].

There is a theory which states that MetS is a consequence of an elevated intake of high GI foods over time, among others unhealthy dietary habits [49]. In this sense, following a diet rich in high GI CHO has been associated with hyperglycemia, insulin resistance, type 2 diabetes, hypertriglyceridemia, CVD, and obesity [47,50,51], abnormalities directly related to MetS.

On the contrary, a low GI diet has been associated with slower absorption of the CHO and subsequently smaller blood glucose fluctuations, which indicate better glycemic control [46]. In patients with type 2 diabetes, diets based on low GI are associated with reductions in glycated hemoglobin (HbA1c) and fructosamine blood levels, two biomarkers used as key monitoring factors in diabetes management [52,53].

For all of this, it is common to find the limitation of CHO at high GI among the advice for MetS treatment [28], in particular with respect to �ready-to-eat processed foods� including sweetened beverages, soft drinks, cookies, cakes, candy, juice drinks, and other foods which contain high amounts of added sugars [54].

2.4. Diets with High Total Antioxidant Capacity

dietary antioxidant foodsDietary total antioxidant capacity (TAC) is an indicator of diet quality defined as the sum of antioxidant activities of the pool of antioxidants present in a food [55]. These antioxidants have the capacity to act as scavengers of free radicals and other reactive species produced in the organisms [56]. Taking into account that oxidative stress is one of the remarkable unfortunate physiological states of MetS, dietary antioxidants are of main interest in the prevention and treatment of this multifactorial disorder [57]. Accordingly, it is well-accepted that diets with a high content of spices, herbs, fruits, vegetables, nuts and chocolate, are associated with a decreased risk of oxidative stress-related diseases development [58�60]. Moreover, several studies have analyzed the effects of dietary TAC in individuals suffering from MetS or related diseases [61,62]. In the Tehran Lipid and Glucose Study it was demonstrated that a high TAC has beneficial effects on metabolic disorders and especially prevents weight and abdominal fat gain [61]. In the same line, research conducted in our institutions also evidenced that beneficial effects on body weight, oxidative stress biomarkers and other MetS features were positively related with higher TAC consumption in patients suffering from MetS [63�65].

In this sense, the World Health Organization (WHO) recommendation for fruit and vegetables consumption (high TAC foods) for the general population is a minimum of 400 g a day [66]. Moreover, cooking with spices is recommended in order to increase the TAC dietary intake and, at the same time, maintain flavor while reducing salt [67].

2.5. Moderate-High Protein Diets

dietary Protein rich FoodsThe macronutrient distribution set in a weight loss dietary plan has commonly been 50%�55% total caloric value from CHO, 15% from proteins and 30% from lipids [57,68]. However, as most people have difficulty in maintaining weight loss achievements over time [69,70], research on increment of protein intake (>20%) at the expense of CHO was carried out [71�77].

Two mechanisms have been proposed to explain the potential beneficial effects of high-moderate protein diets: the increment of diet-induced thermogenesis [73] and the increase of satiety [78]. The increment of the thermogenesis is explained by the synthesis of peptide bonds, production of urea and gluconeogenesis, which are processes with a higher energy requirement than the metabolism of lipids or CHO [75]. An increment of different appetite-control hormones such as insulin, cholecystokinin or glucagon-like peptide 1, may clarify the satiety effect [79].

Other beneficial effects attributed to moderate-high protein diets in the literature are the improvement of glucose homeostasis [80], the possibility of lower blood lipids [81], the reduction of blood pressure [82], the preservation of lean body mass [83] or the lower of cardiometabolic disease risk [84,85]. However, there are other studies that have not found benefits associated to a moderate-high protein diet [76]. This fact may be explained by the different type of proteins and their amino acid composition [80], as well as by the different type of populations included in each study [85]. Therefore, more research in the field is needed in order to make these results consistent.

In any case, when a hypocaloric diet is implemented, it is necessary to slightly increase the amount of proteins. Otherwise it would be difficult to reach the protein energy requirements, established as 0.83 g/kg/day for isocaloric diets and which should probably be at least 1 g/kg/day for energy-restricted diets [86].

2.6. High Meal Frequency Pattern

dietary eating time

The pattern of increasing meal frequency in weight loss and weight control interventions has currently become popular among professionals [87,88]. The idea is to distribute the total daily energy�intake into more frequently and smaller meals. However, there is no strong evidence about the efficacy of this habit yet [89]. While some investigations have found an inverse association between the increment of meals per day and body weight, body mass index (BMI), fat mass percentage or metabolic diseases such as coronary heart disease or type 2 diabetes [71,88,90�92], others have found no association [93�95].

Different mechanisms by which high meal frequency can have a positive effect on weight and metabolism management have been proposed. An increment of energy expenditure was hypothesized; however, the studies carried out in this line have concluded that total energy expenditure does not differ among different meal frequencies [96,97]. Another postulated hypothesis is that the greater the number of meals a day, the higher the fat oxidation, but again no consensus has been achieved [89,98]. An additional suggested mechanism is that increasing meal frequency leads to plasma glucose levels with lower oscillations and reduced insulin secretion which is thought to contribute to a better appetite control. However, these associations have been found in population with overweight or high glucose levels but in normal-weight or normoglycaemic individuals the results are still inconsistent [93,99�101].

2.7. The Mediterranean Diet

dietary Mediterranean DietThe concept of the Mediterranean Diet (MedDiet) was for the first time defined by the scientific Ancel Keys who observed that those countries around the Mediterranean Sea, which had a characteristic diet, had less risk of suffering coronary heart diseases [102,103].

The traditional MedDiet is characterized by a high intake of extra-virgin olive oil and plant foods (fruits, vegetables, cereals, whole grains, legumes, tree nuts, seeds and olives), low intakes of sweets and red meat and moderate consumption of dairy products, fish and red wine [104].

There is a lot of literature supporting the general health benefits of the MedDiet. In this sense, it has been reported that a high adherence to this dietary pattern protects against mortality and morbidity from several causes [105]. Thus, different studies suggested the MedDiet as a successful tool for the prevention and treatment of MetS and related comorbidities [106�108]. Moreover, recent meta-analysis concluded that the MedDiet is associated with less risk of developing type 2 diabetes and with a better glycemic control in people with this metabolic disorder [107,109,110]. Other studies have found a positive correlation between the adherence to a MedDiet pattern and reduced risk of developing CVD [111�114]. In fact, many studies have found a positive association between following a MedDiet and improvements in lipid profile by reduction of total cholesterol, LDL-c and TG, and an increase in HDL-c [111�115]. Finally, different studies also suggest that the MedDiet pattern may be a good strategy for obesity treatment as it has been associated with significant reductions in body weight and waist circumference [108,116,117].

The high amount of fiber which, among other beneficial effects, helps to weight control providing satiety; and the high antioxidants and anti-inflammatory nutrients such as n-3 fatty acids, oleic acid or phenolic compounds, are thought to be the main contributors to the positive effects attributed to the MedDiet [118].

For all these reasons, efforts to maintain the MedDiet pattern in Mediterranean countries and to implement this dietary habits in westernized countries with unhealthy nutritional patterns should be made.

3. Dietary: Single Nutrients and Bioactive Compounds

dietary Nutrition single nutrientNew studies focused on the molecular action of nutritional bioactive compounds with positive effects on MetS are currently an objective of scientific research worldwide with the aim of designing more personalized strategies in the framework of molecular nutrition. Among them, flavonoids and antioxidant vitamins are some of the most studied compounds with different potential benefits such as antioxidant, vasodilatory, anti-atherogenic, antithrombotic, and anti-inflammatory effects [119]. Table 3 summarizes different nutritional bioactive compounds with potential positive effects on MetS, including the possible molecular mechanism of action involved.

dietary table 3

3.1. Ascorbate

dietary AscorbateVitamin C, ascorbic acid or ascorbate is an essential nutrient as human beings cannot synthesize it. It is a water-soluble antioxidant mainly found in fruits, especially citrus (lemon, orange), and vegetables (pepper, kale) [120]. Several beneficial effects have been associated to this vitamin such as antioxidant and anti-inflammatory properties and prevention or treatment of CVD and type 2 diabetes [121�123].

This dietary component produces its antioxidant effect primarily by quenching damaging free radicals and other reactive oxygen and nitrogen species and therefore preventing molecules such as LDL-c from oxidation [122]. It can also regenerate other oxidized antioxidants like tocopherol [124].

Moreover, it has been described that ascorbic acid may reduce inflammation as it is associated with depletion of CRP levels [125]. This is an important outcome to take in consideration in the treatment of MetS sufferers, as they usually present low grade inflammation [27].

Supplementation with vitamin C have also been associated with prevention of CVD by improving the endothelial function [126] and probably by lowering blood pressure [121]. These effects are thought to be exerted by the ability of vitamin C to enhance the endothelial nitric oxide synthase enzyme (eNOS) activity and to reduce HDL-c glycation [127].

Additionally, several studies have attributed to ascorbate supplementation an antidiabetic effect by improving whole body insulin sensitivity and glucose control in people with type 2 diabetes [123]. These antidiabetic properties are thought to be mediated by optimization of the insulin secretory function of the pancreatic islet cells by increasing muscle sodium-dependent vitamin C transporters (SVCTs) [128].

Despite all of this, it should be taken into account that most people reach ascorbic acid requirements (established at 95�110 mg/day in the general population) from diet and do not need supplementation [122,129]. Besides, it should be considered that an excess of vitamin C ingestion leads to the opposite effect and oxidative particles are formed [130,131].

3.2. Hydroxytyrosol

dietary HydroxytyrosolHydroxytyrosol (3,4-dihydroxyphenylethanol) is a phenolic compound mainly found in olives [132].

It is considered the strongest antioxidant of olive oil and one of the main antioxidants in nature [133]. It acts as a powerful scavenger of free radicals, as a radical chain breaker and as metal chelator [134]. It has the ability of inhibiting LDL-c oxidation by macrophages [132]. In this sense, it is the only phenol recognized by the European Food Safety Authority (EFSA) as a protector of blood lipids from oxidative damage [135].

Hydroxytyrosol has also been reported to have anti-inflammatory effects, probably by suppressing cyclooxygenase activity and inducing eNOS expression [136]. Thus, enhancement of olives/olive oil intakes or hydroxytyroxol supplementation in people suffering from MetS may be a good strategy in order to improve inflammatory status.

Another beneficial effect attributed to this phenolic compound is its cardiovascular protective effect. It presents anti-atherogenic properties by decreasing the expression of vascular cell adhesion protein 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) [132,137], which are probably the result of an inactivation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF?B), activator protein 1 (AP-1), GATA transcription factor and nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase [138,139]. Hydroxytyrosol also provides antidyslipidemic effects by lowering plasma levels of LDL-c, total cholesterol and TG, and by rising HDL-c [138].

Despite the beneficial effects attributed to hydfroxytyrosol as an antioxidant, for its antiinflamatory properties and as cardiovascular protector, it should be taken into account that most studies focused on this compound have been performed with mixtures of olive phenols, thus a synergic effect cannot be excluded [140].

3.3. Quercetin

dietaryQuercetin is a predominant flavanol naturally present in vegetables, fruits, green tea or red wine. It is commonly found as glycoside forms, where rutin is the most common and important structure found in nature [141].

Many beneficial effects that can contribute to MetS improvement have been attributed to quercetin. Among them, its antioxidant capacity should be highlighted, as it has been reported to inhibit lipid peroxidation and increase antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT) or glutathione peroxidase (GPX) [142].

Moreover, an anti-inflammatory effect mediated via attenuation of tumor necrosis factor ? (TNF-?), NF?B and mitogen-activated protein kinases (MAPK), as well as depletion of IL-6, IL-1?, IL-8 or monocyte chemoattractant protein-1 (MCP-1) gene expression has also been attributed to this polyphenol [143].

As most people with MetS are overweight or obese, the role of quercetin in body weight reduction and obesity prevention has been of special interest. In this sense, it stands out the capacity of quercetin to inhibit adipogenesis through inducing the activation of AMP-activated protein kinase (AMPK) and decreasing the expression of CCAAT-enhancer-binding protein-? (C/EBP?), peroxisome�proliferator-activated receptor gamma (PPAR?), and sterol regulatory element-binding protein 1 (SREBP-1) [141,144].

According to the antidiabetic effects, it is proposed that quercetin may act as an agonist of peroxisome proliferator-activated receptor gamma (PPAR?), and thus improve insulin-stimulated glucose uptake in mature adipocytes [145]. Moreover, quercetin may ameliorate hyperglycemia by inhibiting glucose transporter 2 (GLUT2) and insulin dependent phosphatidylinositol-3-kinase (PI3K) and blocking tyrosine kinase (TK) [142].

Finally, different studies observed that quercetin has the ability to reduce blood pressure [146�148]. However, the mechanisms of action are not clear, since some authors have suggested that quercetin increases eNOS, contributing to inhibition of platelet aggregation and improvement of the endothelial function [146,147], but there are other studies that have not come across these results [148].

3.4. Resveratrol

dietary

Resveratrol (3,5,4?-trihidroxiestilben) is a phenolic compound mainly found in red grapes and derived products (red wine, grape juice) [149]. It has shown antioxidant and anti-inflammatory activities, and cardioprotective, anti-obesity and antidiabetic capacities [150�156].

The antioxidant effects of resveratrol have been reported to be carried out by scavenging of hydroxyl, superoxide, and metal-induced radicals as well as by antioxidant effects in cells producing reactive oxygen species (ROS) [150].

Moreover, it has been reported that the anti-inflammatory effects of resveratrol are mediated by inhibiting NF?B signaling [151]. Furthermore, this polyphenol reduces the expression of proinflammatory cytokines such as interleukin 6 (IL-6), interleukin 8 (IL-8), TNF-?, monocyte chemoattractant protein-1 (MCP-1) and eNOS [152]. In addition, resveratrol inhibits the cyclooxygenase (COX) expression and activity, a pathway involved in the synthesis of proinflammatory lipid mediators [152].

Concerning the effects of resveratrol against development of type 2 diabetes, it has been reported that treatment of diabetes patients with this polyphenol provides significant improvements in the status of multiple clinically relevant biomarkers such as fasting glucose levels, insulin concentrations or glycated hemoglobin and Homeostasis Model Assessment Insulin Resistance (HOMA-IR) [153,154].

Additionally, cardioprotective effects have been attributed to resveratrol. In this sense, it is suggested that resveratrol improves the endothelial function by producing nitric oxide (NO) through increasing the activity and expression of eNOS. This effect is thought to be conducted through activation of nicotinamide adenine dinucleotide-dependent deacetylase sirtuin-1 (Sirt 1) and 5? AMP-activated protein kinase (AMPK) [155]. Besides, resveratrol exerts endothelial protection by stimulation of NF-E2-related factor 2 (Nrf2) [156] and decreasing the expression of adhesion proteins such as ICAM-1 and VCAM-1 [152].

Finally, it has been described that resveratrol may have a role in preventing obesity as it has been related with energy metabolism improvement, increasing lipolysis and reducing lipogenesis [157]. However, more studies are needed in order to corroborate these findings.

3.5. Tocopherol

dietary vitamin e TocopherolTocopherols, also known as vitamin E, are a family of eight fat-soluble phenolic compounds whose main dietary sources are vegetable oils, nuts and seeds [130,158].

For a long time, it has been suggested that vitamin E could prevent different metabolic diseases as a potent antioxidant, acting as scavenger of lipid peroxyl radicals by hydrogen donating [159]. In this sense, it was described that tocopherols inhibit peroxidation of membrane phospholipids and prevent generation of free radicals in cell membranes [160].

Moreover, it has been shown that supplementation with ?-tocopherol or ?-tocopherol, two of the different isoforms of vitamin E, could have an effect on inflammation status by reducing CRP levels [161]. Additionally, inhibition of COX and protein kinase C (PKC) and reduction of cytokines�such as IL-8 or plasminogen activator inhibitor-1 (PAI-1) are other mechanisms that may contribute to these anti-inflammatory effects [162,163].

However, the beneficial effects attributed to this vitamin previously have lately became controversial as different clinical trials have not come across such benefits, but ineffective or even harmful effects have been observed [164]. It has been recently suggested that this may be explained by the fact that vitamin E may lose most of the antioxidant capacity when ingested by human beings through different mechanisms [162].

3.6. Anthocyanins

dietary Anthocyanins

Anthocyanins are water-soluble polyphenolic compounds responsible for the red, blue and purple colors of berries, black currants, black grapes, peaches, cherries, plums, pomegranate, eggplant, black beans, red radishes, red onions, red cabbage, purple corn or purple sweet potatoes [165�167]. Actually, they are the most abundant polyphenols in fruits and vegetables [167]. Moreover, they can also be found in teas, honey, nuts, olive oil, cocoa, and cereals [168].

These compounds have high antioxidant capacity inhibiting or decreasing free radicals by donating or transferring electrons from hydrogen atoms [167].

Regarding clinical studies, it has been shown that these bioactive compounds may prevent type 2 diabetes development by improving insulin sensitivity [169]. The exact mechanisms by which anthocyanins exert their antidiabetic effect are not yet clear, but an enhancement of the glucose uptake by muscle and adipocyte cells in an insulin-independent manner has been suggested [169].

Moreover, it has been shown that anthocyanins may have the capacity to prevent CVD development by improving endothelial function via increasing brachial artery flow-mediated dilation and HDL-c, and decreasing serum VCAM-1 and LDL-c concentrations [170�173].

Finally, these polyphenolic compounds may exert anti-inflamatory effects via reducing proinflamatory molecules such as IL-8, IL-1? or CRP [172,174].

However, most studies have used anthocyanin-rich extracts instead of purified anthocyanins; thus, a synergic effect with other polyphenols cannot be discarded.

3.7. Catechins

dietary tea leaves CatechinsCatechins are polyphenols that can be found in a variety of foods including fruits, vegetables, chocolate, wine, and tea [175]. The epigallocatechin 3-gallate present in tea leaves is the catechin class most studied [176].

Anti-obesity effects have been attributed to these polyphenols in different studies [176]. The mechanisms of action suggested to explain these beneficial effects on body weight are: increasing energy expenditure and fat oxidation, and reducing fat absorption [177]. It is thought that energy expenditure is enhanced by catechol-O-methyltransferase and phosphodiesterase inhibition, which stimulates the sympathetic nervous system causing an activation of the brown adipose tissue [178]. Fat oxidation is mediated by upregulation of acyl-CoA dehydrogenase and peroxisomal b-oxidation enzymes [178,179].

Moreover, catechin intake has also been associated with lower risk of CVD development by improving lipid biomarkers. Thus, it has been reported that consumption of this kind of polyphenols may increase HDL-c and decrease LDL-c and total cholesterol [180].

Finally, and antidiabetic effect has also been related to catechin comsumption, lowering fasting glucose levels [175] and improving insulin sensitivity [178].

4. Conclusions

As the prevalence of MetS reaches epidemic rates, the finding of an effective and easy-to-follow dietary strategy to combat this heterogenic disease is still a pending subject. This work recompiled different dietary nutrients and nutritional patterns with potential benefits in the prevention and�treatment of MetS and related comorbidities (Figure 1) with the aim of facilitating future clinical�studies in this area. The challenge now is to introduce precision bioactive compounds in personalized�nutritional patterns in order to gain the most benefits for prevention and treatment of this disease�through nutrition.

dietary fig 1

Conflicts of Interest: The authors declare no conflict of interest.

blank
References:

1. Sarafidis, P.A.; Nilsson, P.M. The metabolic syndrome: A glance at its history. J. Hypertens. 2006, 24, 621�626.
[CrossRef] [PubMed]
2. Alberti, K.G.; Zimmet, P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications.
Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
Diabet. Med. 1998, 15, 539�553. [CrossRef]
3. Balkau, B.; Charles, M.A. Comment on the provisional report from the WHO consultation. European Group
for the Study of Insulin Resistance (EGIR). Diabet. Med. 1999, 16, 442�423. [PubMed]
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive
Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA
2001, 285, 2486�2497.
5. Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.;
Krauss, R.M.; Savage, P.J.; Smith, S.C., Jr.; et al. Diagnosis and management of the metabolic syndrome:
An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation
2005, 112, 2735�2752. [CrossRef] [PubMed]
6. Alberti, K.G.; Zimmet, P.; Shaw, J. The metabolic syndrome�A new worldwide definition. Lancet 2005, 366,
1059�1062. [CrossRef]
7. Selassie, M.; Sinha, A.C. The epidemiology and aetiology of obesity: A global challenge. Best Pract. Res.
Clin. Anaesthesiol. 2011, 25, 1�9. [CrossRef] [PubMed]
8. WHO, W.H.O. Available online: http://www.who.int/mediacentre/factsheets/fs311/es/ (accessed on
4 June 2016).
9. Shimano, H. Novel qualitative aspects of tissue fatty acids related to metabolic regulation: Lessons from
Elovl6 knockout. Prog. Lipid Res. 2012, 51, 267�271. [CrossRef] [PubMed]
10. Bosomworth, N.J. Approach to identifying and managing atherogenic dyslipidemia: A metabolic
consequence of obesity and diabetes. Can. Fam. Phys. 2013, 59, 1169�1180.
11. Vidal-Puig, A. The Metabolic Syndrome and its Complex Pathophysiology. In A Systems Biology Approach to
Study Metabolic Syndrome; Oresic, M., Ed.; Springer: New York, NY, USA, 2014; pp. 3�16.
12. Poitout, V.; Robertson, R.P. Glucolipotoxicity: Fuel excess and beta-cell dysfunction. Endocr. Rev. 2008, 29,
351�366. [CrossRef] [PubMed]
13. Rizza, W.; Veronese, N.; Fontana, L. What are the roles of calorie restriction and diet quality in promoting
healthy longevity? Ageing Res. Rev. 2014, 13, 38�45. [CrossRef] [PubMed]
14. Lloyd-Jones, D.M.; Levy, D. Epidemiology of Hypertension. In Hypertension: A Companion to Braunwald�s
Heart Disease; Black, H.R., Elliott, W.J., Eds.; Elsevier: Philadephia, PA, USA, 2013; pp. 1�11.
15. Zanchetti, A. Challenges in hypertension: Prevalence, definition, mechanisms and management. J. Hypertens.
2014, 32, 451�453. [CrossRef] [PubMed]
16. Thomas, G.; Shishehbor, M.; Brill, D.; Nally, J.V., Jr. New hypertension guidelines: One size fits most?
Clevel. Clin. J. Med. 2014, 81, 178�188. [CrossRef] [PubMed]
17. James, P.A.; Oparil, S.; Carter, B.L.; Cushman, W.C.; Dennison-Himmelfarb, C.; Handler, J.; Lackland, D.T.;
LeFevre, M.L.; MacKenzie, T.D.; Ogedegbe, O.; et al. 2014 evidence-based guideline for the management
of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National
Committee (JNC 8). JAMA 2014, 311, 507�520. [CrossRef] [PubMed]
18. Klandorf, H.; Chirra, A.R.; DeGruccio, A.; Girman, D.J. Dimethyl sulfoxide modulation of diabetes onset in
NOD mice. Diabetes 1989, 38, 194�197. [CrossRef] [PubMed]
19. Ballard, K.D.; Mah, E.; Guo, Y.; Pei, R.; Volek, J.S.; Bruno, R.S. Low-fat milk ingestion prevents postprandial
hyperglycemia-mediated impairments in vascular endothelial function in obese individuals with metabolic
syndrome. J. Nutr. 2013, 143, 1602�1610. [CrossRef] [PubMed]
20. Pugliese, G.; Solini, A.; Bonora, E.; Orsi, E.; Zerbini, G.; Fondelli, C.; Gruden, G.; Cavalot, F.; Lamacchia, O.;
Trevisan, R.; et al. Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes
according to different classification systems for chronic kidney disease: A cross-sectional analysis of the
renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc. Diabetol. 2014,
13, 59. [PubMed]
21. Asif, M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J. Educ.
Health Promot. 2014, 3, 1. [CrossRef] [PubMed]
22. Russell, W.R.; Baka, A.; Bjorck, I.; Delzenne, N.; Gao, D.; Griffiths, H.R.; Hadjilucas, E.; Juvonen, K.;
Lahtinen, S.; Lansink, M.; et al. Impact of Diet Composition on Blood Glucose Regulation. Crit. Rev. Food
Sci. Nutr. 2016, 56, 541�590. [CrossRef] [PubMed]
23. Soares, R.; Costa, C. Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome; Springer:
Heidelberg, Germany, 2009.
24. Rahal, A.; Kumar, A.; Singh, V.; Yadav, B.; Tiwari, R.; Chakraborty, S.; Dhama, K. Oxidative Stress,
Prooxidants, and Antioxidants: The Interplay. BioMed Res. Int. 2014, 2014, 761264. [CrossRef] [PubMed]
25. Parthasarathy, S.; Litvinov, D.; Selvarajan, K.; Garelnabi, M. Lipid peroxidation and decomposition�Conflicting
roles in plaque vulnerability and stability. Biochim. Biophys. Acta 2008, 1781, 221�231. [CrossRef] [PubMed]
26. McGrowder, D.; Riley, C.; Morrison, E.Y.; Gordon, L. The role of high-density lipoproteins in reducing the
risk of vascular diseases, neurogenerative disorders, and cancer. Cholesterol 2011, 2011, 496925. [CrossRef]
[PubMed]
27. Ferri, N.; Ruscica, M. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome:
Insights on insulin resistance, inflammation, and atherogenic dyslipidemia. Endocrine 2016. [CrossRef]
28. Oresic, M.; Vidal-Puig, A. A Systems Biology Approach to Study Metabolic Syndrome; Springer: Heidelberg,
Germany, 2014.
29. Lee, E.G.; Choi, J.H.; Kim, K.E.; Kim, J.H. Effects of a Walking Program on Self-management and Risk Factors
of Metabolic Syndrome in Older Korean Adults. J. Phys. Ther. Sci. 2014, 26, 105�109. [CrossRef] [PubMed]
30. Bernabe, G.J.; Zafrilla, R.P.; Mulero, C.J.; Gomez, J.P.; Leal, H.M.; Abellan, A.J. Biochemical and nutritional
markers and antioxidant activity in metabolic syndrome. Endocrinol. Nutr. 2013, 61, 302�308.
31. Bales, C.W.; Kraus, W.E. Caloric restriction: Implications for human cardiometabolic health. J. Cardiopulm.
Rehabil. Prev. 2013, 33, 201�208. [CrossRef] [PubMed]
32. Grams, J.; Garvey, W.T. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle
Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action. Curr. Obes. Rep. 2015, 4, 287�302.
[CrossRef] [PubMed]
33. Lazo, M.; Solga, S.F.; Horska, A.; Bonekamp, S.; Diehl, A.M.; Brancati, F.L.; Wagenknecht, L.E.; Pi-Sunyer, F.X.;
Kahn, S.E.; Clark, J.M. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with
type 2 diabetes. Diabetes Care 2010, 33, 2156�2163. [CrossRef] [PubMed]
34. Rossmeislova, L.; Malisova, L.; Kracmerova, J.; Stich, V. Adaptation of human adipose tissue to hypocaloric
diet. Int. J. Obes. 2013, 37, 640�650. [CrossRef] [PubMed]
35. Wing, R.R.; Lang, W.; Wadden, T.A.; Safford, M.; Knowler, W.C.; Bertoni, A.G.; Hill, J.O.; Brancati, F.L.;
Peters, A.; Wagenknecht, L. Benefits of modest weight loss in improving cardiovascular risk factors in
overweight and obese individuals with type 2 diabetes. Diabetes Care 2011, 34, 1481�1486. [CrossRef]
[PubMed]
36. Golay, A.; Brock, E.; Gabriel, R.; Konrad, T.; Lalic, N.; Laville, M.; Mingrone, G.; Petrie, J.; Phan, T.M.;
Pietilainen, K.H.; et al. Taking small steps towards targets�Perspectives for clinical practice in diabetes,
cardiometabolic disorders and beyond. Int. J. Clin. Pract. 2013, 67, 322�332. [CrossRef] [PubMed]
37. Fock, K.M.; Khoo, J. Diet and exercise in management of obesity and overweight. J. Gastroenterol. Hepatol.
2013, 28, 59�63. [CrossRef] [PubMed]
38. Abete, I.; Parra, D.; Martinez, J.A. Energy-restricted diets based on a distinct food selection affecting the
glycemic index induce different weight loss and oxidative response. Clin. Nutr. 2008, 27, 545�551. [CrossRef]
[PubMed]
39. Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.;
Loria, C.M.; Smith, S.C., Jr. Harmonizing the metabolic syndrome: A joint interim statement of the
International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung,
and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis
Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640�1645. [PubMed]
40. Fleming, J.A.; Kris-Etherton, P.M. The evidence for alpha-linolenic acid and cardiovascular disease benefits:
Comparisons with eicosapentaenoic acid and docosahexaenoic acid. Adv. Nutr. 2014, 5, 863S�876S. [CrossRef]
[PubMed]
41. Gray, B.; Steyn, F.; Davies, P.S.; Vitetta, L. Omega-3 fatty acids: A review of the effects on adiponectin and
leptin and potential implications for obesity management. Eur. J. Clin. Nutr. 2013, 67, 1234�1242. [CrossRef]
[PubMed]
42. Wen, Y.T.; Dai, J.H.; Gao, Q. Effects of Omega-3 fatty acid on major cardiovascular events and mortality
in patients with coronary heart disease: A meta-analysis of randomized controlled trials. Nutr. Metab.
Cardiovasc. Dis. 2014, 24, 470�475. [CrossRef] [PubMed]
43. Lopez-Huertas, E. The effect of EPA and DHA on metabolic syndrome patients: A systematic review of
randomised controlled trials. Br. J. Nutr. 2012, 107, 185�194. [CrossRef] [PubMed]
44. Maiorino, M.I.; Chiodini, P.; Bellastella, G.; Giugliano, D.; Esposito, K. Sexual dysfunction in women with
cancer: A systematic review with meta-analysis of studies using the Female Sexual Function Index. Endocrine
2016, 54, 329�341. [CrossRef] [PubMed]
45. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on Dietary
Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated
fatty acids, trans fatty acids, and cholesterol1. EFSA J. 2010, 8, 1461�1566.
46. Bellastella, G.; Bizzarro, A.; Aitella, E.; Barrasso, M.; Cozzolino, D.; di Martino, S.; Esposito, K.; de Bellis, A.
Pregnancy may favour the development of severe autoimmune central diabetes insipidus in women with
vasopressin cell antibodies: Description of two cases. Eur. J. Endocrinol. 2015, 172, K11�K17. [CrossRef]
[PubMed]
47. Sun, F.H.; Li, C.; Zhang, Y.J.; Wong, S.H.; Wang, L. Effect of Glycemic Index of Breakfast on Energy Intake at
Subsequent Meal among Healthy People: A Meta-Analysis. Nutrients 2016, 8, 37. [CrossRef] [PubMed]
48. Barclay, A.W.; Brand-Miller, J.C.; Wolever, T.M. Glycemic index, glycemic load, and glycemic response are
not the same. Diabetes Care 2005, 28, 1839�1840. [CrossRef] [PubMed]
49. Nakagawa, T.; Hu, H.; Zharikov, S.; Tuttle, K.R.; Short, R.A.; Glushakova, O.; Ouyang, X.; Feig, D.I.;
Block, E.R.; Herrera-Acosta, J.; et al. A causal role for uric acid in fructose-induced metabolic syndrome.
Am. J. Physiol. Ren. Physiol. 2006, 290, F625�F631. [CrossRef] [PubMed]
50. Symons Downs, D.; Hausenblas, H.A. Women�s exercise beliefs and behaviors during their pregnancy and
postpartum. J. Midwifery Women Health 2004, 49, 138�144.
51. Brand-Miller, J.; McMillan-Price, J.; Steinbeck, K.; Caterson, I. Dietary glycemic index: Health implications.
J. Am. Coll. Nutr. 2009, 28, 446S�449S. [CrossRef] [PubMed]
52. Thomas, D.; Elliott, E.J. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus.
Cochrane Database Syst. Rev. 2009. [CrossRef]
53. Barrea, L.; Balato, N.; di Somma, C.; Macchia, P.E.; Napolitano, M.; Savanelli, M.C.; Esposito, K.; Colao, A.;
Savastano, S. Nutrition and psoriasis: Is there any association between the severity of the disease and
adherence to the Mediterranean diet? J. Transl. Med. 2015, 13, 18. [CrossRef] [PubMed]
54. Mathias, K.C.; Ng, S.W.; Popkin, B. Monitoring changes in the nutritional content of ready-to-eat grain-based
dessert products manufactured and purchased between 2005 and 2012. J. Acad. Nutr. Diet. 2015, 115, 360�368.
[CrossRef] [PubMed]
55. Serafini, M.; del Rio, D. Understanding the association between dietary antioxidants, redox status and
disease: Is the Total Antioxidant Capacity the right tool? Redox Rep. 2004, 9, 145�152. [CrossRef] [PubMed]
56. Bellastella, G.; Maiorino, M.I.; Olita, L.; della Volpe, E.; Giugliano, D.; Esposito, K. Premature ejaculation is
associated with glycemic control in Type 1 diabetes. J. Sex. Med. 2015, 12, 93�99. [CrossRef] [PubMed]
57. Zulet, M.A.; Moreno-Aliaga, M.J.; Martinez, J.A. Dietary Determinants of Fat Mass and Body Composition.
In Adipose Tissue Biology; Symonds, M.E., Ed.; Springer: New York, NY, USA, 2012; pp. 271�315.
58. Carlsen, M.H.; Halvorsen, B.L.; Holte, K.; Bohn, S.K.; Dragland, S.; Sampson, L.; Willey, C.; Senoo, H.;
Umezono, Y.; Sanada, C.; et al. The total antioxidant content of more than 3100 foods, beverages, spices,
herbs and supplements used worldwide. Nutr. J. 2010, 9, 3. [CrossRef] [PubMed]
59. Harasym, J.; Oledzki, R. Effect of fruit and vegetable antioxidants on total antioxidant capacity of blood
plasma. Nutrition 2014, 30, 511�517. [CrossRef] [PubMed]
60. Maiorino, M.I.; Bellastella, G.; Petrizzo, M.; della Volpe, E.; Orlando, R.; Giugliano, D.; Esposito, K. Circulating
endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction. Endocrine 2015, 49, 415�421.
[CrossRef] [PubMed]
61. Bahadoran, Z.; Golzarand, M.; Mirmiran, P.; Shiva, N.; Azizi, F. Dietary total antioxidant capacity and the
occurrence of metabolic syndrome and its components after a 3-year follow-up in adults: Tehran Lipid and
Glucose Study. Nutr. Metab. 2012, 9, 70. [CrossRef] [PubMed]
62. Chrysohoou, C.; Esposito, K.; Giugliano, D.; Panagiotakos, D.B. Peripheral Arterial Disease and
Cardiovascular Risk: The Role of Mediterranean Diet. Angiology 2015, 66, 708�710. [CrossRef] [PubMed]
63. De la Iglesia, R.; Lopez-Legarrea, P.; Celada, P.; Sanchez-Muniz, F.J.; Martinez, J.A.; Zulet, M.A. Beneficial
effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome
with hyperglycemia are associated to dietary TAC and fruit consumption. Int. J. Mol. Sci. 2013, 14, 6903�6919.
[CrossRef] [PubMed]
64. Lopez-Legarrea, P.; de la Iglesia, R.; Abete, I.; Bondia-Pons, I.; Navas-Carretero, S.; Forga, L.; Martinez, J.A.;
Zulet, M.A. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese
with metabolic syndrome symptoms: The RESMENA randomized controlled trial. Nutr. Metab. 2013, 10, 22.
[CrossRef] [PubMed]
65. Puchau, B.; Zulet, M.A.; de Echavarri, A.G.; Hermsdorff, H.H.; Martinez, J.A. Dietary total antioxidant
capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition
2010, 26, 534�541. [CrossRef] [PubMed]
66. World Health Organization. Obesity: Preventing and Managing the Global Epidemic; Report of a WHO
Consultation; World Health Organization Technical Report Series; WHO: Geneva, Switzerland, 2000.
67. Tapsell, L.C.; Hemphill, I.; Cobiac, L.; Patch, C.S.; Sullivan, D.R.; Fenech, M.; Roodenrys, S.; Keogh, J.B.;
Clifton, P.M.; Williams, P.G.; et al. Health benefits of herbs and spices: The past, the present, the future.
Med. J. Aust. 2006, 185, S4�S24. [PubMed]
68. Abete, I.; Astrup, A.; Martinez, J.A.; Thorsdottir, I.; Zulet, M.A. Obesity and the metabolic syndrome: Role of
different dietary macronutrient distribution patterns and specific nutritional components on weight loss and
maintenance. Nutr. Rev. 2010, 68, 214�231. [CrossRef] [PubMed]
69. Ebbeling, C.B.; Swain, J.F.; Feldman, H.A.; Wong, W.W.; Hachey, D.L.; Garcia-Lago, E.; Ludwig, D.S. Effects
of dietary composition on energy expenditure during weight-loss maintenance. JAMA 2012, 307, 2627�2634.
[CrossRef] [PubMed]
70. Abete, I.; Goyenechea, E.; Zulet, M.A.; Martinez, J.A. Obesity and metabolic syndrome: Potential benefit
from specific nutritional components. Nutr. Metab. Cardiovasc. Dis. 2011, 21, B1�B15. [CrossRef] [PubMed]
71. Arciero, P.J.; Ormsbee, M.J.; Gentile, C.L.; Nindl, B.C.; Brestoff, J.R.; Ruby, M. Increased protein intake and
meal frequency reduces abdominal fat during energy balance and energy deficit. Obesity 2013, 21, 1357�1366.
[CrossRef] [PubMed]
72. Wikarek, T.; Chudek, J.; Owczarek, A.; Olszanecka-Glinianowicz, M. Effect of dietary macronutrients on
postprandial incretin hormone release and satiety in obese and normal-weight women. Br. J. Nutr. 2014, 111,
236�246. [CrossRef] [PubMed]
73. Bray, G.A.; Smith, S.R.; de Jonge, L.; Xie, H.; Rood, J.; Martin, C.K.; Most, M.; Brock, C.; Mancuso, S.;
Redman, L.M. Effect of dietary protein content on weight gain, energy expenditure, and body composition
during overeating: A randomized controlled trial. JAMA 2012, 307, 47�55. [CrossRef] [PubMed]
74. Westerterp-Plantenga, M.S.; Nieuwenhuizen, A.; Tome, D.; Soenen, S.; Westerterp, K.R. Dietary protein,
weight loss, and weight maintenance. Annu. Rev. Nutr. 2009, 29, 21�41. [CrossRef] [PubMed]
75. Koppes, L.L.; Boon, N.; Nooyens, A.C.; van Mechelen, W.; Saris, W.H. Macronutrient distribution over
a period of 23 years in relation to energy intake and body fatness. Br. J. Nutr. 2009, 101, 108�115. [CrossRef]
[PubMed]
76. De Jonge, L.; Bray, G.A.; Smith, S.R.; Ryan, D.H.; de Souza, R.J.; Loria, C.M.; Champagne, C.M.;
Williamson, D.A.; Sacks, F.M. Effect of diet composition and weight loss on resting energy expenditure in
the POUNDS LOST study. Obesity 2012, 20, 2384�2389. [CrossRef] [PubMed]
77. Stocks, T.; Angquist, L.; Hager, J.; Charon, C.; Holst, C.; Martinez, J.A.; Saris, W.H.; Astrup, A.; Sorensen, T.I.;
Larsen, L.H. TFAP2B-dietary protein and glycemic index interactions and weight maintenance after weight
loss in the DiOGenes trial. Hum. Hered. 2013, 75, 213�219. [CrossRef] [PubMed]
78. Giugliano, D.; Maiorino, M.I.; Esposito, K. Linking prediabetes and cancer: A complex issue. Diabetologia
2015, 58, 201�202. [CrossRef] [PubMed]
79. Bendtsen, L.Q.; Lorenzen, J.K.; Bendsen, N.T.; Rasmussen, C.; Astrup, A. Effect of dairy proteins on appetite,
energy expenditure, body weight, and composition: A review of the evidence from controlled clinical trials.
Adv. Nutr. 2013, 4, 418�438. [CrossRef] [PubMed]
80. Heer, M.; Egert, S. Nutrients other than carbohydrates: Their effects on glucose homeostasis in humans.
Diabetes Metab. Res. Rev. 2015, 31, 14�35. [CrossRef] [PubMed]
81. Layman, D.K.; Evans, E.M.; Erickson, D.; Seyler, J.; Weber, J.; Bagshaw, D.; Griel, A.; Psota, T.; Kris-Etherton, P.
A moderate-protein diet produces sustained weight loss and long-term changes in body composition and
blood lipids in obese adults. J. Nutr. 2009, 139, 514�521. [CrossRef] [PubMed]
82. Pedersen, A.N.; Kondrup, J.; Borsheim, E. Health effects of protein intake in healthy adults: A systematic
literature review. Food Nutr. Res. 2013, 57, 21245. [CrossRef] [PubMed]
83. Daly, R.M.; O�Connell, S.L.; Mundell, N.L.; Grimes, C.A.; Dunstan, D.W.; Nowson, C.A. Protein-enriched
diet, with the use of lean red meat, combined with progressive resistance training enhances lean tissue mass
and muscle strength and reduces circulating IL-6 concentrations in elderly women: A cluster randomized
controlled trial. Am. J. Clin. Nutr. 2014, 99, 899�910. [CrossRef] [PubMed]
84. Arciero, P.J.; Gentile, C.L.; Pressman, R.; Everett, M.; Ormsbee, M.J.; Martin, J.; Santamore, J.; Gorman, L.;
Fehling, P.C.; Vukovich, M.D.; et al. Moderate protein intake improves total and regional body composition
and insulin sensitivity in overweight adults. Metab. Clin. Exp. 2008, 57, 757�765. [CrossRef] [PubMed]
85. Gregory, S.M.; Headley, S.A.; Wood, R.J. Effects of dietary macronutrient distribution on vascular integrity in
obesity and metabolic syndrome. Nutr. Rev. 2011, 69, 509�519. [CrossRef] [PubMed]
86. Consenso FESNAD-SEEDO. Recomendaciones nutricionales basadas en la evidencia para la prevenci�n y el
tratamiento del sobrepeso y la obesidad en adultos (Consenso FESNAD-SEEDO). Rev. Esp. Obes. 2011, 10, 36.
87. Jakubowicz, D.; Froy, O.; Wainstein, J.; Boaz, M. Meal timing and composition influence ghrelin levels,
appetite scores and weight loss maintenance in overweight and obese adults. Steroids 2012, 77, 323�331.
[CrossRef] [PubMed]
88. Schwarz, N.A.; Rigby, B.R.; La Bounty, P.; Shelmadine, B.; Bowden, R.G. A review of weight control strategies
and their effects on the regulation of hormonal balance. J. Nutr. Metab. 2011, 2011, 237932. [CrossRef]
[PubMed]
89. Ohkawara, K.; Cornier, M.A.; Kohrt, W.M.; Melanson, E.L. Effects of increased meal frequency on fat
oxidation and perceived hunger. Obesity 2013, 21, 336�343. [CrossRef] [PubMed]
90. Ekmekcioglu, C.; Touitou, Y. Chronobiological aspects of food intake and metabolism and their relevance on
energy balance and weight regulation. Obes. Rev. 2011, 12, 14�25. [CrossRef] [PubMed]
91. Lioret, S.; Touvier, M.; Lafay, L.; Volatier, J.L.; Maire, B. Are eating occasions and their energy content related
to child overweight and socioeconomic status? Obesity 2008, 16, 2518�2523. [CrossRef] [PubMed]
92. Bhutani, S.; Varady, K.A. Nibbling versus feasting: Which meal pattern is better for heart disease prevention?
Nutr. Rev. 2009, 67, 591�598. [CrossRef] [PubMed]
93. Leidy, H.J.; Tang, M.; Armstrong, C.L.; Martin, C.B.; Campbell, W.W. The effects of consuming frequent,
higher protein meals on appetite and satiety during weight loss in overweight/obese men. Obesity 2011, 19,
818�824. [CrossRef] [PubMed]
94. Mills, J.P.; Perry, C.D.; Reicks, M. Eating frequency is associated with energy intake but not obesity in midlife
women. Obesity 2011, 19, 552�559. [CrossRef] [PubMed]
95. Cameron, J.D.; Cyr, M.J.; Doucet, E. Increased meal frequency does not promote greater weight loss in subjects
who were prescribed an 8-week equi-energetic energy-restricted diet. Br. J. Nutr. 2010, 103, 1098�1101.
[CrossRef] [PubMed]
96. Smeets, A.J.; Lejeune, M.P.; Westerterp-Plantenga, M.S. Effects of oral fat perception by modified sham
feeding on energy expenditure, hormones and appetite profile in the postprandial state. Br. J. Nutr. 2009,
101, 1360�1368. [CrossRef] [PubMed]
97. Taylor, M.A.; Garrow, J.S. Compared with nibbling, neither gorging nor a morning fast affect short-term
energy balance in obese patients in a chamber calorimeter. Int. J. Obes. Relat. Metab. Disord. 2001, 25, 519�528.
[CrossRef] [PubMed]
98. Smeets, A.J.; Westerterp-Plantenga, M.S. Acute effects on metabolism and appetite profile of one meal
difference in the lower range of meal frequency. Br. J. Nutr. 2008, 99, 1316�1321. [CrossRef] [PubMed]
99. Heden, T.D.; LeCheminant, J.D.; Smith, J.D. Influence of weight classification on walking and jogging energy
expenditure prediction in women. Res. Q. Exerc. Sport 2012, 83, 391�399. [CrossRef] [PubMed]
100. Bachman, J.L.; Raynor, H.A. Effects of manipulating eating frequency during a behavioral weight loss
intervention: A pilot randomized controlled trial. Obesity 2012, 20, 985�992. [CrossRef] [PubMed]
101. Perrigue, M.M.; Drewnowski, A.; Wang, C.Y.; Neuhouser, M.L. Higher Eating Frequency Does Not Decrease
Appetite in Healthy Adults. J. Nutr. 2016, 146, 59�64. [CrossRef] [PubMed]
102. Keys, A. Coronary heart disease in seven countries. 1970. Nutrition 1997, 13, 249�253. [CrossRef]
103. Keys, A.; Menotti, A.; Aravanis, C.; Blackburn, H.; Djordevic, B.S.; Buzina, R.; Dontas, A.S.; Fidanza, F.;
Karvonen, M.J.; Kimura, N.; et al. The seven countries study: 2289 deaths in 15 years. Prev. Med. 1984, 13,
141�154. [CrossRef]
104. Davis, C.; Bryan, J.; Hodgson, J.; Murphy, K. Definition of the Mediterranean Diet; a Literature Review.
Nutrients 2015, 7, 9139�9153. [CrossRef] [PubMed]
105. Sofi, F.; Macchi, C.; Abbate, R.; Gensini, G.F.; Casini, A. Mediterranean diet and health status: An updated
meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr. 2014, 17, 2769�2782.
[CrossRef] [PubMed]
106. Mayneris-Perxachs, J.; Sala-Vila, A.; Chisaguano, M.; Castellote, A.I.; Estruch, R.; Covas, M.I.; Fito, M.;
Salas-Salvado, J.; Martinez-Gonzalez, M.A.; Lamuela-Raventos, R.; et al. Effects of 1-year intervention with
a Mediterranean diet on plasma fatty acid composition and metabolic syndrome in a population at high
cardiovascular risk. PLoS ONE 2014, 9, e85202. [CrossRef] [PubMed]
107. Esposito, K.; Maiorino, M.I.; Bellastella, G.; Chiodini, P.; Panagiotakos, D.; Giugliano, D. A journey
into a Mediterranean diet and type 2 diabetes: A systematic review with meta-analyses. BMJ Open
2015, 5, e008222. [CrossRef] [PubMed]
108. Kastorini, C.M.; Milionis, H.J.; Esposito, K.; Giugliano, D.; Goudevenos, J.A.; Panagiotakos, D.B. The effect of
Mediterranean diet on metabolic syndrome and its components: A meta-analysis of 50 studies and 534,906
individuals. J. Am. Coll. Cardiol. 2011, 57, 1299�1313. [CrossRef] [PubMed]
109. Schwingshackl, L.; Missbach, B.; Konig, J.; Hoffmann, G. Adherence to a Mediterranean diet and risk of
diabetes: A systematic review and meta-analysis. Public Health Nutr. 2015, 18, 1292�1299. [CrossRef]
[PubMed]
110. Koloverou, E.; Esposito, K.; Giugliano, D.; Panagiotakos, D. The effect of Mediterranean diet on the
development of type 2 diabetes mellitus: A meta-analysis of 10 prospective studies and 136,846 participants.
Metab. Clin. Exp. 2014, 63, 903�911. [CrossRef] [PubMed]
111. Salas-Salvado, J.; Garcia-Arellano, A.; Estruch, R.; Marquez-Sandoval, F.; Corella, D.; Fiol, M.;
Gomez-Gracia, E.; Vinoles, E.; Aros, F.; Herrera, C.; et al. Components of the Mediterranean-type food
pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. Eur. J.
Clin. Nutr. 2008, 62, 651�659. [CrossRef] [PubMed]
112. Martinez-Gonzalez, M.A.; Garcia-Lopez, M.; Bes-Rastrollo, M.; Toledo, E.; Martinez-Lapiscina, E.H.;
Delgado-Rodriguez, M.; Vazquez, Z.; Benito, S.; Beunza, J.J. Mediterranean diet and the incidence of
cardiovascular disease: A Spanish cohort. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 237�244. [CrossRef]
[PubMed]
113. Fito, M.; Estruch, R.; Salas-Salvado, J.; Martinez-Gonzalez, M.A.; Aros, F.; Vila, J.; Corella, D.; Diaz, O.;
Saez, G.; de la Torre, R.; et al. Effect of the Mediterranean diet on heart failure biomarkers: A randomized
sample from the PREDIMED trial. Eur. J. Heart Fail. 2014, 16, 543�550. [CrossRef] [PubMed]
114. Estruch, R.; Ros, E.; Salas-Salvado, J.; Covas, M.I.; Corella, D.; Aros, F.; Gomez-Gracia, E.; Ruiz-Gutierrez, V.;
Fiol, M.; Lapetra, J.; et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl.
J. Med. 2013, 368, 1279�1290. [CrossRef] [PubMed]
115. Serra-Majem, L.; Roman, B.; Estruch, R. Scientific evidence of interventions using the Mediterranean diet:
A systematic review. Nutr. Rev. 2006, 64, S27�S47. [CrossRef] [PubMed]
116. Esposito, K.; Kastorini, C.M.; Panagiotakos, D.B.; Giugliano, D. Mediterranean diet and weight loss:
Meta-analysis of randomized controlled trials. Metab. Syndr. Relat. Disord. 2011, 9, 1�12. [CrossRef]
[PubMed]
117. Razquin, C.; Martinez, J.A.; Martinez-Gonzalez, M.A.; Mitjavila, M.T.; Estruch, R.; Marti, A. A 3 years
follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity
and reduced body weight gain. Eur. J. Clin. Nutr. 2009, 63, 1387�1393. [CrossRef] [PubMed]
118. Bertoli, S.; Spadafranca, A.; Bes-Rastrollo, M.; Martinez-Gonzalez, M.A.; Ponissi, V.; Beggio, V.; Leone, A.;
Battezzati, A. Adherence to the Mediterranean diet is inversely related to binge eating disorder in patients
seeking a weight loss program. Clin. Nutr. 2015, 34, 107�114. [CrossRef] [PubMed]
119. Rios-Hoyo, A.; Cortes, M.J.; Rios-Ontiveros, H.; Meaney, E.; Ceballos, G.; Gutierrez-Salmean, G. Obesity,
Metabolic Syndrome, and Dietary Therapeutical Approaches with a Special Focus on Nutraceuticals
(Polyphenols): A Mini-Review. Int. J. Vitam. Nutr. Res. 2014, 84, 113�123. [CrossRef] [PubMed]
120. Juraschek, S.P.; Guallar, E.; Appel, L.J.; Miller, E.R., 3rd. Effects of vitamin C supplementation on blood
pressure: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2012, 95, 1079�1088. [CrossRef]
[PubMed]
121. Michels, A.J.; Frei, B. Myths, artifacts, and fatal flaws: Identifying limitations and opportunities in vitamin C
research. Nutrients 2013, 5, 5161�5192. [CrossRef] [PubMed]
122. Frei, B.; Birlouez-Aragon, I.; Lykkesfeldt, J. Authors� perspective: What is the optimum intake of vitamin C
in humans? Crit. Rev. Food Sci. Nutr. 2012, 52, 815�829. [CrossRef] [PubMed]
123. Mason, S.A.; della Gatta, P.A.; Snow, R.J.; Russell, A.P.; Wadley, G.D. Ascorbic acid supplementation
improves skeletal muscle oxidative stress and insulin sensitivity in people with type 2 diabetes: Findings of
a randomized controlled study. Free Radic. Biol. Med. 2016, 93, 227�238. [CrossRef] [PubMed]
124. Chambial, S.; Dwivedi, S.; Shukla, K.K.; John, P.J.; Sharma, P. Vitamin C in Disease Prevention and Cure:
An Overview. Indian J. Clin. Biochem. 2013, 28, 314�328. [CrossRef] [PubMed]
125. Block, G.; Jensen, C.D.; Dalvi, T.B.; Norkus, E.P.; Hudes, M.; Crawford, P.B.; Holland, N.; Fung, E.B.;
Schumacher, L.; Harmatz, P. Vitamin C treatment reduces elevated C-reactive protein. Free Radic. Biol. Med.
2009, 46, 70�77. [CrossRef] [PubMed]
126. Ashor, A.W.; Siervo, M.; Lara, J.; Oggioni, C.; Afshar, S.; Mathers, J.C. Effect of vitamin C and vitamin E
supplementation on endothelial function: A systematic review and meta-analysis of randomised controlled
trials. Br. J. Nutr. 2015, 113, 1182�1194. [CrossRef] [PubMed]
127. Kim, S.M.; Lim, S.M.; Yoo, J.A.; Woo, M.J.; Cho, K.H. Consumption of high-dose vitamin C (1250 mg
per day) enhances functional and structural properties of serum lipoprotein to improve anti-oxidant,
anti-atherosclerotic, and anti-aging effects via regulation of anti-inflammatory microRNA. Food Funct.
2015, 6, 3604�3612. [CrossRef] [PubMed]
128. Monfared, S.; Larijani, B.; Abdollahi, M. Islet transplantation and antioxidant management: A comprehensive
review. World J. Gastroenterol. 2009, 15, 1153�1161. [CrossRef]
129. German Nutrition Society (DGE). New Reference Values for Vitamin C Intake. Ann. Nutr. Metab. 2015,
67, 13�20.
130. Mamede, A.C.; Tavares, S.D.; Abrantes, A.M.; Trindade, J.; Maia, J.M.; Botelho, M.F. The role of vitamins in
cancer: A review. Nutr. Cancer 2011, 63, 479�494. [CrossRef] [PubMed]
131. Moser, M.A.; Chun, O.K. Vitamin C and Heart Health: A Review Based on Findings from Epidemiologic
Studies. Int. J. Mol. Sci. 2016, 17, 1328. [CrossRef] [PubMed]
132. Vilaplana-Perez, C.; Aunon, D.; Garcia-Flores, L.A.; Gil-Izquierdo, A. Hydroxytyrosol and potential uses in
cardiovascular diseases, cancer, and AIDS. Front. Nutr. 2014, 1, 18. [PubMed]
133. Achmon, Y.; Fishman, A. The antioxidant hydroxytyrosol: Biotechnological production challenges and
opportunities. Appl. Microbiol. Biotechnol. 2015, 99, 1119�1130. [CrossRef] [PubMed]
134. Bulotta, S.; Celano, M.; Lepore, S.M.; Montalcini, T.; Pujia, A.; Russo, D. Beneficial effects of the olive
oil phenolic components oleuropein and hydroxytyrosol: Focus on protection against cardiovascular and
metabolic diseases. J. Transl. Med. 2014, 12, 219. [CrossRef] [PubMed]
135. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on the
substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative
damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL cholesterol concentrations
(ID 1639). EFSA J. 2011, 9, 2033�2058.
136. Scoditti, E.; Nestola, A.; Massaro, M.; Calabriso, N.; Storelli, C.; De Caterina, R.; Carluccio, M.A.
Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes
via PKCalpha and PKCbeta1 inhibition. Atherosclerosis 2014, 232, 17�24. [CrossRef] [PubMed]
137. Giordano, E.; Dangles, O.; Rakotomanomana, N.; Baracchini, S.; Visioli, F. 3-O-Hydroxytyrosol glucuronide
and 4-O-hydroxytyrosol glucuronide reduce endoplasmic reticulum stress in vitro. Food Funct. 2015, 6,
3275�3281. [CrossRef] [PubMed]
138. Granados-Principal, S.; Quiles, J.L.; Ramirez-Tortosa, C.L.; Sanchez-Rovira, P.; Ramirez-Tortosa, M.C.
Hydroxytyrosol: From laboratory investigations to future clinical trials. Nutr. Rev. 2010, 68, 191�206.
[CrossRef] [PubMed]
139. Carluccio, M.A.; Siculella, L.; Ancora, M.A.; Massaro, M.; Scoditti, E.; Storelli, C.; Visioli, F.;
Distante, A.; De Caterina, R. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation:
Antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler. Thromb. Vasc. Biol. 2003, 23,
622�629. [CrossRef] [PubMed]
140. Visioli, F.; Bernardini, E. Extra virgin olive oil�s polyphenols: Biological activities. Curr. Pharm. Des. 2011, 17,
786�804. [CrossRef] [PubMed]
141. Nabavi, S.F.; Russo, G.L.; Daglia, M.; Nabavi, S.M. Role of quercetin as an alternative for obesity treatment:
You are what you eat! Food Chem. 2015, 179, 305�310. [CrossRef] [PubMed]
142. Vinayagam, R.; Xu, B. Antidiabetic properties of dietary flavonoids: A cellular mechanism review.
Nutr. Metab. 2015, 12, 60. [CrossRef] [PubMed]
143. Shibata, T.; Nakashima, F.; Honda, K.; Lu, Y.J.; Kondo, T.; Ushida, Y.; Aizawa, K.; Suganuma, H.; Oe, S.;
Tanaka, H.; et al. Toll-like receptors as a target of food-derived anti-inflammatory compounds. J. Biol. Chem.
2014, 289, 32757�32772. [CrossRef] [PubMed]
144. Ahn, J.; Lee, H.; Kim, S.; Park, J.; Ha, T. The anti-obesity effect of quercetin is mediated by the AMPK and
MAPK signaling pathways. Biochem. Biophys. Res. Commun. 2008, 373, 545�549. [CrossRef] [PubMed]
145. Fang, X.K.; Gao, J.; Zhu, D.N. Kaempferol and quercetin isolated from Euonymus alatus improve glucose
uptake of 3T3-L1 cells without adipogenesis activity. Life Sci. 2008, 82, 615�622. [CrossRef] [PubMed]
146. Clark, J.L.; Zahradka, P.; Taylor, C.G. Efficacy of flavonoids in the management of high blood pressure.
Nutr. Rev. 2015, 73, 799�822. [CrossRef] [PubMed]
147. D�Andrea, G. Quercetin: A flavonol with multifaceted therapeutic applications? Fitoterapia 2015, 106, 256�271.
[CrossRef] [PubMed]
148. Larson, A.; Witman, M.A.; Guo, Y.; Ives, S.; Richardson, R.S.; Bruno, R.S.; Jalili, T.; Symons, J.D. Acute,
quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower
plasma angiotensin-converting enzyme activity or endothelin-1: Nitric oxide. Nutr. Res. 2012, 32, 557�564.
[CrossRef] [PubMed]
149. Tome-Carneiro, J.; Gonzalvez, M.; Larrosa, M.; Yanez-Gascon, M.J.; Garcia-Almagro, F.J.; Ruiz-Ros, J.A.;
Tomas-Barberan, F.A.; Garcia-Conesa, M.T.; Espin, J.C. Resveratrol in primary and secondary prevention of
cardiovascular disease: A dietary and clinical perspective. Ann. N. Y. Acad. Sci. 2013, 1290, 37�51. [CrossRef]
[PubMed]
150. Leonard, S.S.; Xia, C.; Jiang, B.H.; Stinefelt, B.; Klandorf, H.; Harris, G.K.; Shi, X. Resveratrol scavenges
reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 2003,
309, 1017�1026. [CrossRef] [PubMed]
151. Ren, Z.; Wang, L.; Cui, J.; Huoc, Z.; Xue, J.; Cui, H.; Mao, Q.; Yang, R. Resveratrol inhibits NF-?B signaling
through suppression of p65 and I?B kinase activities. Die Pharm. 2013, 68, 689�694.
152. Latruffe, N.; Lancon, A.; Frazzi, R.; Aires, V.; Delmas, D.; Michaille, J.J.; Djouadi, F.; Bastin, J.;
Cherkaoui-Malki, M. Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on
inflammation. Ann. N. Y. Acad. Sci. 2015, 1348, 97�106. [CrossRef] [PubMed]
153. Hausenblas, H.A.; Schoulda, J.A.; Smoliga, J.M. Resveratrol treatment as an adjunct to pharmacological
management in type 2 diabetes mellitus�Systematic review and meta-analysis. Mol. Nutr. Food Res. 2015,
59, 147�159. [CrossRef] [PubMed]
154. Liu, K.; Zhou, R.; Wang, B.; Mi, M.T. Effect of resveratrol on glucose control and insulin sensitivity:
A meta-analysis of 11 randomized controlled trials. Am. J. Clin. Nutr. 2014, 99, 1510�1519. [CrossRef]
[PubMed]
155. Bitterman, J.L.; Chung, J.H. Metabolic effects of resveratrol: Addressing the controversies. Cell. Mol. Life Sci.
2015, 72, 1473�1488. [CrossRef] [PubMed]
156. Han, S.; Park, J.S.; Lee, S.; Jeong, A.L.; Oh, K.S.; Ka, H.I.; Choi, H.J.; Son, W.C.; Lee, W.Y.; Oh, S.J.; et al.
CTRP1 protects against diet-induced hyperglycemia by enhancing glycolysis and fatty acid oxidation.
J. Nutr. Biochem. 2016, 27, 43�52. [CrossRef] [PubMed]
157. Gambini, J.; Ingles, M.; Olaso, G.; Lopez-Grueso, R.; Bonet-Costa, V.; Gimeno-Mallench, L.; Mas-Bargues, C.;
Abdelaziz, K.M.; Gomez-Cabrera, M.C.; Vina, J.; et al. Properties of Resveratrol: In Vitro and In Vivo
Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans. Oxid. Med.
Cell. Longev. 2015, 2015, 837042. [CrossRef] [PubMed]
158. Yang, C.S.; Suh, N. Cancer prevention by different forms of tocopherols. Top. Curr. Chem. 2013, 329, 21�33.
[PubMed]
159. Jiang, Q. Natural forms of vitamin E: Metabolism, antioxidant, and anti-inflammatory activities and their
role in disease prevention and therapy. Free Radic. Biol. Med. 2014, 72, 76�90. [CrossRef] [PubMed]
160. Witting, P.K.; Upston, J.M.; Stocker, R. The molecular action of alpha-tocopherol in lipoprotein lipid
peroxidation. Pro- and antioxidant activity of vitamin E in complex heterogeneous lipid emulsions.
In Fat-Soluble Vitamins; Quinn, P.J., Kagan, V.E., Eds.; Springer: New York, NY, USA; pp. 345�390.
161. Saboori, S.; Shab-Bidar, S.; Speakman, J.R.; Yousefi Rad, E.; Djafarian, K. Effect of vitamin E supplementation
on serum C-reactive protein level: A meta-analysis of randomized controlled trials. Eur. J. Clin. Nutr. 2015,
69, 867�873. [CrossRef] [PubMed]
162. Azzi, A.; Meydani, S.N.; Meydani, M.; Zingg, J.M. The rise, the fall and the renaissance of vitamin E.
Arch. Biochem. Biophys. 2016, 595, 100�108. [CrossRef] [PubMed]
163. Raederstorff, D.; Wyss, A.; Calder, P.C.; Weber, P.; Eggersdorfer, M. Vitamin E function and requirements in
relation to PUFA. Br. J. Nutr. 2015, 114, 1113�1122. [CrossRef] [PubMed]
164. Loffredo, L.; Perri, L.; Di Castelnuovo, A.; Iacoviello, L.; De Gaetano, G.; Violi, F. Supplementation
with vitamin E alone is associated with reduced myocardial infarction: A meta-analysis. Nutr. Metab.
Cardiovasc. Dis. 2015, 25, 354�363. [CrossRef] [PubMed]
165. Giampieri, F.; Tulipani, S.; Alvarez-Suarez, J.M.; Quiles, J.L.; Mezzetti, B.; Battino, M. The strawberry:
Composition, nutritional quality, and impact on human health. Nutrition 2012, 28, 9�19. [CrossRef] [PubMed]
166. Amiot, M.J.; Riva, C.; Vinet, A. Effects of dietary polyphenols on metabolic syndrome features in humans:
A systematic review. Obes. Rev. 2016, 17, 573�586. [CrossRef] [PubMed]
167. Smeriglio, A.; Barreca, D.; Bellocco, E.; Trombetta, D. Chemistry, Pharmacology and Health Benefits of
Anthocyanins. Phytother. Res. 2016, 30, 1265�1286. [CrossRef] [PubMed]
168. Lila, M.A. Anthocyanins and Human Health: An In Vitro Investigative Approach. J. Biomed. Biotechnol. 2004,
2004, 306�313. [CrossRef] [PubMed]
169. Stull, A.J.; Cash, K.C.; Johnson, W.D.; Champagne, C.M.; Cefalu, W.T. Bioactives in blueberries improve
insulin sensitivity in obese, insulin-resistant men and women. J. Nutr. 2010, 140, 1764�1768. [CrossRef]
[PubMed]
170. Zhu, Y.; Xia, M.; Yang, Y.; Liu, F.; Li, Z.; Hao, Y.; Mi, M.; Jin, T.; Ling, W. Purified anthocyanin supplementation
improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals. Clin. Chem.
2011, 57, 1524�1533. [CrossRef] [PubMed]
171. Qin, Y.; Xia, M.; Ma, J.; Hao, Y.; Liu, J.; Mou, H.; Cao, L.; Ling, W. Anthocyanin supplementation improves
serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer
protein in dyslipidemic subjects. Am. J. Clin. Nutr. 2009, 90, 485�492. [CrossRef] [PubMed]
172. Zhu, Y.; Ling, W.; Guo, H.; Song, F.; Ye, Q.; Zou, T.; Li, D.; Zhang, Y.; Li, G.; Xiao, Y.; et al. Anti-inflammatory
effect of purified dietary anthocyanin in adults with hypercholesterolemia: A randomized controlled trial.
Nutr. Metab. Cardiovasc. Dis. 2013, 23, 843�849. [CrossRef] [PubMed]
173. Zhu, Y.; Huang, X.; Zhang, Y.; Wang, Y.; Liu, Y.; Sun, R.; Xia, M. Anthocyanin supplementation
improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects
with hypercholesterolemia. J. Clin. Endocrinol. Metab. 2014, 99, 561�569. [CrossRef] [PubMed]
174. Karlsen, A.; Retterstol, L.; Laake, P.; Paur, I.; Bohn, S.K.; Sandvik, L.; Blomhoff, R. Anthocyanins inhibit
nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory
mediators in healthy adults. J. Nutr. 2007, 137, 1951�1954. [PubMed]
175. Keske, M.A.; Ng, H.L.; Premilovac, D.; Rattigan, S.; Kim, J.A.; Munir, K.; Yang, P.; Quon, M.J. Vascular and
metabolic actions of the green tea polyphenol epigallocatechin gallate. Curr. Med. Chem. 2015, 22, 59�69.
[CrossRef] [PubMed]
176. Johnson, R.; Bryant, S.; Huntley, A.L. Green tea and green tea catechin extracts: An overview of the clinical
evidence. Maturitas 2012, 73, 280�287. [CrossRef] [PubMed]
177. Huang, J.; Wang, Y.; Xie, Z.; Zhou, Y.; Zhang, Y.; Wan, X. The anti-obesity effects of green tea in human
intervention and basic molecular studies. Eur. J. Clin. Nutr. 2014, 68, 1075�1087. [CrossRef] [PubMed]
178. Hursel, R.; Westerterp-Plantenga, M.S. Catechin- and caffeine-rich teas for control of body weight in humans.
Am. J. Clin. Nutr. 2013, 98, 1682S�1693S. [CrossRef] [PubMed]
179. Gutierrez-Salmean, G.; Ortiz-Vilchis, P.; Vacaseydel, C.M.; Rubio-Gayosso, I.; Meaney, E.; Villarreal, F.;
Ramirez-Sanchez, I.; Ceballos, G. Acute effects of an oral supplement of (?)-epicatechin on postprandial fat
and carbohydrate metabolism in normal and overweight subjects. Food Funct. 2014, 5, 521�527. [CrossRef]
[PubMed]
180. Khalesi, S.; Sun, J.; Buys, N.; Jamshidi, A.; Nikbakht-Nasrabadi, E.; Khosravi-Boroujeni, H. Green tea
catechins and blood pressure: A systematic review and meta-analysis of randomised controlled trials.
Eur. J. Nutr. 2014, 53, 1299�1311. [CrossRef] [PubMed]

Close Accordion
Metabolic Syndrome And Chiropractic

Metabolic Syndrome And Chiropractic

Metabolic Syndrome:

Key indexing terms:

  • Metabolic syndrome X
  • Insulin resistance
  • Hyperglycemia
  • Inflammation
  • Weight loss

Abstract
Objective: This article presents an overview of metabolic syndrome (MetS), which is a collection of risk factors that can lead to diabetes, stroke, and heart disease. The purposes of this article are to describe the current literature on the etiology and pathophysiology of insulin resistance as it relates to MetS and to suggest strategies for dietary and supplemental management in chiropractic practice.

Methods: The literature was searched in PubMed, Google Scholar, and the Web site of the American Heart Association, from the earliest date possible to May 2014. Review articles were identified that outlined pathophysiology of MetS and type 2 diabetes mellitus (T2DM) and relationships among diet, supplements, and glycemic regulation, MetS, T2DM, and musculoskeletal pain.

Results: Metabolic syndrome has been linked to increased risk of developing T2DM and cardiovascular disease and increased risk of stroke and myocardial infarction. Insulin resistance is linked to musculoskeletal complaints both through chronic inflammation and the effects of advanced glycosylation end products. Although diabetes and cardiovascular disease are the most well-known diseases that can result from MetS, an emerging body of evidence demonstrates that common musculoskeletal pain syndromes can be caused by MetS.

Conclusions: This article provides an overview of lifestyle management of MetS that can be undertaken by doctors of chiropractic by means of dietary modification and nutritional support to promote blood sugar regulation.

Introduction: Metabolic Syndrome

Metabolic syndrome (MetS) has been described as a cluster of physical examination and laboratory findings�that directly increases the risk of degenerative metabolic disease expression. Excess visceral adipose tissue, insulin resistance, dyslipidemia, and hypertension are conditions that significantly contribute to the syndrome. These conditions are united by a pathophysiological basis in low-grade chronic inflammation and increase an individual’s risk of cardiovascular disease, type 2 diabetes mellitus (T2DM), and all-cause mortality.1

The National Health and Nutrition Examination Survey (NHANES) 2003-2006 estimated that approximately 34% of United States adults aged 20 years and more had MetS.2 The same NHANES data found that 53% had abdominal adiposity, a condition that is closely linked to visceral adipose stores. Excess visceral adiposity generates increased systemic levels of pro-inflammatory mediator molecules. Chronic, low- grade inflammation has been well documented as an associated and potentially inciting factor for the development of insulin resistance and T2DM.1

NHANES 2003-2006 data showed that 39% of subjects met criteria for insulin resistance. Insulin resistance is a component of MetS that significantly contributes to the expression of chronic, low-grade inflammation and predicts T2DM expression. T2DM costs the United States in excess of $174 billion in 2007. 3 It is estimated that 1 in 4 adults will have T2DM by the year 2050.3 Currently, more than one third of US adults (34.9%) are obese, 4 and, in 2008, the annual medical cost of obesity was $147 billion.4,5 This clearly represents a health care concern.

The pervasiveness of MetS dictates that doctors of chiropractic will see a growing proportion of patients who fit the syndrome criteria.6 Chiropractic is most commonly used for musculoskeletal complaints believed to be mechanical in nature;6 however, an emerging body of evidence identifies MetS as a biochemical promoter of musculoskeletal complaints such as neck pain, shoulder pain, patella tendinopathy, and widespread musculoskeletal pain. 7�13 As an example, the cross-linking of collagen fibers can be caused by increased advanced glycation end-product (AGE) formation as seen in insulin resistance.14 Increased collagen cross-linking is observed in both osteoarthritis and degenerative disc disease, 15 and reduced mobility in elderly patients with T2DM has also been attributed to AGE-induced collagen cross-linking. 16,17

A diagnosis of MetS is made from a patient having 3 of the 5 findings presented in Table 1. Fasting hyperglycemia is termed impaired fasting glucose and indicates insulin resistance. 18,19 An elevated hemoglobin A1c (HbA1c) level measures long-term blood glucose�regulation and is diagnostic for T2DM when elevated in the presence of impaired fasting glucose. 3,18

metabolic table 1

The emerging evidence demonstrates that we cannot view musculoskeletal pain as only coming from conditions that are purely mechanical in nature. Doctors of chiropractic must demonstrate prowess in identification and management of MetS and an understanding of insulin resistance as its main pathophysiological feature. The purposes of this article are to describe the current literature on the etiology and pathophysiology of insulin resistance as it relates to MetS and to suggest strategies for dietary and supplemental management in chiropractic practice.

Methods

metabolic method arrowsPubMed was searched from the earliest possible date to May 2014 to identify review articles that outlined the pathophysiology of MetS and T2DM. This led to further search refinements to identify inflammatory mechanisms that occur in the pancreas, adipose tissue, skeletal muscle, and hypothalamus. Searches were also refined to identify relationships among diet, supplements, and glycemic regulation. Both animal and human studies were reviewed. The selection of specific supplements was based on those that were most commonly used in the clinical setting, namely, gymnema sylvestre, vanadium, chromium and ?-lipoic acid.

Discussion

Insulin Resistance Overview

metabolic insulin resistance 1Under normal conditions, skeletal muscle, hepatic, and adipose tissues require the action of insulin for cellular glucose entry. Insulin resistance represents an inability of insulin to signal glucose passage into insulin-dependent cells. Although a genetic predisposition can exist, the�etiology of insulin resistance has been linked to chronic low-grade inflammation.1 Combined with insulin resistance-induced hyperglycemia, chronic low-grade inflammation also sustains MetS pathophysiology.1

Two thirds of postprandial blood glucose metabolism occurs within skeletal muscle via an insulin-dependent mechanism.18,19 Insulin binding to its receptor triggers glucose entry and subsequently inhibits lipolysis within the target tissue.21,22 Glucose enters skeletal muscles cells by way of a glucose transporter designated Glut4. 18 Owing to genetic variability, insulin-mediated glucose uptake can vary more than 6-fold among non-diabetic individuals. 23

Prolonged insulin resistance leads to structural changes within skeletal muscle such as decreased Glut4 transporter number, intramyocellular fat accu- mulation, and a reduction in mitochondrial con- tent.19,24 These events are thought to impact energy generation and functioning of affected skeletal mus- cle.24 Insulin-resistant skeletal muscle is less able to suppress lipolysis in response to insulin binding.25 Subsequently, saturated free fatty acids accumulate and generate oxidative stress. 22 The same phenomenon within adipose tissue generates a rapid adipose cell expansion and tissue hypoxia.26 Both these processes increase inflammatory pathway activation and the generation of proinflammatory cytokines (PICs).27

Multiple inflammatory mediators are associated with the promotion of skeletal muscle insulin resistance. The PICs tumor necrosis factor ? (TNF-?), interleukin 1 (IL- 1), and IL-6 have received much attention because of their direct inhibition of insulin signaling.28�30 Since cytokine testing is not performed clinically, elevated levels of high- sensitivity C-reactive protein (hsCRP) best represent the low-grade systemic inflammation that characterizes insulin resistance.31,32

Insulin resistance�induced hyperglycemia can lead to irreversible changes in protein structure, termed glycation, and the formation of AGEs. Cells such as those of the vascular endothelium are most vulnerable to hyperglycemia due to utilization of an insulin-independent Glut1 transporter. 33 This makes AGE generation responsible for most diabetic complications, 15,33,34 including collagen cross-linking.15

If unchanged, prolonged insulin resistance can lead to T2DM expression. The relationship between chronic low-grade inflammation and T2DM has been well characterized. 35 Research has demonstrated that patients with T2DM also have chronic inflammation within the pancreas, termed insulitis, and it worsens hyperglycemia due to the progressive loss of insulin- producing ? cells.36�39

Visceral Adiposity And Insulin Resistance

metabolic Visceral Adiposity Insulin resistanceCaloric excess and a sedentary lifestyle contribute to the accumulation of subcutaneous and visceral adipose tissue. Adipose tissue was once thought of as a metabolically inert passive energy depot. A large body of evidence now demonstrates that excess visceral adipose tissue acts as a driver of chronic low-grade inflammation and insulin resistance.27,34

It has been documented that immune cells infiltrate rapidly expanding visceral adipose tissue. 26,40 Infil- trated macrophages become activated and release PICs that ultimately cause a phenotypic shift in resident macrophage phenotype to a classic inflammatory M1 profile.27 This vicious cycle creates a chronic inflam- matory response within adipose tissue and decreases the production of adipose-derived anti-inflammatory cytokines.43 As an example, adiponectin is an adipose- derived anti-inflammatory cytokine. Macrophage- invaded adipose tissue produces less adiponectin, and this has been correlated with increasing insulin resistance. 26

Hypothalamic Inflammation And Insulin Resistance

metabolic Hypothalamic Inflammation And Insulin ResistanceEating behavior in the obese and overweight has been popularly attributed to a lack of will power or genetics. However, recent research has demonstrated a link between hypothalamic inflammation and increased body weight.41,41

Centers that govern energy balance and glucose homeostasis are located within the hypothalamus. Recent studies demonstrate that inflammation in the hypothalamus coincides with metabolic inflammation and an increase in appetite.43 These hypothalamic centers simultaneously become resistant to anorexigenic stimuli, leading to altered energy intake. It has been suggested that this provides a neuropathological basis for MetS and drives a progressive increase in body weight. 41

Central metabolic inflammation pathologically activates hypothalamic immune cells and disrupts central insulin and leptin signaling.41 Peripherally, this has been associated with dysregulated glucose homeostasis that also impairs pancreatic ? cell functioning.41,44 Hypothalamic inflammation contributes to hypertension through similar mechanisms, and it is thought that central inflammation parallels chronic low-grade systemic inflammation and insulin resistance.41�44

Clinical Correlates Diet-Induced Inflammation & Insulin Resistance

Fatty foodsFeeding generally leads to a short-term increase in both oxidative stress and inflammation. 41 Total�calories consumed, glycemic index, and fatty acid profile of a meal all influence the degree of postprandial inflammation. It is estimated that the average American consumes approximately 20% of calories from refined sugar, 20% from refined grains and flour, 15% to 20% from excessively fatty meat products, and 20% from refined seed/legume oils.45 This pattern of eating contains a macronutrient composition and glycemic index that promote hyperglycemia, hyperlipemia, and an acute postprandial inflammatory response. 46 Collectively referred to as postprandial dysmetabolism, this pro-inflammatory response can sustain levels of chronic low-grade inflammation that leads to excess body fat, coronary heart disease (CHD), insulin resistance, and T2DM.28,29,47

Recent evidence suggests that several MetS criteria may not sufficiently identify all individuals with postprandial dysmetabolism. 48,49 A 2-hour oral glucose tolerance test (2-h OGTT) result greater than 200 mg/dL can be used clinically to diagnose T2DM. Although MetS includes a fasting blood glucose level less than 100 mg/dL, population studies have shown that a fasting glucose as low as 90 mg/dL can be associated with an 2-h OGTT level greater than 200 mg/dL.49 Further, a recent large cohort study indicated that an increased 2-h OGTT was independently predictive of cardiovascular and all-cause mortality in a nondiabetic population. 48 Mounting evidence indicates that post- prandial glucose levels are better correlated with MetS and predicting future cardiovascular events than fasting blood glucose alone.41,48

Fasting triglyceride levels generally correlate with postprandial levels, and a fasting triglyceride level greater than 150 mg/dL reflects MetS and insulin resistance. Contrastingly, epidemiologic data indicate that a fasting triglyceride level greater than 100 mg/dL influences CHD risk via postprandial dysmetabolism. 48 The acute postprandial inflammatory response that contributes to CHD risk includes an increase in PICs, free radicals, and hsCRP.48,49 These levels are not measured clinically but, monitoring fasting glucose, 2-hour postprandial glucose and fasting triglycerides can be used as correlates of postprandial dysmetabolic and low-grade systemic inflammation.

MetS And Disease Expression

metabolic diabetes related wordsDiagnosis of MetS has been linked to an increased risk of developing T2DM and cardiovascular disease over the following 5 to 10 years. 1 It further increases a patient’s risk of stroke, myocardial infarction, and death from any of the aforementioned conditions.1

Facchini et al47 followed 208 apparently healthy, non-obese subjects for 4 to 11 years while monitoring the incidence of clinical events such as hypertension, stroke, CHD, cancer, and T2DM. Approximately one fifth of participants experienced clinical events, and all of these subjects were either classified as intermediately or severely insulin resistant. It is important to note that all of these clinical events have a pathological basis in chronic low-grade inflammation,50 and no events were experienced in the insulin-sensitive groupings. 47

Insulin resistance is linked to musculoskeletal com- plaints both through chronic inflammation and the effects of AGEs. Advanced glycation end-products have been shown to extensively accumulate in osteoarthritic cartilage and treatment of human chondrocytes with AGEs increased their catabolic activity. 51 Advanced glycation end-products increase collagen stiffness via cross-linking and likely contribute to reduced joint mobility seen in elderly patients with T2DM.52 Com- pared to non-diabetics, type II diabetic patients are known to have altered proteoglycan metabolism in their intervertebral discs. This altered metabolism may pro- mote weakening of the annular fibers and subsequently, disc herniation.53 The presence of T2DM increases a person’s risk of expressing disc herniation in both the cervical and lumbar spines.17,54 Patients with T2DM are also more likely to develop lumbar stenosis compared with non-diabetics, and this has been documented as a plausible relationship between MetS risk factors and physician-diagnosed lumbar disc herniation. 55�57

There are no specific symptoms that denote early skeletal muscle structural changes. Fatty infiltration and decreased muscle mitochondria content are observed within age-related sarcopenia 58 ; however, it is still being argued whether fatty infiltration is a risk factor for low back pain. 59,60

Clinical management of MetS should be geared toward improving insulin sensitivity and reducing chronic low-grade inflammation. 1 Regular exercise without weight loss is associated with reduced insulin resistance, and at least 30 minutes of aerobic activity and resistance training is recommended daily. 61,62 Although frequently considered preventative, exercise, dietary, and weight loss interventions should be considered alongside pharmacological management in those with MetS. 1

Data regarding the exact amount of weight loss needed to improve chronic inflammation are inconclusive. In overweight individuals without diagnosed MetS, a very-low-carbohydrate diet (b 10% calories from carbohydrate) has significantly reduced plasma inflammatory markers (TNF-?, hsCRP, and IL-6) with�as little as 6% reduction in body weight.63,64 Individuals who meet MetS criteria may require 10% to 20% body weight loss to reduce inflammatory markers. 65 Interestingly, the Mediterranean Diet has been shown to reduce markers of systemic inflammation independent of weight loss65 and was recommended in the American College of Cardiology and American Heart Association Adult Treatment Panel 4 guidelines.66

A growing body of research has examined the effects of the Spanish ketogenic Mediterranean diet, including olive oil, green vegetables and salads, fish as the primary protein, and moderate red wine consumption. In a sample of 22 patients, adoption of the Spanish ketogenic Mediterranean diet with 9 g of supplemental salmon oil on days when fish was not consumed has led to complete resolution of MetS.67 Significant reductions in markers of chronic systemic inflammation were seen in 31 patients following this diet for 12 weeks.68

A Paleolithic diet based on lean meat, fish, fruits, vegetables, root vegetables, eggs, and nuts has been described as more satiating per calorie than a diabetes diet in patients with T2DM.69 In a randomized crossover study, a Paleolithic diet resulted in lower mean HbA1c values, triglycerides, diastolic blood pressure, waist circumference, improved glucose tolerance, and higher high-density lipoprotein (HDL) values compared to a diabetes diet.70 Within the context of these changes, a referral for medication management may be advisable.

Irrespective of name, a low-glycemic diet that focuses on vegetables, fruits, lean meats, omega-3 fish, nuts, and tubers can be considered anti-inflammatory and has been shown to ameliorate insulin resistance. 49,71�73 Inflammatory markers and insulin resistance further improve when weight loss coincides with adherence to an anti-inflammatory diet.70 A growing body of evidence suggests that specific supplemental nutrients also reduce insulin resistance and improve chronic low-grade inflammation.

Key Nutrients That Promote Insulin Sensitivity

metabolic nutrientsResearch has identified nutrients that play key roles in promoting proper insulin sensitivity, including vitamin D, magnesium, omega-3 (n-3) fatty acids, curcumin, gymnema, vanadium, chromium, and ?-lipoic acid. It is possible to get adequate vitamin D from sun exposure and adequate amounts of magnesium and omega-3 fatty acids from food. Contrastingly, the therapeutic levels of chromium and ?-lipoic acid that affect insulin sensitivity and reduce�insulin resistance cannot be obtained in food and must be supplemented.

Vitamin D, Magnesium, Omega-3 Fatty Acids, & Curcumin

metabolic Vitamin D, Magnesium, Omega-3 Fatty Acids, CurcuminVitamin D, magnesium, and n-3 fatty acids have multiple functions, and generalized inflammation reduction is a common mechanism of action.74�80 Their supplemental use should be considered in the context of low-grade inflammation reduction and health promotion, rather than as a specific treatment for MetS or T2DM.

Evidence pertaining to the precise role of vitamin D in MetS and insulin resistance is inconclusive. Increas- ing dietary and supplemental vitamin D intake in young men and women may lower the risk of MetS and T2DM development,81 and a low serum vitamin D level has been associated with insulin resistance and T2DM expression. 82 Supplementation to improve low serum vitamin D (reference range, 32-100 ng/mL) is effective, but its impact on improving central glycemia and insulin sensitivity is conflicting. 83 Treating insulin resistance and MetS with vitamin D as a monotherapy appears to be unsuccessful. 82,83 Achieving normal vitamin D blood levels through adequate sun exposure and/or supplementation is advised for general health. 84�86

The average American diet commonly contains a low magnesium intake.80 Recent studies suggest that supple- mental magnesium can improve insulin sensitivity. 81,82 Taking 365 mg/d may be effective in reducing fasting glucose and raising HDL cholesterol in T2DM,83 as well as normomagnesemic, overweight, nondiabetics. 84

Diets high in the omega-6 fat linoleic acid have been associated with insulin resistance85 and higher levels of serum pro-inflammatory mediator markers including IL-6, IL-1?, TNF-?, and hsCRP.87 Supplementation to increase dietary omega-3 fatty acids at the expense of omega-6 fatty acids has been shown to improve insulin sensitivity. 88�90 Six months of omega-3 supplementation at 3 g/d with meals has been shown to reduce MetS markers including fasting triglycerides, HDL cholesterol, and an increase in anti-inflammatory adiponectin. 91

Curcumin is responsible for the yellow pigmentation of the spice turmeric. Its biological effects can be characterized as antidiabetic and antiobesity via down- regulating TNF-?, suppressing nuclear factor ?B activation, adipocytokine expression, and leptin level modulation,. 92�95 Curcumin has been reported to activate peroxisome proliferator-activated receptor-?, the nuclear target of the thiazolidinedione class of antidiabetic drugs,93 and it also protects hepatic and pancreatic cells. 92,93 Numerous studies have reported�weight loss, hsCRP reduction, and improved insulin sensitivity after curcumin supplementation.92�95

There is no established upper limit for curcumin, and doses of up to 12 g/d are safe and tolerable in humans. 96 A randomized, double-blinded, placebo- controlled trial (N = 240) showed a reduced progression of prediabetes to T2DM after 9 months of 1500 mg/d curcumin supplementation.97

Curcumin, 98 vitamin D, 84 magnesium, 91 and omega-3 fatty acids80 are advocated as daily supplements to promote general health. A growing body of evidence supports the views of Gymnema sylvestre, vanadium, chromium, and ?-lipoic acid should as therapeutic supplements to assist in glucose homeostasis.

G Sylvestre

metabolic Gymnema sylvestre medicinal herbGymnemic acids are the active component of the G sylvestre plant leaves. Gymnemic acids are the active component of the G sylvestre plant leaves. Studies evaluating G sylvestre’s effects on diabetes in humans have generally been of poor methodological quality. Experimental animal studies have found that gymnemic acids may decrease glucose uptake in the small intestine, inhibit gluconeogenesis, and reduce hepatic and skeletal muscle insulin resistance.99 Other animal studies suggest that gymnemic acids may have comparable efficacy in reducing blood sugar levels to the first-generation sulfonylurea, tolbutamide.100

Evidence from open-label trials suggests its use as a supplement to oral antidiabetic hypoglycemic agents. 96 One quarter of patients were able to discontinue their drug and maintain normal glucose levels on an ethanolic gymnema extract alone. Although the evidence to date suggests its use in humans and animals is safe and well tolerated, higher quality human studies are warranted.

Vanadyl Sulfate

metabolic Vanadyl SulfateVanadyl sulfate has been reported to prolong the events of insulin signaling and may actually improve insulin sensitivity.101 Limited data suggest that it inhibits gluconeogenesis, possibly ameliorating hepatic insulin resistance. 100,101 Uncontrolled clinical trials have reported improvements in insulin sensitivity using 50 to 300 mg daily for periods ranging from 3 to 6 weeks. 101�103 Contrastingly, a recent randomized, double-blind, placebo-controlled trial found that 50 mg of vanadyl sulfate twice daily for 4 weeks had no effect in individuals with impaired glucose tolerance. 104 Limited clinical and experimental data exist supporting the use of vanadyl sulfate to improve insulin resistance,�and further research is warranted regarding its safety and efficacy.

Chromium

metabolic ChromiumDiets high in refined sugar and flour are deficient in chromium (Cr) and lead to an increased urinary excretion of chromium. 105,106 The progression of MetS is not likely caused by a chromium deficiency, 107 and dosages that benefit glycemic regulation are not achievable through food. 106,108,109

A recent randomize, double-blind trial demonstrated that 1000 ?g Cr per day for 8 months improved insulin sensitivity by 10% in subjects with T2DM.110 Cefalu et al110 further suggested that these improvements might be more applicable to patients with a greater degree of insulin resistance, impaired fasting plasma glucose, and higher HbA1c values. Chromium’s mechanism of action for improving insulin sensitivity is through increased Glut4 translocation via prolonging insulin receptor signaling.109 Chromium has been well tolerated at 1000 ?g/d,105 and animal models using significantly more than 1000 ? Cr per day were not associated with toxicological consequences.109

?-Lipoic Acid

metabolic alpha-lipoic-acidHumans derive ?-lipoic acid through dietary means and from endogenous synthesis. 111 The foods richest in ?-lipoic acid are animal tissues with extensive metabolic activity such as animal heart, liver, and kidney, which are not consumed in large amounts in the typical American diet. 111 Supplemental amounts of ?-lipoic acid used in the treatment of T2DM (300-600 mg) are likely to be as much as 1000 times greater than the amounts that could be obtained from the diet.112

Lipoic acid synthase (LASY) appears to be the key enzyme involved in the generation of endogenous lipoic acid, and obese mice with diabetes have reduced LASY expression when compared with age-and sex- matched controls.111 In vitro studies to identify potential inhibitors of lipoic acid synthesis suggest a role for diet-induced hyperglycemia and the PIC TNF- ? in the down-regulation of LASY.113 The inflammatory basis of insulin resistance may therefore drive lowered levels of endogenous lipoic acid via reducing the activity of LASY.

?-Lipoic acid has been found to act as insulin mimetic via stimulating Glut4-mediated glucose trans- port in muscle cells. 110,114?-Lipoic acid is a lipophilic free radical scavenger and may affect glucose homeostasis through protecting the insulin receptor from damage114 and indirectly via decreasing nuclear factor ?B�mediated TNF-? and IL-1 production. 110 In�postmenopausal women with MetS (presence of at least 3 ATPIII clinical criteria) 4 g/d of a combined inositol and ?-lipoic acid supplement for 6 months significantly improved OGTT scores by 20% in two thirds of the subjects. 114 A recent randomized double-blinded placebo-controlled study showed that 300 mg/d ?- lipoic acid for 90 days significantly decreased HbA1c values in subjects with T2DM.115

Side effects to ?-lipoic acid supplementation as high as 1800 mg/d have largely been limited to nausea. 116 It may be best to take supplemental ?-lipoic acid on an empty stomach (1 hour before or 2 hours after eating) because food intake reportedly reduces its bioavailability.117 Clinicians should be aware that ?-lipoic acid supplementation might increase the risk of hypoglycemia in diabetic patients using insulin or oral antidiabetic agents.117

Limitations

metabolic limitations signThis is a narrative overview of the topic of MetS. A systematic review was not performed; therefore, there may be relevant information missing from this review. The contents of this overview focuses on the opinions of the authors, and therefore, others may disagree with our opinions or approaches to management. This overview is limited by the studies that have been published. To date, no studies have been published that identify the effectiveness of a combination of a dietary intervention, such as the Spanish ketogenic diet, and nutritional supplementation on the expression of the MetS. Similarly, this approach has not been studied in patients with musculoskeletal pain who also have the MetS. Consequently, the information presented in this article is speculative. Longitudinal studies are needed before any specific recommendations can be made for patients with musculoskeletal that may be influenced by the MetS.

Conclusion: Metabolic Syndrome

This overview suggests that MetS and type 2 diabetes are complex conditions, and their prevalence is expected to increase substantially in the coming years. Thus, it is important to identify if the MetS may be present in patients who are nonresponsive to manual care and to help predict who may not respond adequately.

We suggest that diet and exercise are essential to managing these conditions, which can be supported with key nutrients, such as vitamin D, magnesium, and�omega-3 fatty acids. We also suggest that curcumin, G sylvestre, vanadyl sulfate chromium, and ?-lipoic acid could be viewed as specific nutrients that may be taken during the process of restoring appropriate insulin sensitivity and signaling.

Chiropractic Care

 

David R. Seaman DC, MS,?, Adam D. Palombo DC

Professor, Department of Clinical Sciences, National University of Health Sciences, Pinellas Park, FL Private Chiropractic Practice, Newburyport, MA

Funding Sources and Conflicts of Interest

No funding sources were reported for this study. David Seaman is a paid consultant for Anabolic Laboratories, a manufacturer of nutritional products for health care professionals. Adam Palombo was sponsored and remunerated by Anabolic laboratories to speak at chiropractic conventions/meetings.

Blank
References:

1. Kaur J. A comprehensive review on metabolic syndrome.<br />
Cardiol Res Pract 2014:943162, http://dx.doi.org/10.1155/<br />
2014/943162.<br />
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic<br />
syndrome among US adults. Findings from the Third National<br />
Health and Nutrition Examination Survey. J Am Med Assoc<br />
2006;287:356�9.<br />
3. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson<br />
DF. Projection of the year 2050 burden of diabetes in the US<br />
adult population: dynamic modeling of incidence, mortality,<br />
and prediabetes prevalence. Popul Health Metr 2010;8:29,<br />
http://dx.doi.org/10.1186/1478-7954-8-29.<br />
4. [Internet]Centers for Disease Control and Prevention.<br />
Adult Obesity Facts. Atlanta: CDC; 2014. [Available from<br />http://www.cdc.gov/obesity/data/adult.html].<br />
5. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of<br />
childhood and adult obesity in the United States, 2011�2012.<br />
JAMA 2014;311(8):806�14.<br />
6. Riksman JS, Williamson OD, Walker BF. Delineating<br />
inflammatory and mechanical sub-types of low back pain: a<br />
pilot survey of fifty low back pain patients in a chiropractic<br />
setting. Chiropr Man Therap 2011;19(1):5, http://dx.doi.org/<br />
10.1186/2045-709X-19-5.<br />
7. Dobretsov M, Ghaleb AH, Romanovsky D, Pablo CS, Stimers<br />
JR. Impaired insulin signaling as a potential trigger of<br />
pain in diabetes and prediabetes. Int Anesthesiol Clin<br />
2007;45(2):95�105.<br />
8. Mantyselka P, Miettola J, Niskanen L, Kumpusalo E. Glucose<br />
regulation and chronic pain at multiple sites. Rheumatology<br />
2008;47(8):1235�8.<br />
9. M�ntyselk� P, Miettola J, Niskanen L, Kumpusalo E.<br />
Persistent pain at multiple sites�connection to glucose<br />
derangement. Diabetes Res Clin Pract 2009;84(2):e30�2.<br />
10. Mantyselka P, Kautianen H, Vanhala M. Prevalence of neck<br />
pain in subjects with metabolic syndrome�a cross-sectional<br />
population-based study. BMC Musculoskelet Disord 2010;11:<br />
171, http://dx.doi.org/10.1186/1471-2474-11-171.<br />
11. Rechardt M, Shiri R, Karppinen J, Jula A, Heli�vaara M,<br />
Viikari-Juntura E. Lifestyle and metabolic factors in relation<br />
to shoulder pain and rotator cuff tendinitis: a population-based<br />
study. BMC Musculoskelet Disord 2010;11:165.<br />
12. Gaida JE, Alfredson L, Kiss ZS, Wilson AM, Alfredson H,<br />
Cook JL. Dyslipidemia in Achilles tendinopathy is<br />
characteristic of insulin resistance. Med Sci Sports Exerc<br />
2009;41:1194�7.<br />
13. Malliaras P, Cook JL, Kent PM. Anthropometric risk factors<br />
for patellar tendon injury among volleyball players. Br J<br />
Sports Med 2007;41:259�63.<br />
14. Skrzynski S. DSC study of collagen in disc disease. J Biophys<br />
2009;2009:819635, http://dx.doi.org/10.1155/2009/819635.<br />
15. Luevano-Contreras C, Chapman-Novakofski K. Dietary<br />
advanced glycation end products and aging. Nutrients<br />
2010;2(12):1247�65 [2009;2009:819635].<br />
16. Abate M, Schiavone C, Pelotti P, Salini V. Limited joint<br />
mobility (LJM) in elderly subjects with type II diabetes<br />
mellitus. Arch Gerontol Geriatrics 2011;53:135�40.<br />
17. Sakellaridis N. The influence of diabetes mellitus on lumbar<br />
intervertebral disk herniation. Surg Neurol 2006;66:152�4.<br />
18. Shepherd PR, Kahn BB. Glucose transporters and insulin<br />
action: implications for insulin resistance and diabetes<br />
mellitus. New Eng J Med 1999;341(4):248�57.<br />
19. Abdul-Ghani MA, DeFronzo RA. Pathogenesis of insulin<br />
resistance in skeletal muscle. J Biomed Biotechnol 2010:19,<br />
http://dx.doi.org/10.1155/2010/476279 [Article ID 476279].<br />
20. [Internet]American Heart Association. About metabolic<br />
syndrome. Dallas: The Association; 2014. [Available from<br />http://www.heart.org/HEARTORG/Conditions/More/<br />MetabolicSyndrome/About-Metabolic-Syndrome_UCM_<br />301920_Article.jsp].<br />
21. Hotamisligil GS. Inflammation and metabolic disorders.<br />
Nature 2006;444:860�7.<br />
22. Glass CK, Olefsky JM. Inflammation and lipid signaling in the<br />
etiology of insulin resistance. Cell Metab 2012;15(5):635�45.<br />
23. Reaven GM. All obese individuals are not created equal:<br />
insulin resistance is the major determinant of cardiovascular<br />
disease in overweight/obese individuals. Diabetes Vasc Dis<br />
Res 2005;2:105�12.<br />
24. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster<br />
BH, Kelley DE. Deficiency of subsarcolemmal mitochondria<br />
in obesity and type 2 diabetes. Diabetes 2005;54:8�14.<br />
25. Corcoran MP, Lamon-Fava S, Fielding RA. Trans fats and<br />
insulin resistance: skeletal muscle lipid deposition and insulin<br />
resistance: effect of dietary fatty acids and exercise. Am J Clin<br />
Nutr 2007;85:662�77.<br />
26. Schipper HS, Prakken B, Kalkhoven E, Boes M. Adipose<br />
tissue-resident immune cells: key players in immunometabolism.<br />
Trends Endocrinol Metab 2012;23:407�15.<br />
27. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines:<br />
the missing link between insulin resistance and obesity.<br />
Diabetes Metab 2008;34:2�11.<br />
28. Grimble RF. Inflammatory status and insulin resistance. Curr<br />
Opin Clin Nutr Metab Care 2003;5:551�9.<br />
29. Tilg H, Moschen AR. Inflammatory mechanisms in<br />
the regulation of insulin resistance. Mol Med 2008;3�4:222�31.<br />
30. Johnson DR, O’Conner JC, Satpathy A, Freund GG.<br />
Cytokines in type 2 diabetes. Vitam Horm 2006;74:405�41.<br />
31. Ridker PM, Wilson PW, Grundy SM. Should C-reactive<br />
protein be added to the metabolic syndrome and to<br />
assessment of global cardiovascular risk? Circulation 2004;<br />
109:2818�25.<br />
32. Gelaye B, Revilla L, Lopez T, et al. Association between<br />
insulin resistance and c-reactive protein among Peruvian<br />
adults. Diabetol Metab Syn 2010;2:30.<br />
33. Singh VP, Bali A, Singh N, et al. Advanced glycation end<br />
products and diabetic complications. Korean J Physiol<br />
Pharmacol 2014;18(1):1�14.<br />
34. Baker RG, Hayden MS. NF-kB, inflammation and metabolic<br />
disease. Cell Metab 2011;13(1):11�22.<br />
35. Purkayastha S, Cair D. Neuroinflammatory basis of metabolic<br />
syndrome. Mol Metab Nov 2013;2(4):356�63.<br />
36. Ehse JA, Boni-Schnetzler M, Faulenbach M, Donath MY.<br />
Macrophages, cytokines and beta-cell death in type 2 diabetes.<br />
Biochem Soc Trans 2008;36(3):340�2.<br />
37. Boni-Schnetzler M, Ehses JA, Faulenbach M, Donath MY.<br />
Insulitis in type 2 diabetes. Diabetes Obes Metab 2008;10<br />
(Suppl 4):201�4.<br />
38. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H,<br />
Perren A, Ehses JA. Islet inflammation in type 2<br />
diabetes: from metabolic stress to therapy. Diabetes Care<br />
2008;31(Suppl 2):S161�4.<br />
39. Donath MY, Boni-Schnetzler M, Ellingsgaard H, Ehses JA.<br />
Islet inflammation impairs the pancreatic beta-cell in type 2<br />
diabetes. Physiology 2009;24:325�31.<br />
40. Harford KA, Reynolds CM, McGillicuddy FC, Roche HM.<br />
Fats, inflammation and insulin resistance: insights to the role<br />
of macrophage and T-cell accumulation in adipose tissue.<br />
Proc Nutr Soc 2011;70:408�17.<br />
41. Munoz A, Costa M. Nutritionally mediated oxidative stress and<br />
inflammation. Oxid Med Cell Longev 2013;2013:610950, http://<br />
dx.doi.org/10.1155/2013/610950.<br />
42. Wisse BE, Schwartz MW. Does hypothalamic inflammation<br />
cause obesity? Cell Metab 2009;10(4):241�2.<br />
43. Purkayastha S, Cair D. Neuroinflammatory basis of metabolic<br />
syndrome. Mol Metab Nov 2013;2(4):356�63.<br />
44. Calegari VC, Torsoni AS, Vanzela EC, Ara�jo EP, Morari<br />
J, Zoppi CC, et al. Inflammation of the hypothalamus leads<br />
to defective pancreatic islet function. J Biol Chem 2011;<br />
286(15):12870�80.<br />
45. Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution<br />
of the Western diet: health implications for the 21st century.<br />
Am J Clin Nutr 2005;81:341�54.<br />
46. Barclay AW, Petocz P, McMillan-Price J, et al. Glycemic<br />
index, glycemic load, and chronic disease risk�a metaanalysis<br />
of observational studies. Am J Clin Nutr<br />
2008;87:627�37.<br />
47. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance<br />
as a predictor of age-related disease. J Clin Endocrinol Metab<br />
2001;86:3574�8.<br />
48. Lin H, Lee B, Ho Y, et al. Postprandial glucose improves the<br />
risk prediction of cardiovascular death beyond the metabolic<br />
syndrome in the nondiabetic population. Diabetes Care Sep<br />
2009;32(9):1721�6.<br />
49. O’Keefe JH, Bell DS. Postprandial hyperglycemia/<br />
hyperlipidemia (postprandial dysmetabolism) is a cardiovascular<br />
risk factor. Am J Cardiol 2007;100:899�904.<br />
50. Cao H. Adipocytokines in obesity and metabolic disease.<br />
J Endocrinol 2014;220(2):T47�59.<br />
51. Nah SS, Choi IY, Lee CK, et al. Effects of advanced glycation<br />
end products on the expression of COX2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology (Oxford)<br />
2008;47(4):425�31.<br />
52. Abate M, Schiavone C, Pelotti P, Salini V. Limited joint<br />
mobility (LJM) in elderly subjects with type II diabetes<br />
mellitus. Arch Gerontol Geriatr 2011;53:135�40.<br />
53. Robinson D, Mirovsky Y, Halperin N, Evron Z, Nevo Z.<br />
Changes in proteoglycans of intervertebral disc in diabetic<br />
patients: a possible cause of increased back pain. Spine<br />
1998;23:849�56.<br />
54. Sakellaridis N, Androulis A. Influence of diabetes mellitus on<br />
cervical intervertebral disc herniation. Clin Neurol Neurosurg<br />
2008;110:810�2.<br />
55. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Cardiovascular<br />
risk factors for physician-diagnosed lumbar disc<br />
herniation. Spine J 2006;6:684�91.<br />
56. Lotan R, Oron A, Anekstein Y, Shalmon E, Mirovsky Y.<br />
Lumbar stenosis and systemic diseases: is there any relevance.<br />
J Spinal Disord Tech 2008;21:247�51.<br />
57. Anekstein Y, Smorgick Y, Lotan R, et al. Diabetes mellitus as<br />
a risk factor for the development of lumbar spinal stenosis. Isr<br />
Med Assoc J 2010;12:16�20.<br />
58. Choi KM. Sarcopenia and sarcopenic obesity. Endocrinol<br />
Metab (Seoul) 2013;28(2):86�9.<br />
59. D’hooge R, Cagnie B, Crombez G, et al. Increased<br />
intramuscular fatty infiltration without differences in lumbar<br />
muscle cross-sectional area during remission of unilateral<br />
recurrent low back pain. Man Ther 2012 Dec;17(6):5584�8.<br />
60. Chen YY, Pao JL, Liaw CK, et al. Image changes of paraspinal<br />
muscles and clinical correlations in patients with unilateral<br />
lumbar spinal stenosis. Eur Spine J 2014;23(5):999�1006.<br />
61. Kim Y, Park H. Does regular exercise without weight loss<br />
reduce insulin resistance in children and adolescents? In J<br />
Endocrinol 2013:402592, http://dx.doi.org/10.1155/2013/<br />
402592 [Epub 2013 Dec 12].<br />
62. Strasser B, Siebert U, Schobersberger W. Resistance training<br />
in the treatment of the metabolic syndrome: a systematic<br />
review and meta-analysis of the effect of resistance training on<br />
metabolic clustering in patients with abnormal glucose<br />
metabolism. Sports Med 2010;40:397�415.<br />
63. Sharman MJ, Volek JS. Weight loss leads to reductions in<br />
inflammatory biomarkers after a very-low-carbohydrate diet<br />
and a low-fat diet in overweight men. Clin Sci (Lond)<br />
2004;13:365�9.<br />
64. Teng KT, Chang CY, Chang LF, et al. Modulation of obesityinduced<br />
inflammation by dietary fats: mechanisms and<br />
clinical evidence. Nutr J 2014;13:12, http://dx.doi.org/<br />
10.1186/1475-2891-13-12.<br />
65. Tzotzas T, Evangelou P, Kiortsis DN. Obesity, weight loss<br />
and conditional cardiovascular risk factors. Obes Rev 2011;12<br />
(5):e282�9.<br />
66. Stone N, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA<br />
Guideline on the Treatment of Blood Cholesterol to Reduce<br />
Atherosclerotic Cardiovascular Risk in Adults: A report of<br />
the American College of Cardiology/American Heart<br />
Association Task Force on practice guidelines. Circulation<br />
2014;129(25 Suppl 2):S1�S45.<br />
67. P�rez-Guisado J, Mu�oz-Serrano A. A pilot study of the<br />
Spanish ketogenic Mediterranean diet: an effective therapy for<br />
the metabolic syndrome. J Med Food 2011;14(7�8):681�7.<br />
68. P�rez-Guisado J, Mu�oz-Serrano A, Alonso-Moraga A.<br />
Spanish ketogenic Mediterranean diet: a healthy cardiovascular<br />
diet for weight loss. Nutr J 2008;7:30, http://dx.doi.org/<br />
10.1186/1475-2891-7-30.<br />
69. Jonsson T, Granfeldt Y, Lindeberg S, et al. Subjective satiety<br />
and other experiences of a Paleolithic diet compared to a<br />
diabetes diet in patients with T2DM. Nutr J 2013;12:105,<br />
http://dx.doi.org/10.1186/1475-2891-12-105.<br />
70. Jonsson T, Granfeldt Y, Ahren B, et al. Beneficial effects of a<br />
Paleolithic diet on cardiovascular risk factors in T2DM: a<br />
randomized cross-over pilot study. Cardiovasc Diabetol<br />
2009;8:35, http://dx.doi.org/10.1186/1475-2840-8-35.<br />
71. Nicklas BJ, You T, Pahor M. Behavioural treatments<br />
for chronic system inflammation: effects of dietary<br />
weight loss and exercise training. Can Med Assoc J<br />
2005;172(9):1199�209.<br />
72. O’Keefe JH, Gheewala NM, O’Keefe JO. Dietary<br />
strategies for improving post-prandial glucose, lipids, inflammation,<br />
and cardiovascular health. J Am Coll Cardiol<br />
2008;51:249�55.<br />
73. O’Keefe Jr JH, Cordain L. Cardiovascular disease resulting<br />
from a diet and lifestyle at odds with our Paleolithic genome:<br />
how to become a 21st-century hunter�gatherer. Mayo Clin<br />
Proc 2004;79(1):101�8.<br />
74. Ames BN. Low micronutrient intake may accelerate the<br />
degenerative diseases of aging through allocation of scarce<br />
micronutrients by triage. Proc Natl Acad Sci U S A 2006;103<br />
(47):17589�94.<br />
75. Holick MF, Chen TC. Vitamin D deficiency: a worldwide<br />
problem with health consequences. Am J Clin Nutr<br />
2008;87:1080S�6S [Suppl.].<br />
76. Toubi E, Shoenfeld Y. The role of vitamin D in regulating<br />
immune responses. Isr Med Assoc J 2010;12(3):174�5.<br />
77. King DE, Mainous AG, Geesey ME, Egan BM, Rehman S.<br />
Magnesium supplement intake and C-reactive protein levels<br />
in adults. Nutr Res 2006;26:193�6.<br />
78. Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium<br />
status in the United States: are the health consequences<br />
underestimated? Nutr Rev 2012;70(3):153�64.<br />
79. Simopoulos AP. Omega-3 fatty acids in inflammation and<br />
autoimmune diseases. J Am Coll Nutr 2002;21(6):495�505.<br />
80. Simopoulos AP. The importance of the omega-6/omega-3<br />
fatty acid ratio in cardiovascular disease and other chronic<br />
diseases. Exp Biol Med 2008;233:674�88.<br />
81. Fung GJ, Steffen LM, Zhou X, et al. Vitamin D intake is<br />
inversely related to risk of developing metabolic syndrome<br />
in African American and white men and women over 20 y:<br />
the Coronary Artery Risk Development in Young Adults<br />
study. Am J Clin Nutr 2012;96(1):24�9 [Published online<br />2012 May 30].<br />
82. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio<br />
D. Role of vitamin D in the pathogenesis of type 2 diabetes<br />
mellitus. Diabetes Obes Metab 2008;10:185�97.<br />
83. Guadarrama-Lopez AL, Valdes-Ramos R, Martinex-Carrillo<br />
BE. T2DM, PUFAs, and vitamin D: their relation to<br />
inflammation. J Immunol Res 2014;2014:860703, http://dx.<br />
doi.org/10.1155/2014/860703.<br />
84. Cannell JJ, Hollis BW. Use of vitamin D in clinical practice.<br />
Altern Med Rev 2008;13(1):6�20.<br />
85. Davidson MB, Duran P, Lee ML, Friedman TC. High-dose<br />
vitamin D supplementation in people with prediabetes and<br />
hypovitaminosis D. Diabetes Care 2013;36(2):260�6, http://<br />
dx.doi.org/10.2337/dc12-1204.<br />
86. Schwalfenberg G. Vitamin D, and diabetes: improvement of<br />
glycemic control with vitamin D3 repletion. Can Fam<br />
Physician 2008;54:864�6.<br />
87. Kim DJ, Xun P, Liu K, et al. Magnesium intake in relation to<br />
systemic inflammation, insulin resistance, and the incidence<br />
of diabetes. Diabetes Care 2010;33(12):2604�10, http://dx.<br />
doi.org/10.2337/dc10-0994.<br />
88. Guerrero-Romero F, Tamez-Perez HE, Gonz�lez-Gonz�lez G,<br />
et al. Oral magnesium supplementation improves insulin<br />
sensitivity in non-diabetic subjects with insulin resistance. A<br />
double-blind placebo-controlled randomized trial. Diabetes<br />
Metab 2004;30(3):253�8.<br />
89. Rodr�guez-Mor�n M, Guerrero-Romero F. Oral magnesium<br />
supplementation improves insulin sensitivity and metabolic<br />
control in type 2 diabetic subjects: a randomized double-blind<br />
controlled trial. Diabetes Care 2003;26(4):1147�52.<br />
90. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral<br />
magnesium supplementation on glycaemic control in type 2<br />
diabetes: a meta-analysis of randomized double-blind controlled<br />
trials. Diabet Med 2006;23(10):1050�6.<br />
91. Mooren FC, Kr�ger K, V�lker K, Golf SW,Wadepuhl M, Kraus<br />
A. Oral magnesium supplementation reduces insulin resistance<br />
in non-diabetic subjects�a double-blind, placebo-controlled,<br />
randomized trial. Diabetes Obes Metab 2011;13(3):281�4.<br />
92. Aggarwal BB. Targeting inflammation induced obesity and<br />
metabolic diseases by curcumin and other nutraceuticals.<br />
Annu Rev Nutr 2010;30:173�9.<br />
93. Alappat L, Awad AB. Curcumin and obesity: evidence and<br />
mechanisms. Nutr Rev 2010;68(12):729�38.<br />
94. Gonzales AM, Orlando RA. Curcumin and resveratrol inhibit<br />
nuclear factor-kappaB-mediated cytokine expression in adipocytes.<br />
Nutr Metab 2008;5:17, http://dx.doi.org/10.1186/<br />
1743-7075-5-17.<br />
95. Sahebkar A. Why it is necessary to translate curcumin into<br />
clinical practice for the prevention and treatment of metabolic<br />
syndrome? Biofactors 2012, http://dx.doi.org/10.1002/<br />
biof.1062 [Epub ahead of print].<br />
96. Hsu CH, Cheng AL. Clinical studies with curcumin. Adv Exp<br />
Med Biol 2007;595:471�80.<br />
97. Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R,<br />
Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention<br />
of type 2 diabetes. Diabetes Care 2012;35(11):2121�7.<br />
98. Jurenka JS. Anti-inflammatory properties of curcumin, a<br />
major constituent of curcuma longa: a review of preclinical<br />
and clinical research. Altern Med Rev 2009;14(2):141�53.<br />
99. Leach M. Gymnema sylvestre for diabetes mellitus: a systematic<br />
review. J Altern Complement Med 2007;13(9):977�83.<br />
100. Chattopadhyay R. A comparative evaluation of some blood<br />
sugar lowering agents of plant origin. J Ethnopharmacol<br />
1999;67:367�72.<br />
101. Nahas R, Moher M. Complementary and alternative medicine<br />
for the treatment of type 2 diabetes. Can Fam Physician<br />
2009;55:591�6.<br />
102. Vanadium/Vanadyl sulfate: monograph. Altern Med Rev<br />
2009;14:17�80.<br />
103. Boden G, Chen X, Ruiz J, et al. Effects of vanadyl sulfate<br />
on carbohydrate and lipid metabolism in patients with noninsulin-dependent<br />
diabetes mellitus. Metabolism 1996;45:<br />
1130�5.<br />
104. Jacques-Camarena O, Gonz�lez-Ortiz M, Mart�nez-Abundis E,<br />
et al. Effect of vanadium on insulin sensitivity in patients with<br />
impaired glucose tolerance. Ann Nutr Metab 2008;53:195�8.<br />
105. Vincent JB. The biochemisty of chromium. J Nutr<br />
2000;130:715�8.<br />
106. Anderson RA. Chromium and insulin resistance. Nutr Res<br />
Rev 2003;16:267�75.<br />
107. Vincent JB. Chromium: celebrating 50 years as an essential<br />
element? Dalton Trans 2010;39:3787�94.<br />
108. Office of Dietary Supplements. [Internet]. Dietary supplement<br />
fact sheet: Chromium. Washington, DC: United States<br />
Department of Health and Human Services. http://ods.od.nih.<br />
gov/factsheets/chromium/. Reviewed November 4, 2013.<br />
109. Anderson RA. Chromium, glucose intolerance and diabetes.<br />
J Am Coll Nutr 1998;17(6):548�55.<br />
110. Cefalu WT, Rood J, Patricia Pinsonat P, et al. Characterization<br />
of the metabolic and physiologic response to chromium<br />
supplementation in subjects with type 2 diabetes mellitus.<br />
Metab Clin Exp 2010;59:755�62.<br />
111. Heimbach JT, Anderson RA. Chromium: recent studies regarding<br />
nutritional roles and safety. Nutr Today 2005;40(4):180�95.<br />
112. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM.<br />
Alpha-lipoic acid as a dietary supplement: molecular<br />
mechanisms and therapeutic potential. Biochim Biophys<br />
Acta 2009;1790:1149�60.<br />
113. Morikawa T, Yasuno R, Wada H. Do mammalian cells<br />
synthesize lipoic acid? Identification of a mouse cDNA<br />
encoding a lipoic acid synthase located in mitochondria.<br />
FEBS Lett 2001;498:16�21.<br />
114. Singh U, Jialal I. Alpha-lipoic acid supplementation and<br />
diabetes. Nutr Rev 2008;66(11):646�57.<br />
115. Padmalayam I, Hasham S, Saxena U, Pillarisetti S. Lipoic acid<br />
synthase (LASY): a novel role in inflammation, mitochondrial<br />
function, and insulin resistance. Diabetes 2009;58:600�8.<br />
116. Capasso I, Esposito E, Maurea N, et al. Combination of<br />
inositol and alpha lipoic acid in metabolic syndrome-affected<br />
women: a randomized placebo-controlled trial. Trial<br />
2013;14:273, http://dx.doi.org/10.1186/1745-6215-14-273.<br />
117. Udupa A, Nahar P, Shah S, et al. A comparative study of<br />
effects of omega-3 fatty acids, alpha lipoic acid and vitamin E<br />
in T2DM. Ann Med Health Sci Res 2013;3(3):442�6.

Close Accordion
The Role Of Epigenetics In Obesity And Metabolic Disease

The Role Of Epigenetics In Obesity And Metabolic Disease

Epigenetic Abstract:

The increased prevalence of obesity and related comorbidities is a major public health problem. While genetic factors undoubtedly play a role in determining individual susceptibility to weight gain and obesity, the identified genetic variants only explain part of the variation. This has led to growing interest in understanding the potential role of epigenetics as a mediator of gene-environment interactions underlying the development of obesity and its associated comorbidities. Initial evidence in support of a role of epigenetics in obesity and type 2 diabetes mellitus (T2DM) was mainly provided by animal studies, which reported epigenetic changes in key metabolically important tissues following high-fat feeding and epigenetic differences between lean and obese animals and by human studies which showed epigenetic changes in obesity and T2DM candidate genes in obese/diabetic individuals. More recently, advances in epigenetic methodologies and the reduced cost of epigenome-wide association studies (EWAS) have led to a rapid expansion of studies in human populations. These studies have also reported epigenetic differences between obese/T2DM adults and healthy controls and epigenetic changes in association with nutritional, weight loss, and exercise interventions. There is also increasing evidence from both human and animal studies that the relationship between perinatal nutritional exposures and later risk of obesity and T2DM may be mediated by epigenetic changes in the offspring. The aim of this review is to summarize the most recent developments in this rapidly moving field, with a particular focus on human EWAS and studies investigating the impact of nutritional and lifestyle factors (both pre- and postnatal) on the epigenome and their relationship to metabolic health outcomes. The difficulties in distinguishing consequence from causality in these studies and the critical role of animal models for testing causal relationships and providing insight into underlying mechanisms are also addressed. In summary, the area of epigenetics and metabolic health has seen rapid developments in a short space of time. While the outcomes to date are promising, studies are ongoing, and the next decade promises to be a time of productive research into the complex interactions between the genome, epigenome, and environment as they relate to metabolic disease.

Keywords: Epigenetics, DNA methylation, Obesity, Type 2 diabetes, Developmental programming

Introduction

Epigenetic mechanismsObesity is a complex, multifactorial disease, and better understanding of the mechanisms underlying the interactions between lifestyle, environment, and genetics is critical for developing effective strategies for prevention and treatment [1].

In a society where energy-dense food is plentiful and the need for physical activity is low, there is a wide variation in individuals� susceptibility to develop�obesity and metabolic health problems. Estimates of the role of heredity in this variation are in the range of 40�70 %, and while large genome-wide association studies (GWAS) have identified a number of genetic loci associated with obesity risk, the ~100 most common genetic variants only account for a few percent of variance in obesity [2, 3]. Genome-wide estimates are higher, accounting for ~20 % of the variation [3]; however, a large portion of the heritability remains unexplained.

Recently, attention has turned to investigating the role of epigenetic changes in the etiology of obesity. It has been argued that the epigenome may represent the mechanistic link between genetic variants and environmental�factors in determining obesity risk and could help explain the �missing heritability.� The first human epigenetic studies were small and only investigated a limited number of loci. While this generally resulted in poor reproducibility, some of these early findings, for instance the relationship between PGC1A methylation and type 2 diabetes mellitus (T2DM) [4] and others as discussed in van Dijk et al. [5], have been replicated in later studies. Recent advances and increased affordability of high- throughput technologies now allow for large-scale epigenome wide association studies (EWAS) and integration of different layers of genomic information to explore the complex interactions between the genotype, epigenome, transcriptome, and the environment [6�9]. These studies are still in their infancy, but the results thus far have shown promise in helping to explain the variation in obesity susceptibility.

There is increasing evidence that obesity has develop mental origins, as exposure to a suboptimal nutrient supply before birth or in early infancy is associated with an increased risk of obesity and metabolic disease in later life [10�13]. Initially, animal studies demonstrated that a range of early life nutritional exposures, especially those experienced early in gestation, could induce epigenetic changes in key metabolic tissues of the offspring that persisted after birth and result in permanent alterations in gene function [13�17]. Evidence is emerging to support the existence of the same mechanism in humans. This has led to a search for epigenetic marks present early in life that predict later risk of metabolic disease, and studies to determine whether epigenetic programming of metabolic disease could be prevented or reversed in later life.

This review provides an update of our previous systematic review of studies on epigenetics and obesity in humans [5]. Our previous review showcased the promising outcomes of initial studies, including the first potential epigenetic marks for obesity that could be detected at birth (e.g., RXRA) [18]. However, it also highlighted the limited reproducibility of the findings and the lack of larger scale longitudinal investigations. The current review focuses on recent developments in this rapidly moving field and, in particular, on human EWAS and studies investigating the impact of (pre- and postnatal) nutritional and lifestyle factors on the epigenome and the emerging role of epigenetics in the pathology of obesity. We also address the difficulties in identifying causality in these studies and the importance of animal models in providing insight into mechanisms.

Review

Epigenetic Changes In Animal Models Of Obesity

rabbit eatingAnimal models provide unique opportunities for highly controlled studies that provide mechanistic insight into�the role of specific epigenetic marks, both as indicators of current metabolic status and as predictors of the future risk of obesity and metabolic disease. A particularly important aspect of animal studies is that they allow for the assessment of epigenetic changes within target tissues, including the liver and hypothalamus, which is much more difficult in humans. Moreover, the ability to harvest large quantities of fresh tissue makes it possible to assess multiple chromatin marks as well as DNA methylation. Some of these epigenetic modifications either alone or in combination may be responsive to environmental programming. In animal models, it is also possible to study multiple generations of offspring and thus enable differentiation between trans-generational and intergenerational transmission of obesity risk mediated by epigenetic memory of parental nutritional status, which cannot be easily distinguished in human studies. We use the former term for meiotic transmission of risk in the absence of continued exposure while the latter primarily entails direct transmission of risk through metabolic reprogramming of the fetus or gametes.

Animal studies have played a critical role in our current understanding of the role of epigenetics in the developmental origins of obesity and T2DM. Both increased and decreased maternal nutrition during pregnancy have been associated with increased fat deposition in offspring of most mammalian species studied to date (reviewed in [11, 13�15, 19]). Maternal nutrition during pregnancy not only has potential for direct effects on the fetus, it also may directly impact the developing oocytes of female fetuses and primordial germ cells of male fetuses and therefore could impact both the off- spring and grand-offspring. Hence, multigenerational data are usually required to differentiate between maternal intergenerational and trans-generational transmission mechanisms.

Table 1 summarizes a variety of animal models that have been used to provide evidence of metabolic and epigenetic changes in offspring associated with the parental plane of nutrition. It also contains information pertaining to studies identifying altered epigenetic marks in adult individuals who undergo direct nutritional challenges. The table is structured by suggested risk transmission type.

table 1(i) Epigenetic Changes In Offspring Associated With Maternal Nutrition During Gestation

Maternal nutritional supplementation, undernutrition, and over nutrition during pregnancy can alter fat deposition and energy homeostasis in offspring [11, 13�15, 19]. Associated with these effects in the offspring are changes in DNA methylation, histone post-translational modifications, and gene expression for several target genes,�especially genes regulating fatty acid metabolism and insulin signaling [16, 17, 20�30]. The diversity of animal models used in these studies and the common metabolic pathways impacted suggest an evolutionarily conserved adaptive response mediated by epigenetic modification. However, few of the specific identified genes and epigenetic changes have been cross-validated in related studies, and large-scale genome-wide investigations have typically not been applied. A major hindrance to comparison of these studies is the different develop mental windows subjected to nutritional challenge, which may cause considerably different outcomes. Proof that the epigenetic changes are causal rather than being associated with offspring phenotypic changes is also required. This will necessitate the identification of a parental nutritionally induced epigenetic �memory� response that precedes development of the altered phenotype in offspring.

(ii)Effects Of Paternal Nutrition On Offspring Epigenetic Marks

baby sleeping holding handsEmerging studies have demonstrated that paternal plane of nutrition can impact offspring fat deposition and epigenetic marks [31�34]. One recent investigation using mice has demonstrated that paternal pre-diabetes leads to increased susceptibility to diabetes in F1 offspring with associated changes in pancreatic gene expression and DNA methylation linked to insulin signaling [35]. Importantly, there was an overlap of these epigenetic changes in pancreatic islets and sperm suggesting germ line inheritance. However, most of these studies, although intriguing in their implications, are limited in the genomic scale of investigation and frequently show weak and somewhat transient epigenetic alterations associated with mild metabolic phenotypes in offspring.

(iii)Potential Trans-generational Epigenetic Changes Promoting Fat Deposition In Offspring

excess nutritionStable transmission of epigenetic information across multiple generations is well described in plant systems and C. elegans, but its significance in mammals is still much debated [36, 37]. An epigenetic basis for grand- parental transmission of phenotypes in response to dietary exposures has been well established, including in livestock species [31]. The most influential studies demonstrating effects of epigenetic transmission impacting offspring phenotype have used the example of the viable yellow agouti (Avy) mouse [38]. In this mouse, an insertion of a retrotransposon upstream of the agouti gene causes its constitutive expression and consequent yellow coat color and adult onset obesity. Maternal transmission through the germ line results in DNA methylation�mediated silencing of agouti expression resulting in wild-type coat color and lean phenotype of the offspring [39, 40]. Importantly, subsequent studies in these mice demonstrated that maternal exposure to methyl donors causes a shift in coat color [41]. One study has reported transmission of a phenotype to the F3 generation and alterations in expression of large number of genes in response to protein restriction in F0 [42]; however, alterations in expression were highly variable and a direct link to epigenetic changes was not identified in this system.

(iv) Direct Exposure Of Individuals To Excess Nutrition In Postnatal Life

modern western lifestyleWhile many studies have identified diet-associated epigenetic changes in animal models using candidate site-specific regions, there have been few genome-wide analyses undertaken. A recent study focussed on determining the direct epigenetic impact of high-fat diets/ diet-induced obesity in adult mice using genome-wide gene expression and DNA methylation analyses [43]. This study identified 232 differentially methylated regions (DMRs) in adipocytes from control and high-fat fed mice. Importantly, the corresponding human regions for the murine DMRs were also differentially methylated in adipose tissue from a population of obese and lean humans, thereby highlighting the remarkable evolutionary conservation of these regions. This result emphasizes the likely importance of the identified DMRs in regulating energy homeostasis in mammals.

Human Studies

anatomy 3D model

Drawing on the evidence from animal studies and with the increasing availability of affordable tools for genome- wide analysis, there has been a rapid expansion of epigenome studies in humans. These studies have mostly focused on the identification of site-specific differences in DNA methylation that are associated with metabolic phenotypes.

A key question is the extent to which epigenetic modifications contribute to the development of the metabolic phenotype, rather than simply being a con- sequence of it (Fig. 1). Epigenetic programming could contribute to obesity development, as well as playing a role in consequent risk of cardiovascular and metabolic problems. In human studies, it is difficult to prove causality [44], but inferences can be made from a number of lines of evidence:

fig 1(i) Genetic association studies. Genetic polymorphisms that are associated with an increased risk of developing particular conditions are a priori linked to the causative genes. The presence of differential�methylation in such regions infers functional relevance of these epigenetic changes in controlling expression of the proximal gene(s). There are strong cis-acting genetic effects underpinning much epigenetic variation [7, 45], and in population-based studies, methods that use genetic surrogates to infer a causal or mediating role of epigenome differences have been applied [7, 46�48]. The use of familial genetic information can also lead to the identification of potentially causative candidate regions showing phenotype-related differential methylation [49].

(ii)Timing of epigenetic changes. The presence of an epigenetic mark prior to development of a phenotype is an essential feature associated with causality. Conversely, the presence of a mark in association with obesity, but not before its development, can be used to exclude causality but would not exclude a possible role in subsequent obesity-related pathology.

(iii)Plausible inference of mechanism. This refers to epigenetic changes that are associated with altered expression of genes with an established role in regulating the phenotype of interest. One such example is the association of methylation at two CpG sites at the CPT1A gene with circulating triglyceride levels [50]. CPT1A encodes carnitine palmitoyltransferase 1A, an enzyme with a central role in fatty acid metabolism, and this is strongly indicative that differential methylation of this gene may be causally related to the alterations in plasma triglyceride concentrations.

Epigenome-Wide Association Studies: Identifying Epigenetic Biomarkers Of Metabolic Health

A number of recent investigations have focused on exploring associations between obesity/metabolic diseases�and DNA methylation across the genome (Table 2). The largest published EWAS so far, including a total of 5465 individuals, identified 37 methylation sites in blood that were associated with body mass index (BMI), including sites in CPT1A, ABCG1, and SREBF1 [51]. Another large-scale study showed consistent associations between BMI and methylation in HIF3A in whole blood and adipose tissue [52], a finding which was also partially replicated in other studies [9, 51]. Other recently reported associations between obesity-related measures and DNA methylation include (i) DNA methylation differences between lean and obese individuals in LY86 in blood leukocytes [53]; (ii) associations between PGC1A promoter methylation in whole blood of children and adiposity 5 years later [54]; (iii) associations between waist-hip ratio and ADRB3 methylation in blood [55]; and (iv) associations between BMI, body fat distribution measures, and multiple DNA methylation sites in adipose tissue [9, 56]. EWAS have also shown associations between DNA methylation sites and blood lipids [55, 57�59], serum metabolites [60], insulin resistance [9, 61], and T2DM [48, 62, 63] (Table 2).

table 2 contdFrom these studies, altered methylation of PGC1A, HIF3A, ABCG1, and CPT1A and the previously described RXRA [18] have emerged as biomarkers associated with, or perhaps predictive of, metabolic health that are also plausible candidates for a role in development of metabolic disease.

Interaction Between Genotype And The Epigenome

Genotype EpigenomeEpigenetic variation is highly influenced by the underlying genetic variation, with genotype estimated to explain ~20�40 % of the variation [6, 8]. Recently, a number of studies have begun to integrate methylome and genotype data to identify methylation quantitative trait loci (meQTL) associated with disease phenotypes. For instance, in adipose tissue, an meQTL overlapping�with a BMI genetic risk locus has been identified in an enhancer element upstream of ADCY3 [8]. Other studies have also identified overlaps between known obesity and T2DM risk loci and DMRs associated with obesity and T2DM [43, 48, 62]. Methylation of a number of such DMRs was also modulated by high-fat feeding in mice [43] and weight loss in humans [64]. These results identify an intriguing link between genetic variations linked with disease susceptibility and their association with regions of the genome that undergo epigenetic modifications in response to nutritional challenges, implying a causal relationship. The close connection between genetic and epigenetic variation may signify their essential roles in generating individual variation [65, 66]. However, while these findings suggest that DNA methylation may be a mediator of genetic effects, it is also important to consider that both genetic and epigenetic processes could act independently on the same genes. Twin studies [8, 63, 67] can provide important insights and indicate that inter-individual differences in levels of DNA methylation arise predominantly from non-shared environment and stochastic influences, minimally from shared environmental effects, but also with a significant impact of genetic variation.

The Impact Of The Prenatal And Postnatal Environment On The Epigenome

fetus modelPrenatal environment: Two recently published studies made use of human populations that experienced �natural� variations in nutrient supply to study the impact of maternal nutrition before or during pregnancy on DNA methylation in the offspring [68, 69]. The first study used a Gambian mother-child cohort to show that both seasonal variations in maternal methyl donor intake during pregnancy and maternal pre-pregnancy BMI were associated with altered methylation in the infants [69]. The second study utilized adult offspring from the Dutch Hunger Winter cohort to investigate the effect of prenatal exposure to an acute period of severe maternal undernutrition on DNA methylation of genes involved in growth and metabolism in adulthood [68]. The results highlighted the importance of the timing of the exposure in its impact on the epigenome, since significant epigenetic effects were only identified in individuals exposed to famine during early gestation. Importantly, the epigenetic changes occurred in conjunction with increased BMI; however, it was not possible to establish in this study whether these changes were present earlier in life or a consequence of the higher BMI.

Other recent studies have provided evidence that prenatal over-nutrition and an obese or diabetic maternal environment are also associated with DNA methylation changes in genes related to embryonic development, growth, and metabolic disease in the offspring [70�73].

While human data are scarce, there are indications that paternal obesity can lead to altered methylation of imprinted genes in the newborn [74], an effect thought to be mediated via epigenetic changes acquired during spermatogenesis.

baby walking in the grass and mudPostnatal environment: The epigenome is established de novo during embryonic development, and therefore, the prenatal environment most likely has the most significant impact on the epigenome. However, it is now clear that changes do occur in the �mature� epigenome under the influence of a range of conditions, including aging, exposure to toxins, and dietary alterations. For example, changes in DNA methylation in numerous genes in skeletal muscle and PGC1A in adipose tissue have been demonstrated in response to a high-fat diet [75, 76]. Interventions to lose body fat mass have also been associated with changes in DNA methylation. Studies have reported that the DNA methylation profiles of adipose tissue [43, 64], peripheral blood mononuclear cells [77], and muscle tissue [78] in formerly obese patients become more similar to the profiles of lean subjects following weight loss. Weight loss surgery also partially reversed non-alcoholic fatty liver disease-associated methylation changes in liver [79] and in another study led to hypomethylation of multiple obesity candidate genes, with more pronounced effects in subcutaneous compared to omental (visceral) fat [64]. Accumulating evidence suggests that exercise interventions can also influence DNA methylation. Most of these studies have been conducted in lean individuals [80�82], but one exercise study in obese T2DM subjects also demonstrated changes in DNA methylation, including in genes involved in fatty acid and glucose transport [83]. Epigenetic changes also occur with aging, and recent data suggest a role of obesity in augmenting them [9, 84, 85]. Obesity accelerated the epigenetic age of liver tissue, but in contrast to the findings described above, this effect was not reversible after weight loss [84].

Collectively, the evidence in support of the capacity to modulate the epigenome in adults suggests that there may be the potential to intervene in postnatal life to modulate or reverse adverse epigenetic programming.

Effect Sizes And Differences Between Tissue Types

connective tissuesDNA methylation changes associated with obesity or induced by diet or lifestyle interventions and weight loss are generally modest (<15 %), although this varies depending on the phenotype and tissue studied. For instance, changes greater than 20 % have been reported in adipose tissue after weight loss [64] and associations between HIF3A methylation and BMI in adipose tissue were more pronounced than in blood [52].

The biological relevance of relatively small methylation changes has been questioned. However, in tissues consisting of a mixture of cell types, a small change in DNA methylation may actually reflect a significant change in a specific cell fraction. Integration of epigenome data with transcriptome and other epigenetic data, such as histone modifications, is important, since small DNA methylation changes might reflect larger changes in chromatin structure and could be associated with broader changes in gene expression. The genomic context should also be considered; small changes within a regulatory element such as a promotor, enhancer, or insulator may have functional significance. In this regard, DMRs for obesity, as well as regions affected by prenatal famine exposure and meQTL for metabolic trait loci have been observed to overlap enhancer elements [8, 43, 68]. There is evidence that DNA methylation in famine-associated regions could indeed affect enhancer activity [68], supporting a role of nutrition-induced methylation changes in gene regulation.

A major limitation in many human studies is that epigenetic marks are often assessed in peripheral blood, rather than in metabolically relevant tissues (Fig. 2). The heterogeneity of blood is an issue, since different cell populations have distinct epigenetic signatures, but algorithms have been developed to estimate the cellular composition to overcome this problem [86]. Perhaps more importantly, epigenetic marks in blood cells may not necessarily report the status of the tissues of primary interest. Despite this, recent studies have provided clear evidence of a relationship between epigenetic marks in blood cells and BMI. In the case of HIF3A for which the level of methylation (beta-value) in the study population ranged from 0.14�0.52, a 10 % increase in methylation was associated with a BMI increase of 7.8 %�[52]. Likewise, a 10 % difference in PGC1A methylation may predict up to 12 % difference in fat mass [54].

fig 2Conclusions

The study of the role of epigenetics in obesity and metabolic disease has expanded rapidly in recent years, and evidence is accumulating of a link between epigenetic modifications and metabolic health outcomes in humans. Potential epigenetic biomarkers associated with obesity and metabolic health have also emerged from recent studies. The validation of epigenetic marks in multiple cohorts, the fact that several marks are found in genes with a plausible function in obesity and T2DM development, as well as the overlap of epigenetic marks with known obesity and T2DM genetic loci strengthens the evidence that these associations are real. Causality has so far been difficult to establish; however, regardless of whether the associations are causal, the identified epigenetic marks may still be relevant as biomarkers for obesity and metabolic disease risk.

Effect sizes in easily accessible tissues such as blood are small but do seem reproducible despite variation in ethnicity, tissue type, and analysis methods [51]. Also, even small DNA methylation changes may have biological significance. An integrative �omics� approach will be crucial in further unraveling the complex interactions between the epigenome, transcriptome, genome, and metabolic health. Longitudinal studies, ideally spanning multiple generations, are essential to establishing causal relationships. We can expect more such studies in the future, but this will take time.

While animal studies continue to demonstrate an effect of early life nutritional exposure on the epigenome and metabolic health of the offspring, human data are still limited. However, recent studies have provided clear�evidence that exposure to suboptimal nutrition during specific periods of prenatal development is associated with methylation changes in the offspring and therefore have the potential to influence adult phenotype. Animal studies will be important to verify human findings in a more controlled setting, help determine whether the identified methylation changes have any impact on metabolic health, and unravel the mechanisms underlying this intergenerational/transgenerational epigenetic regulation. The identification of causal mechanisms underlying metabolic memory responses, the mode of transmission of the phenotypic effects into successive generations, the degree of impact and stability of the transmitted trait, and the identification of an overarching and unifying evolutionary context also remain important questions to be addressed. The latter is often encapsulated by the predictive adaptive response hypothesis, i.e., a response to a future anticipated environment that increases fitness of the population. However, this hypothesis has increasingly been questioned as there is limited evidence for increased fitness later in life [87].

In summary, outcomes are promising, as the epigenetic changes are linked with adult metabolic health and they act as a mediator between altered prenatal nutrition and subsequent increased risk of poor metabolic health outcomes. New epigenetic marks have been identified that are associated with measures of metabolic health. Integration of different layers of genomic information has added further support to causal relationships, and there have been further studies showing effects of pre- and postnatal environment on the epigenome and health. While many important questions remain, recent methodological advances have enabled the types of large-scale population-based studies that will be required to address the knowledge gaps. The next decade promises to be a period of major activity in this important research area.

Susan J. van Dijk1, Ross L. Tellam2, Janna L. Morrison3, Beverly S. Muhlhausler4,5� and Peter L. Molloy1*�

Competing interests

The authors declare that they have no competing interests.

Authors� contributions
All authors contributed to the drafting and critical revision of the manuscript, and all authors read and approved the final manuscript.

Authors� information
Beverly S. Muhlhausler and Peter L. Molloy are joint last authors.

Acknowledgements

This work has been supported by a grant from the Science and Industry Endowment Fund (Grant RP03-064). JLM and BSM are supported by the National Health and Medical Research Council Career Development Fellowships (JLM, APP1066916; BSM, APP1004211). We thank Lance Macaulay and Sue Mitchell for critical reading and comments on the manuscript.

Author details

1CSIRO Food and Nutrition Flagship, PO Box 52, North Ryde, NSW 1670, Australia. 2CSIRO Agriculture Flagship, 306 Carmody Road, St Lucia, QLD 4067, Australia. 3Early Origins of Adult Health Research Group, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia�4FOODplus Research Centre, Waite Campus, The University of Adelaide, PMB 1, Glen Osmond, SA 5064, Australia. 5Women�s and Children�s Health Research Institute, 72 King William Road, North Adelaide, SA 5006, Australia.

Blank
References:

1. WHO. WHO | Overweight and obesity. http://www.who.int/gho/ncd/
risk_factors/overweight/en/index.html. Accessed 29 January 2015.
2. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery.
Am J Hum Genet. 2012;90:7�24.
3. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic
studies of body mass index yield new insights for obesity biology. Nature.
2015;518:197�206.
4. Ling C, Del Guerra S, Lupi R, R�nn T, Granhall C, Luthman H, et al.
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and
effect on insulin secretion. Diabetologia. 2008;51:615�22.
5. Van Dijk SJ, Molloy PL, Varinli H, Morrison JL, Muhlhausler BS. Epigenetics
and human obesity. Int J Obes (Lond). 2015;39:85�97.
6. Teh AL, Pan H, Chen L, Ong M-L, Dogra S, Wong J, et al. The effect of
genotype and in utero environment on interindividual variation in neonate
DNA methylomes. Genome Res. 2014;24:1064�74.
7. Olsson AH, Volkov P, Bacos K, Dayeh T, Hall E, Nilsson EA, et al. Genomewide
associations between genetic and epigenetic variation influence
mRNA expression and insulin secretion in human pancreatic islets. PLoS
Genet. 2014;10:e1004735.
8. Grundberg E, Meduri E, Sandling JK, Hedman AK, Keildson S, Buil A, et al.
Global analysis of DNA methylation variation in adipose tissue from twins
reveals links to disease-associated variants in distal regulatory elements.
Am J Hum Genet. 2013;93:876�90.
9. Ronn T, Volkov P, Gillberg L, Kokosar M, Perfilyev A, Jacobsen AL, et al.
Impact of age, BMI and HbA1c levels on the genome-wide DNA
methylation and mRNA expression patterns in human adipose tissue
and identification of epigenetic biomarkers in blood. Hum Mol Genet.
2015;24:3792�813.
10. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental
origins hypothesis. Annu Rev Nutr. 2007;27:363�88.
11. McMillen IC, Rattanatray L, Duffield JA, Morrison JL, MacLaughlin SM, Gentili
S, et al. The early origins of later obesity: pathways and mechanisms. Adv
Exp Med Biol. 2009;646:71�81.
12. Ravelli A, van der Meulen J, Michels R, Osmond C, Barker D, Hales C, et al.
Glucose tolerance in adults after prenatal exposure to famine. Lancet.
1998;351:173�7.
13. McMillen IC, MacLaughlin SM, Muhlhausler BS, Gentili S, Duffield JL,
Morrison JL. Developmental origins of adult health and disease: the role of
periconceptional and foetal nutrition. Basic Clin Pharmacol Toxicol.
2008;102:82�9.
14. Zhang S, Rattanatray L, McMillen IC, Suter CM, Morrison JL. Periconceptional
nutrition and the early programming of a life of obesity or adversity. Prog
Biophys Mol Biol. 2011;106:307�14.
15. Bouret S, Levin BE, Ozanne SE. Gene-environment interactions controlling
energy and glucose homeostasis and the developmental origins of obesity.
Physiol Rev. 2015;95:47�82.
16. Borengasser SJ, Zhong Y, Kang P, Lindsey F, Ronis MJ, Badger TM, et al.
Maternal obesity enhances white adipose tissue differentiation and alters
genome-scale DNA methylation in male rat offspring. Endocrinology.
2013;154:4113�25.
17. Gluckman PD, Lillycrop KA, Vickers MH, Pleasants AB, Phillips ES, Beedle AS,
et al. Metabolic plasticity during mammalian development is directionally
dependent on early nutritional status. Proc Natl Acad Sci U S A.
2007;104:12796�800.
18. Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C,
et al. Epigenetic gene promoter methylation at birth is associated with
child�s later adiposity. Diabetes. 2011;60:1528�34.
19. McMillen IC, Adam CL, Muhlhausler BS. Early origins of obesity:
programming the appetite regulatory system. J Physiol. 2005;565(Pt 1):9�17.
20. Begum G, Stevens A, Smith EB, Connor K, Challis JR, Bloomfield F, et al.
Epigenetic changes in fetal hypothalamic energy regulating pathways are
associated with maternal undernutrition and twinning. FASEB J.
2012;26:1694�703.
21. Ge ZJ, Liang QX, Hou Y, Han ZM, Schatten H, Sun QY, et al. Maternal obesity
and diabetes may cause DNA methylation alteration in the spermatozoa of
offspring in mice. Reprod Biol Endocrinol. 2014;12:29.
22. Jousse C, Parry L, Lambert-Langlais S, Maurin AC, Averous J, Bruhat A, et al.
Perinatal undernutrition affects the methylation and expression of the leptin
gene in adults: implication for the understanding of metabolic syndrome.
FASEB J. 2011;25:3271�8.
23. Lan X, Cretney EC, Kropp J, Khateeb K, Berg MA, Penagaricano F, et al.
Maternal diet during pregnancy induces gene expression and DNA
methylation changes in fetal tissues in sheep. Front Genet. 2013;4:49.
24. Li CC, Young PE, Maloney CA, Eaton SA, Cowley MJ, Buckland ME, et al.
Maternal obesity and diabetes induces latent metabolic defects and
widespread epigenetic changes in isogenic mice. Epigenetics. 2013;8:602�11.
25. Lillycrop KA, Phillips ES, Jackson AA, Hanson MA, Burdge GC. Dietary protein
restriction of pregnant rats induces and folic acid supplementation prevents
epigenetic modification of hepatic gene expression in the offspring. J Nutr.
2005;135:1382�6.
26. Radford EJ, Ito M, Shi H, Corish JA, Yamazawa K, Isganaitis E, et al. In utero
effects. In utero undernourishment perturbs the adult sperm methylome
and intergenerational metabolism. Science. 2014;345(80):1255903.
27. Suter M, Bocock P, Showalter L, Hu M, Shope C, McKnight R, et al.
Epigenomics: maternal high-fat diet exposure in utero disrupts
peripheral circadian gene expression in nonhuman primates. FASEB J.
2011;25:714�26.
28. Suter MA, Ma J, Vuguin PM, Hartil K, Fiallo A, Harris RA, et al. In utero
exposure to a maternal high-fat diet alters the epigenetic histone code in a
murine model. Am J Obs Gynecol. 2014;210:463 e1�463 e11.
29. Tosh DN, Fu Q, Callaway CW, McKnight RA, McMillen IC, Ross MG, et al.
Epigenetics of programmed obesity: alteration in IUGR rat hepatic IGF1
mRNA expression and histone structure in rapid vs. delayed postnatal
catch-up growth. Am J Physiol Gastrointest Liver Physiol.
2010;299:G1023�9.
30. Sandovici I, Smith NH, Nitert MD, Ackers-Johnson M, Uribe-Lewis S, Ito Y,
et al. Maternal diet and aging alter the epigenetic control of a promoterenhancer
interaction at the Hnf4a gene in rat pancreatic islets. Proc Natl
Acad Sci U S A. 2011;108:5449�54.
31. Braunschweig M, Jagannathan V, Gutzwiller A, Bee G. Investigations on
transgenerational epigenetic response down the male line in F2 pigs. PLoS
One. 2012;7, e30583.
32. Carone BR, Fauquier L, Habib N, Shea JM, Hart CE, Li R, et al. Paternally
induced transgenerational environmental reprogramming of metabolic
gene expression in mammals. Cell. 2010;143:1084�96.
33. Ost A, Lempradl A, Casas E, Weigert M, Tiko T, Deniz M, et al. Paternal diet
defines offspring chromatin state and intergenerational obesity. Cell.
2014;159:1352�64.
34. Mart�nez D, Pentinat T, Rib� S, Daviaud C, Bloks VW, Cebri� J, et al. In utero
undernutrition in male mice programs liver lipid metabolism in the secondgeneration
offspring involving altered Lxra DNA methylation. Cell Metab.
2014;19:941�51.
35. Wei Y, Yang C-R, Wei Y-P, Zhao Z-A, Hou Y, Schatten H, et al. Paternally
induced transgenerational inheritance of susceptibility to diabetes in
mammals. Proc Natl Acad Sci U S A. 2014;111:1873�8.
36. Grossniklaus U, Kelly WG, Kelly B, Ferguson-Smith AC, Pembrey M, Lindquist
S. Transgenerational epigenetic inheritance: how important is it? Nat Rev
Genet. 2013;14:228�35.
37. Pembrey M, Saffery R, Bygren LO. Human transgenerational responses to
early-life experience: potential impact on development, health and
biomedical research. J Med Genet. 2014;51:563�72.
38. Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl
supplements affect agouti gene expression in Avy/a mice. FASEB J.
1998;12:949�57.
39. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility.
Nat Rev Genet. 2007;8:253�62.
40. Morgan HD, Sutherland HG, Martin DI, Whitelaw E. Epigenetic inheritance at
the agouti locus in the mouse. Nat Genet. 1999;23:314�8.
41. Cropley JE, Suter CM, Beckman KB, Martin DI. Germ-line epigenetic
modification of the murine A vy allele by nutritional supplementation. Proc
Natl Acad Sci U S A. 2006;103:17308�12.
42. Hoile SP, Lillycrop KA, Thomas NA, Hanson MA, Burdge GC. Dietary protein
restriction during F0 pregnancy in rats induces transgenerational changes in
the hepatic transcriptome in female offspring. PLoS One. 2011;6, e21668.
43. Multhaup ML, Seldin MM, Jaffe AE, Lei X, Kirchner H, Mondal P, et al. Mousehuman
experimental epigenetic analysis unmasks dietary targets and
genetic liability for diabetic phenotypes. Cell Metab. 2015;21:138�49.
44. Michels KB, Binder AM, Dedeurwaerder S, Epstein CB, Greally JM, Gut I, et al.
Recommendations for the design and analysis of epigenome-wide
association studies. Nat Methods. 2013;10:949�55.
45. Dayeh TA, Olsson AH, Volkov P, Almgren P, R�nn T, Ling C. Identification of
CpG-SNPs associated with type 2 diabetes and differential DNA methylation
in human pancreatic islets. Diabetologia. 2013;56:1036�46.
46. Relton CL, Davey Smith G. Two-step epigenetic Mendelian randomization: a
strategy for establishing the causal role of epigenetic processes in pathways
to disease. Int J Epidemiol. 2012;41:161�76.
47. Liu Y, Aryee MJ, Padyukov L, Fallin MD, Hesselberg E, Runarsson A, et al.
Epigenome-wide association data implicate DNA methylation as an
intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol.
2013;31:142�7.
48. Yuan W, Xia Y, Bell CG, Yet I, Ferreira T, Ward KJ, et al. An integrated
epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic
twins. Nat Commun. 2014;5:5719.
49. Nitert MD, Dayeh T, Volkov P, Elgzyri T, Hall E, Nilsson E, et al. Impact of an
exercise intervention on DNA methylation in skeletal muscle from firstdegree
relatives of patients with type 2 diabetes. Diabetes. 2012;61:3322�32.
50. Gagnon F, A�ssi D, Carri� A, Morange P-E, Tr�gou�t D-A. Robust validation of
methylation levels association at CPT1A locus with lipid plasma levels.
J Lipid Res. 2014;55:1189�91.
51. Demerath EW, Guan W, Grove ML, Aslibekyan S, Mendelson M, Zhou Y-H,
et al. Epigenome-wide association atudy (EWAS) of BMI, BMI change, and
waist circumference in African American adults identifies multiple replicated
loci. Hum Mol Genet. 2015:ddv161�.
52. Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, A�ssi D, Wahl S, et al. DNA
methylation and body-mass index: a genome-wide analysis. Lancet.
2014;6736:1�9.
53. Su S, Zhu H, Xu X, Wang X, Dong Y, Kapuku G, et al. DNA methylation of
the LY86 gene is associated with obesity, insulin resistance, and
inflammation. Twin Res Hum Genet. 2014;17:183�91.
54. Clarke-Harris R, Wilkin TJ, Hosking J, Pinkney J, Jeffery AN, Metcalf BS, et al.
PGC1? promoter methylation in blood at 5�7 years predicts adiposity from
9 to 14 years (EarlyBird 50). Diabetes. 2014;63:2528�37.
55. Guay S-P, Brisson D, Lamarche B, Biron S, Lescelleur O, Biertho L, et al.
ADRB3 gene promoter DNA methylation in blood and visceral adipose
tissue is associated with metabolic disturbances in men. Epigenomics.
2014;6:33�43.
56. Agha G, Houseman EA, Kelsey KT, Eaton CB, Buka SL, Loucks EB. Adiposity is
associated with DNA methylation profile in adipose tissue. Int J Epidemiol.
2014:1�11.
57. Irvin MR, Zhi D, Joehanes R, Mendelson M, Aslibekyan S, Claas SA, et al.
Epigenome-wide association study of fasting blood lipids in the genetics of
lipid-lowering drugs and diet network study. Circulation. 2014;130:565�72.
58. Frazier-Wood AC, Aslibekyan S, Absher DM, Hopkins PN, Sha J, Tsai MY, et al.
Methylation at CPT1A locus is associated with lipoprotein subfraction
profiles. J Lipid Res. 2014;55:1324�30.
59. Pfeifferm L, Wahl S, Pilling LC, Reischl E, Sandling JK, Kunze S, et al. DNA
methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc
Genet. 2015.
60. Petersen A-K, Zeilinger S, Kastenm�ller G, R�misch-Margl W, Brugger M, Peters
A, et al. Epigenetics meets metabolomics: an epigenome-wide association
study with blood serum metabolic traits. Hum Mol Genet. 2014;23:534�45.
61. Hidalgo B, Irvin MR, Sha J, Zhi D, Aslibekyan S, Absher D, et al. Epigenomewide
association study of fasting measures of glucose, insulin, and HOMA-IR
in the genetics of lipid lowering drugs and diet network study. Diabetes.
2014;63:801�7.
62. Dayeh T, Volkov P, Sal� S, Hall E, Nilsson E, Olsson AH, et al. Genome-wide
DNA methylation analysis of human pancreatic islets from type 2 diabetic
and non-diabetic donors identifies candidate genes that influence insulin
secretion. PLoS Genet. 2014;10, e1004160.
63. Nilsson E, Jansson PA, Perfilyev A, Volkov P, Pedersen M, Svensson MK, et al.
Altered DNA methylation and differential expression of genes influencing
metabolism and inflammation in adipose tissue from subjects with type 2
diabetes. Diabetes. 2014;63:2962�76.
64. Benton MC, Johnstone A, Eccles D, Harmon B, Hayes MT, Lea RA, et al. An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight
loss. Gene. 2015;16:1�21.
65. Bateson P, Gluckman P. Plasticity and robustness in development and
evolution. Int J Epidemiol. 2012;41:219�23.
66. Feinberg AP, Irizarry RA, Feinberg AP, Irizarry RA. Evolution in health and
medicine Sackler colloquium: stochastic epigenetic variation as a driving
force of development, evolutionary adaptation, and disease. Proc Natl Acad
Sci U S A. 2010;107(Suppl):1757�64.
67. Martino D, Loke YJ, Gordon L, Ollikainen M, Cruickshank MN, Saffery R, et al.
Longitudinal, genome-scale analysis of DNA methylation in twins from birth
to 18 months of age reveals rapid epigenetic change in early life and pairspecific
effects of discordance. Genome Biol. 2013;14:R42.
68. Tobi EW, Goeman JJ, Monajemi R, Gu H, Putter H, Zhang Y, et al. DNA
methylation signatures link prenatal famine exposure to growth and
metabolism. Nat Commun. 2014;5:5592.
69. Dominguez-Salas P, Moore SE, Baker MS, Bergen AW, Cox SE, Dyer RA, et al.
Maternal nutrition at conception modulates DNA methylation of human
metastable epialleles. Nat Commun. 2014;5:3746.
70. Quilter CR, Cooper WN, Cliffe KM, Skinner BM, Prentice PM, Nelson L, et al.
Impact on offspring methylation patterns of maternal gestational diabetes
mellitus and intrauterine growth restraint suggest common genes and
pathways linked to subsequent type 2 diabetes risk. FASEB J. 2014:1�12.
71. Morales E, Groom A, Lawlor DA, Relton CL. DNA methylation signatures in
cord blood associated with maternal gestational weight gain: results from
the ALSPAC cohort. BMC Res Notes. 2014;7:278.
72. Ruchat SM, Houde AA, Voisin G, St-Pierre J, Perron P, Baillargeon JP, et al.
Gestational diabetes mellitus epigenetically affects genes predominantly
involved in metabolic diseases. Epigenetics. 2013;8:935�43.
73. Liu X, Chen Q, Tsai H-J, Wang G, Hong X, Zhou Y, et al. Maternal
preconception body mass index and offspring cord blood DNA
methylation: exploration of early life origins of disease. Environ Mol
Mutagen. 2014;55:223�30.
74. Soubry A, Murphy SK, Wang F, Huang Z, Vidal AC, Fuemmeler BF, et al.
Newborns of obese parents have altered DNA methylation patterns at
imprinted genes. Int J Obes (Lond). 2015;39:650�7.
75. Jacobsen SC, Br�ns C, Bork-Jensen J, Ribel-Madsen R, Yang B, Lara E, et al.
Effects of short-term high-fat overfeeding on genome-wide DNA
methylation in the skeletal muscle of healthy young men. Diabetologia.
2012;55:3341�9.
76. Gillberg L, Jacobsen SC, R�nn T, Br�ns C, Vaag A. PPARGC1A DNA
methylation in subcutaneous adipose tissue in low birth weight subjects�
impact of 5 days of high-fat overfeeding. Metabolism. 2014;63:263�71.
77. Huang Y-T, Maccani JZJ, Hawley NL, Wing RR, Kelsey KT, McCaffery JM.
Epigenetic patterns in successful weight loss maintainers: a pilot study. Int J
Obes (Lond). 2015;39:865�8.
78. Barres R, Kirchner H, Rasmussen M, Yan J, Kantor FR, Krook A, N�slund E,
Zierath JR. Weight loss after gastric bypass surgery in human obesity
remodels promoter methylation. Cell Rep. 2013:1�8.
79. Ahrens M, Ammerpohl O, von Sch�nfels W, Kolarova J, Bens S, Itzel T, et al.
DNA methylation analysis in nonalcoholic fatty liver disease suggests
distinct disease-specific and remodeling signatures after bariatric surgery.
Cell Metab. 2013;18:296�302.
80. Voisin S, Eynon N, Yan X, Bishop DJ. Exercise training and DNA methylation
in humans. Acta Physiol (Oxf). 2014;213:39�59.
81. Lindholm ME, Marabita F, Gomez-Cabrero D, Rundqvist H, Ekstr�m TJ,
Tegn�r J, et al. An integrative analysis reveals coordinated reprogramming
of the epigenome and the transcriptome in human skeletal muscle after
training. Epigenetics. 2014;9:1557�69.
82. Denham J, O�Brien BJ, Marques FZ, Charchar FJ. Changes in the leukocyte
methylome and its effect on cardiovascular related genes after exercise.
J Appl Physiol. 2014:jap.00878.2014.
83. Rowlands DS, Page RA, Sukala WR, Giri M, Ghimbovschi SD, Hayat I, et al.
Multi-omic integrated networks connect DNA methylation and miRNA with
skeletal muscle plasticity to chronic exercise in type 2 diabetic obesity.
Physiol Genomics. 2014;46:747�65.
84. Horvath S, Erhart W, Brosch M, Ammerpohl O, von Schonfels W, Ahrens M,
et al. Obesity accelerates epigenetic aging of human liver. Proc Natl Acad
Sci. 2014;111:15538�43.
85. Alm�n MS, Nilsson EK, Jacobsson JA, Kalnina I, Klovins J, Fredriksson R, et al.
Genome-wide analysis reveals DNA methylation markers that vary with
both age and obesity. Gene. 2014.;548:61�7
86. Houseman EA, Molitor J, Marsit CJ. Reference-free cell mixture adjustments
in analysis of DNA methylation data. Bioinformatics. 2014;30:1431�9.
87. Wells JC. A critical appraisal of the predictive adaptive response hypothesis.
Int J Epidemiol. 2012;41:229�35.
88. Williams-Wyss O, Zhang S, MacLaughlin SM, Kleemann D, Walker SK, Suter
CM, et al. Embryo number and periconceptional undernutrition in the
sheep have differential effects on adrenal epigenotype, growth, and
development. Am J Physiol Endocrinol Metab. 2014;307:E141�50.
89. Zhang S, Rattanatray L, Morrison JL, Nicholas LM, Lie S, McMillen IC.
Maternal obesity and the early origins of childhood obesity: weighing up
the benefits and costs of maternal weight loss in the periconceptional
period for the offspring. Exp Diabetes Res. 2011;2011:585749.
90. Zhang S, Williams-Wyss O, MacLaughlin SM, Walker SK, Kleemann DO, Suter
CM, et al. Maternal undernutrition during the first week after conception
results in decreased expression of glucocorticoid receptor mRNA in the
absence of GR exon 17 hypermethylation in the fetal pituitary in late
gestation. J Dev Orig Heal Dis. 2013;4:391�401.
91. Lie S, Morrison JL, Williams-Wyss O, Suter CM, Humphreys DT, Ozanne SE,
et al. Periconceptional undernutrition programs changes in insulin-signaling
molecules and microRNAs in skeletal muscle in singleton and twin fetal
sheep. Biol Reprod. 2014;90:5.
92. Van Straten EM, van Meer H, Huijkman NC, van Dijk TH, Baller JF, Verkade
HJ, et al. Fetal liver X receptor activation acutely induces lipogenesis but
does not affect plasma lipid response to a high-fat diet in adult mice. Am J
Physiol Endocrinol Metab. 2009;297:E1171�8.
93. Fernandez-Twinn DS, Alfaradhi MZ, Martin-Gronert MS, Duque-Guimaraes
DE, Piekarz A, Ferland-McCollough D, et al. Downregulation of IRS-1 in
adipose tissue of offspring of obese mice is programmed cellautonomously
through post-transcriptional mechanisms. Mol Metab.
2014;3:325�33.
94. Waterland RA, Travisano M, Tahiliani KG. Diet-induced hypermethylation at
agouti viable yellow is not inherited transgenerationally through the female.
FASEB J. 2007;21:3380�5.
95. Ge ZJ, Luo SM, Lin F, Liang QX, Huang L, Wei YC, et al. DNA methylation in
oocytes and liver of female mice and their offspring: effects of high-fat-dietinduced
obesity. Env Heal Perspect. 2014;122:159�64.
96. Ollikainen M, Ismail K, Gervin K, Kyll�nen A, Hakkarainen A, Lundbom J, et al.
Genome-wide blood DNA methylation alterations at regulatory elements
and heterochromatic regions in monozygotic twins discordant for obesity
and liver fat. Clin Epigenetics. 2015;7:1�13.

Close Accordion
Mastodon